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   Introduction 
1. Introduction. 
The interest in compounds containing rings in the C10 – C20 range stems from the 
discovery of their importance in many natural products or biologically active 
compounds. Since then, the development of synthetic methods for the formation of 
macrocyclic compounds has increased enormously and the construction of large rings 
with appropriately situated functional groups poses a synthetic challenge of substantial 
utility. Among methods employed directed ring-closing reactions of open chain 
precursors of bifunctional molecules is described by Illuminati and Mandolini1. In the 
1920s and 1930s Ruzicka et al.2 and Ziegler et al.3 studied macrocyclization reactions. 
Macrocyclic ring formation requires an intramolecular cyclization reaction of a 
bifunctional molecule such as 1 (Scheme 1), where cyclisation gives the macrocycle 2. 
In this model, X and Y are reactive functional groups that generate a new group Z 
(which could contain X, Y or both). An important reaction, which competes with 
cyclization, is the intermolecular reaction where initial coupling generates the dimeric 
product 3. Repeated intermolecular reactions give the oligomer or polymer 4 (Scheme 
1).  
 
 
Scheme 1: Intramolecular cyclization reaction of a bifunctional molecule (1)  
 
Ruggli discovered that high substrate concentrations favor polymerization while low 
concentrations favor cyclization4. The rate of cyclization is a function of the structure of 
the open-chain precursor and that of the product-like transition state. The activation 
energy for ring closure is largely determined by the strain energy of the final ring5. 
X
Y
Z
Z
Y
X
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n
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   Introduction 
Strain energy is due to 1) bond opposition forces due to imperfect staggering (Pitzer 
strain), 2) deformation of the ring bond angles (Baeyer strain) and 3) transannular strain 
due to repulsive interactions between atoms across the ring when they are forced close 
to each other1,6. As the chain length increases for a cyclization reaction, the probability 
of the chain terminals approaching each other decrease (negative ∆S‡ due to less 
freedom of internal rotation around single bonds of the molecular backbone when the 
disordered, open chain precursor is converted into the ring shaped transition state). In 
general, the ring product is a good model of the transition state of cyclization for the 
shorter chains7. In short chains, there is an advantage in terms of entropy but it is offset 
by enthalpy due to extremely large strain energies. Ziegler first used this principle of a 
ring-shaped transition state to generate large membered rings by the high dilution 
method8. A strategy to overcome the entropic factors cited above is to make use of 
cyclic compounds (such as cycloalkanones) converting these via ring expansion or 
contraction. The synthesis of macrocycles by means of a ring enlargement strategy are 
performed using different reaction types which could be classified according to the 
number of atoms being incorporated in the ring enlargement step. For example, 
carbocyclic compounds augmented by one atom could be achieved by Wolff 
rearrangement9 (Scheme 2, example a) and related reactions such as Schmidt10, Baeyer 
– Villiger11 and the Tiffenau12 reaction representing formal 1,2-migrations. Pinacol13 
and α-ketol14 type rearrangements proceed by a similar mechanism. The Wagner-
Meerwein15 (example b) and Demjanov16 (Scheme 2, example c) reactions have also 
been used for ring enlargement reactions.  
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Scheme 2: Synthesis of macrocyclic compounds by ring enlargement  
 
A second reaction could be represented by a formal 1,3-migration of allylic alcohols or 
ethers17 which could lead to (n+2)-membered rings (Scheme 3, example d). Expansion 
of cyclic compounds by four atoms can be achieved by the Cope rearrangement18 
(example e, Scheme 3). 
 
 
Scheme 3: Expansion of cyclic compounds by two or four carbon-atoms. 
n n
d)
e)
R2O
O
n n+2
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Besides the reactions mentioned so far, in which a specific number of atoms are being 
incorporated to an existing ring, there are other methods of ring enlargement, allowing 
expansions by a variable number of atoms. Examples pointing out these strategies are 
the oxidative cleavage of bridge bonds in bicyclic systems19 (example f), the α,β-enone-
alkynone fragmentation20 (example g) and the thermal cycloreversion of tricyclic [2+2]-
adducts (example h, Scheme 4). 
 
 
Scheme 4: Expansion of cyclic compounds by a variable number of carbon-atoms 
 
The advent of readily available twelve-membered ring systems provides an attractive 
starting point for rings expansion or ring contraction to gain access to larger or smaller 
rings21. Ring expansion reactions based on cyclododecanone as starting material are by 
far the most economical approaches to 15-membered macrocyclic musks. 
Musk has been used in perfumes for over 900 years22 and it is an important odor class. 
Natural sources of musk possessing macrocyclic structures mainly originate from 
animals, whose death is sometimes a prerequisite for the extraction of the musk scent.23 
As a result, the price of natural and synthetic musks, depicted in the Scheme 5, has 
always been high24. 
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Scheme 5: Natural and synthetic macrocyclic musks. 
 
While, Exaltone® was first synthesized by Ruzicka in 1926 yielding the macrocycle in 
low yields, the first industrial synthesis of compounds Exaltone® and Muscone are 
elaborated using an intramolecular acyloin condensation25. Since then, numerous 
syntheses of these cyclic ketones have been reported20a,26.One important approach is the 
three-carbon ring expansion of easily available cyclododecanone27. These attempts 
utilize mostly bicyclo[10.3.0]pentadec-1(12)-en-13-one as a precursor. Several methods 
for the synthesis of this ketone and its expansion reactions have been reported28. 
Recently, a two-carbon ring enlargement procedure, in which medium-and large-ring l-
vinylcycloalkanols are thermally isomerized at temperatures of 600 °C to about 650 °C, 
producing the isomeric ring-expanded cycloalkanones.  
 
 
 
  15
   Introduction 
 
Scheme 6: Thermo-isomerization of the corresponding ethynylic cycloalkanols 
 
This ring expansion protocol can easily be applied in the preparation of Exaltone® from 
cycloundecanone in two repetitive cycles29.  
The aim of the project presented here is to investigate a new approach towards the 
synthesis of macrocyclic musks. 2-alkenyl cyclododecanones (12) (Scheme 7), easily 
prepared from cyclododecanone (11), is chosen as starting material, and the strategy is 
depicted in the Scheme 7. The general idea is to begin from an optimization of one-pot 
tandem hydroformylation / aldol addition sequence as key step towards the formation of 
precursor of type 14 (step IV) being available after only three steps followed by a ring-
expansion (step V). Moreover, the application of the stepwise approach, directed to 
prepare the compound 14 , could allow investigating the regio-, chemo-selectivity of the 
whole process (step II and III).  
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Scheme 7: A new strategy towards the intermediates 15 in the preparation of the natural 
macrocycles musk. 
 
In general, reaction sequences combining hydroformylation with various subsequent 
transformations of the oxo-aldehydes in one pot procedures are gaining growing 
interest30,31. Aldol reactions are often observed as side products under hydroformylation 
conditions32. Then, following earlier investigations in the tandem hydroformylation / 
aldol addition different conditions are performed allowing the aldol product formation 
directly under the hydroformylation conditions. Therefore, the aim, at first is to find out 
how to control the regioselectivity of the hydroformylation reaction and how to direct 
the aldol cyclisation. 
Since its discovery, by O. Roelen33 in 1938, the hydroformylation is considered as one 
of the most important homogeneously catalyzed industrial processes. 
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Scheme 8: General scheme of hydroformylation of n-alkenes. 
 
Usually in hydroformylation of teminal alkenes are obtained two different regioisomers 
(Scheme 8). Control of the regiochemistry, the influence of the substrate as well the 
reaction parameters of the hydroformylation of terminal alkenes in the presence of 
phosphorus ligands has been extensively investigated31,34. The important discovery by 
Wilkinson35 that rhodium complexes afford active and selective hydroformylation 
catalysts under mild conditions in the presence of triphenylphosphine as a ligand 
triggered intensive research on hydroformylation, especially on ligand effects and 
mechanistic aspects. Shortly after the discovery of Wilkinson, Pruett and Smith of UCC 
reported the beneficial effect of phosphite ligands in the rhodium catalyzed 
hydroformylation of 1-octene and methyl methacrylate36. They studied a wide variety of 
phosphite and phosphine ligands36 finding out that the general trend is an increasing 
selectivity for the linear aldehyde when the electron withdrawing properties of the 
ligand increases. Moreover, the high catalytic activity of rhodium complexes modified 
by bulky phosphite system was also evident in the hydroformylation of 1-alkenes37. The 
high reactivity induced by bulky phosphite ligands has also led to the application of 
hydroformylation in functionalization of natural product derivatives that are otherwise 
hardly reactive. Syntheses of important intermediates to fine chemicals have been 
reported by hydroformylation of dihydrofuran38, glucal derivatives39 and methyl 
oleate40. 
As reported above, phosphite ligands, especially bulky phosphates, are very useful in 
rhodium-catalyzed hydroformylation because of the higher reaction rates obtained when 
compared to triphenylphosphine. An important drawback, however, is the loss of 
selectivity. The change from bulky monophosphite to bulky diphosphite ligands by 
using bisphenol linkers resulted, in several cases, in a tremendous increase of the 
selectivity towards the linear aldehyde in rhodium catalyzed hydroformylation of 1 -
alkenes41,42. The reaction rates are in general much lower than those of the bulky 
R R
R
O
+
CO / H2
O
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monophosphite system, but still relatively high if compared with the triphenylphosphine 
based catalyst. The selectivity is found to be highly dependent on the ligand structure43. 
The bridge length of the diphosphites has a large influence on the selectivity for the 
linear aldehyde. As it is found for diphosphine ligands44 the bite angle of the 
diphosphite ligands is probably an important parameter determining the selectivity of 
the hydroformylation reaction. The highest selectivities are achieved using bisphenol 
bridges. Along these lines, in 1988, a catalytic system derived from bis-organophosphite 
rhodium complex 17, which gives high n: iso ratio and operates under mild 
conditions45, has been found to affect the regioselectivity in the hydroformylation of 
terminal olefins producing a variety of ω−functionalized aldehydes46. This catalyst 
system notably demonstrates increased regioselectivity, and it is tolerant of a variety of 
potentially reactive functional groups. The active hydroformylation catalyst, presumably 
17, is generated in situ, in the presence of the substrate, by addition of the bis-
organophosphite ligand47,48 BIPHEPHOS (16) to dicarbonylacetylacetonato rhodium at 
60°C (Scheme 9). 
 
 
Scheme 9: Active hydroformylation species 17 of BIPHEPHOS (16) 
 
The synthesis of the BIPHEPHOS (16) is achieved following the method described by 
Cuny and Buchwald, starting from 3-t-butyl-4-hydroxyanisol (18) and 2, 2’-biphenol 
(20) through a three-step sequence in high yield (87%, Scheme 10). 
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Scheme 10: Synthesis of BIPHEPHOS (16) 
 
The bis-organophosphite rhodium complex 17, operating under significantly milder 
conditions, notably with increasing regioselectivity, and being tolerant of a variety of 
potentially reactive functional groups could be chosen as ligand in the hydroformylation 
of 2-alkenyl-cyclododecanones.  
As reported in the Scheme 7, following a general trend in organic chemistry49, 
hydroformylation can also be integrated into tandem or domino reaction sequences. 
Thus, reduction, nucleophilic addition, such as aldol condensation or reductive 
amination can be achieved directly under the reaction conditions of hydroformylation. 
Traditionally, the aldol reactions are carried out in protic solvents with a base or acid as 
catalyst, wherein the enol or enolate of the nucleophilic carbonyl component 22 is 
generated reversibly in the presences of the electrophilic component 2350(Scheme 11). 
 
 
Scheme 11: Aldol addition of ketone 22 with aldehyde 23. 
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Then, aldol reactions, under different catalyzed conditions, provide an efficient method 
for formation of new carbon-carbon bonds and could be used for the preparation of key 
intermediates in the synthesis of important natural products. As reported by Hegarty and 
Mann51 a variety of base-catalyzed aldolizations of tricyclic keto aldehyde 26 gives poor 
results in the construction of the stemodin skeleton 27. In contrast, reaction of 26 with a 
catalytic amount of p-TsOH results in complete conversion and production of β-
hydroxy ketone 27 in 55% yield after equilibration (Scheme 12).  
 
 
Scheme 12: Construction of stemodin skeleton 27 
 
Keto aldehyde 26 involved in an intramolecular mixed aldol reaction, such as reported 
in the Scheme 12, are intrinsically unsymmetrical, and at least two or three isomeric 
compounds are usually possible. Conditions are known in which either the ketone or the 
aldehyde could function as the nucleophilic component. 
Corey and Nozoe cyclized a keto-aldehyde in one-step in a total synthesis of 
helminthosphoral52. In this case, the aldehyde enolate of compound 28 adds to the more 
hindered ketone carbonyl to form a five-membered ring 29 (Scheme 13). The alternative 
addition of the ketone enolate to the aldehyde would give a seven-membered ring. 
 
 
 
 
 
 
 
H
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10-15%
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Scheme 13: Intramolecular aldol reaction in the synthesis of helminthosphoral52 
 
The regiochemistry of cyclisation the keto-aldehyde 30 is studied by Lalande and 
coworkers53 and the results are shown in the Scheme 14. 
 
 
Scheme 14: Chemoselectivity of intramolecular aldol condensation of keto-aldehyde 
30. 
 
In this system, aqueous KOH gives exclusively the cyclopentenyl methyl ketone 32, 
while piperidine acetate leads to cyclopentene carbaldhyde 31 (Scheme 14). 
Taking into account these observations, the keto aldehyde 33, could cyclize in three 
different ways. Moreover, under certain conditions the secondary alcohol 35 or alcohol 
37 generated could undergo dehydration resulting in α,β-unsaturated carbonyl 
compounds 36 or 38, respectively (Scheme 15). Then, controlling aldol addition 
conditions of preformed ketoaldehydes such as 33, compound of type 34, 35 or 37 could 
be obtained. 
O
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Scheme 15: Possible pathways in the aldol cyclization of compound 33 
 
As previously mentioned, aldol reactions are often observed as a side reaction under 
hydroformylation conditions. An intramolecular aldol reaction is observed in the 
hydroformylation of 1, 3-butadienes (39) forming formyl cyclopentanes (40) (Scheme 
16), in low yields54,55,56,57. 
 
 
Scheme 16: Intramolecular aldol reactions hydroformylation of 1,3-butadienes (39). 
 
The synthesis of carbocyclic rings via hydroformylation / aldol addition sequences 
starting from a variety of acyclic carbonyl compounds bearing remote olefinic 
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functions, catalyzed by the rhodium (I) complex in the presence of catalytic amounts of 
acid is also reported58. Using the bidentate diphosphite ligand BIPHEPHOS (16) the 
hydroformylation proceeds with high n-selectivity generating dicarbonyl compounds 
that undergo an intramolecular aldol reaction in a one-pot procedure.  
 
 
Scheme 17: General scheme of tandem hydroformylation / aldol addition. 
 
Thus, unsatured ketones of type 41 can undergo n-selective hydroformylation at the 
olefinic double bond followed by an intramolecular aldol addition of keto aldehyde 42 
to form 43 (Scheme 17). The second step of the sequence, the mixed aldol addition, 
usually shows high chemo- and regioselectivity in agreement with the literature59 in 
which is reported that ketone moieties and especially activated methylene groups of 
malonic acid or β-keto carboxylate derivatives act as the enol equivalent and add to the 
stronger electrophile, the oxo aldehyde function. Starting from unsymmetrical β,γ- or 
γ,δ-unsaturated ketones with C, H acidic α and α’-positions, in most cases the 
cyclisations take place via the kinetically more stable enol regioisomers generating the 
thermodynamically favored five or six-membered rings. Thus, the method offers a 
convenient access to carbocyclic aldols and α,β -unsaturated carbonyl compounds. In 
addition, this one-pot procedure could be applied in the synthesis of bicyclic products 
starting from vinyl- and allylsubstituted cycloalkanones60. Thus, starting with 3-vinyl 
substituted cyclic ketone 44, the tandem hydroformylation reaction offers an approach 
to ring annulations and bicyclic systems of type 45 (Scheme 18). 
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Scheme 18: Tandem hydroformylation / aldol addition of 3-vinyl cyclopentanone (44). 
 
Besides the synthesis of annulated carbocycles, the method also offers an access to 
spirocyclic compounds. There, the conversions of 2-allyl-cyclopentanone (46a), -
cyclohexanone (46b) and -cyclooctanone (46c) gives the spirocyclic β-hydroxy-ketones 
47a-c in medium to good yields (Scheme 19). According to the results discussed above 
the cyclisations proceed regioselectively via the keto enols of the intermediate keto 
aldehyde that generate the five-membered rings.  
 
 
Scheme 19: Syntheses of the hydroxy-spiroalkanones 47a-c. 
 
Surprisingly, if starting with 2-allyl-cyclododecanone (48) the tandem reaction does not 
lead to the spirocyclic aldol adduct (49) but the cyclisation gives the 
bicyclo[9.4.1]hexadecane 50 (Scheme 20). Presumably, formation of the quaternary 
center is avoided in this case because of lower ring strain in the large annulated ring of 
50. 
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Scheme 20: Synthesis of 12-hydroxybicyclo[9.4.1]hexadecan-16-one (50) 
 
In this project, taking into consideration the results reported above, cyclododecanone 
derivatives such as compounds 52 would be involved in the tandem hydroformylation / 
aldol addition (Scheme 21). When a tandem reaction sequence is run with 
functionalized cyclododecanones highest possible selectivity in each single 
transformation is required in order to obtain good yields for the overall sequence. Thus, 
to achieve regioselectivity in the hydroformylation of terminal, monosubstituted olefinic 
double bonds the rhodium catalyzed hydroformylation under mild conditions have to be 
run using the ligand BIPHEPHOS (16)46 which is known to be one of the most efficient 
ligands for highly n-selective hydroformylation of many functionalized olefins with 
excellent yields. As previously discussed, intramolecular aldol additions, involving 
ketoaldehyde, present problems of chemoselectivity. In order to circumvent these 
problems many investigations have been accomplished in this area.  
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Scheme 21: Preparation of substituted bicyclic cycloalkanones (54) 
 
Directed aldol additions of activated ketones in the presence of a large number of 
transition metal complexes have been tested61. Among various examples, rhodium (I) 
catalyzed reactions of enol silanes and aldehyde are investigated by Matsuda62, Reetz63 
and Heathcock64. Previous work65 has shown that a rhodium-catalyzed 
hydroformylation / Mukaiyama aldol addition of the corresponding preformed silyl enol 
ether such as compound 55 bearing remote olefinic functionalities is an effective 
method to prepare aldol adducts 57 in a one-pot procedure with good yields. Moreover, 
silyl enol ethers are reported to be stable under hydroformylation conditions84 and 
undergo selective n-hydroformylation at the olefinic double bond followed by a 
Mukaiyama type aldol addition66 (Scheme 22).  
 
 
Scheme 22: Tandem hydroformylation /aldol addition under Mukaiyama conditions 
 
52 54
O
O
51
O
R
R
R
HO
R2
n=0,1,2....
R=H, COOEt
R1= H, COOEt
R2=H, CH3
R1
R1
R1
53
O
R
R1
R2R2
OHC
(  )n ( )n(  )n
55
56 57
Me
OSiR3
Me CHO
OSiR3 OSiR3
Me
O
CO / H2
[Rh]
  27
   Introduction 
The application of the latter conditions on cyclododecanones derivatives of type 52 
could offer a new method to obtain the corresponding aldol adducts from ketoaldehydes 
and subsequently to build up a precursor of natural macrocyclic musk. 
Initial attempts to accomplish the preparation of macrocycles have been conducted, 
making use of 1,3 diketone 59 in the presence of KOH (Scheme 23). Unfortunately, the 
reaction proceeds with the formation of the retro-aldol product 60 in high yield. When 
considering the skeleton of products of type 58 and compound 50 (R=R1=H, n=1), it 
could be useful to envisage alternative ring-enlargement methods involving the cleavage 
of the keto-bridge in the presence of other functional groups in appropriate positions. 
 
 
Scheme 23: Ring-enlargement towards the preparation of compounds of type 61  
 
Along these lines, the base-promoted Grob fragmentation67 of tosylates of 
bicyclo[9.4.1]hexadecane 5068 will be investigated as well as a retro-Dieckmann 
reaction could be tested. Finally, an oxidative approach, such as Baeyer-Villiger 
oxidation followed by lactone hydrolysis could be performed. Consequently, various 
unsaturated cyclododecanone derivatives of type 52 (Scheme 21) should be prepared. 
As mentioned above by introduction or variation of the functional groups, such as –
NO2, -COOEt, -CN, the precursor 58 could undergo subsequent conversions to 
compounds of type 61 (Scheme 23). 
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2. Theoretical part 
2.1. One-pot hydroformylation / aldol addition of 2-alkenyl 
cyclododecanones and unsaturated β-ketoesters 
2.1.1. Preparation of starting materials 
2-Allyl-cyclododecanone (48) 
As stated in the introduction, choosing 2-alkenyl cyclododecanones of type 52 (Scheme 
21) as first substrates for the tandem hydroformylation / aldol addition, an efficient 
preparation of α-substituted cycloalkanones has to be developed.  
General methods to synthesize 2-alkenyl cycloalkanones are reported. These 
compounds could be obtained by alkylation of the corresponding cycloalkanones, or, 
more conveniently, by an adaptation of the Claisen rearrangement performed by heating 
the ketone with allyl alcohol and 2,2-dimethoxypropane in the presence of an acid 
catalyst69. This results in the in situ generation and thermal rearrangement of allyl vinyl 
ether intermediate. A different approach could be represented as a rearrangement of 
allyl enol carbonates, prepared from ketones or aldehydes by trapping their enolates, 
with allyl chloroformate catalyzed by Pd – phosphine under mild conditions70. 
Alternatively, oxidative additions applied to C-allylation of 1, 3-dioxo compounds by 
using allylsilanes are reported71. Oxidative additions of 1,3-dioxo compounds to alkenes 
can be initiated by use of one-electron oxidizing agents,72 such as ceric ammonium 
nitrate73 (CAN). Application of this reaction to 1, 3-dioxo compounds by using a 
combination of allyltrimethylsilane and CAN afforded the monoallylated products in 
good to excellent yields. Although combination of allyltrimethylsilane and CAN in 
methanol efficiently monoallylated most 1, 3-dioxo compounds, this method is not 
applied widely to monoketones with the only exception for conversion of 
cyclododecanone. Then, following the procedure reported by Hwu and al., the 
preparation of 2-allyl-cyclododecanone (48) is performed in the presence 1.6 eq. of 
allyltrimethylsilane (62) and 3 eq. of ceric ammonium nitrate (CAN) (Scheme 24) give 
48 in 58 % yield (R 1). 
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Scheme 24: Preparation of 2-allyl-cyclododecanone (48) in the presence of CAN. 
 
In order to improve the yield of 48, the alkylation reaction is performed by generating 
the enolate of cyclododecanone (11) and use of allylbromide as alkylating agent (63) 
(Scheme 25). Treatment of 11 with a strong base such as LDA74 (generated in situ from 
n-BuLi and DIA) allows a slightly higher yield compared to this obtained when n-
BuLi75 is used (Table 1, R 2, R 3). If the alkylation of 11 is run in the presence of a 
weaker base such as K2CO376 no product is detected in the reaction mixture and only 
starting material is recovered (Table 1, R 4). 
 
 
Scheme 25: Preparation of 2-allyl-cyclododecanone (48) 
 
In addition to the last results, an efficient and convenient method is employed if a 
solution of 11 in toluene is treated with allylbromide (63) in the presence of KOH and a 
phase transfer catalyst (dibenzo-[18]-crown-6)77. The alkylation proceeds with good 
yield (76% yield, Table 1, R 5) and 2-allyl-cyclododecanone (48) could be obtained in 
shorter reaction time.  
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Table 1: Preparation of 2-allyl-cyclododecanone (48). 
R t, [h] ϑ, [°C] Reaction conditions Yield 48, [%] 
R 2 18 20 LDA, THF 87 
R 3 20 20 n-BuLi, THF 63 
R 4 16 80 K2CO3, MeOH starting material 
R 5 6 125 KOH, toluene, dibenzo-[18]-crown-6 79 
 
2-(2-Methylprop-2-enyl)cyclododecanone (66). 
If using the tandem hydroformylation / aldol addition to prepare bicyclic compounds, 
bearing a methyl group in 1, 3 relationships to the ketone moiety, a methallyl chain has 
to be introduced. Using the same methods as reported above, the methallylation of 11 to 
synthesize 2-(2-methylprop-2-enyl)-cyclododecanone (66) is performed with 3-halo-2-
methylpropene starting from different enolate anions of cyclododecanone (11) (Scheme 
26, Table 2). 
 
 
Scheme 26: Synthesis of 2-(2-methylprop-2-enyl)-cyclododecanone (66). 
 
Table 2: Methallylation of cyclododecanone (11) 
O O
X
6611
   Base
71 - 98 %
X=Cl, 64
X=Br, 65
+
R t, [h] ϑ, [°C] Reaction conditions Yield 66, [%]
R 6 18 80 64 (X=Cl); NaH, HMPA, THF 98 
R 7 18 20 64 (X=Cl), LDA, THF SM 
R 8 18 20 65 (X=Br), LDA, THF 85 
R 9 6 125 64 (X=Cl), KOH, toluene, dibenzo-[18]-crown-6 71 
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According to the results compiled in Table 2, the methallylation of 11 is best carried out 
using HMPA and NaH78 (98%yield, R 6) but cost and safety considerations discourage 
its use for larger scale synthesis. In contrast to these results no conversion is observed 
when 3-chloro-2-methyl-1-propene (64) and LDA are used (Table 2, R 7). If using 3-
bromo-2-methyl-1-propene (65) and LDA changes the outcome of the reaction (Table 2, 
R 8) and compound 66 is obtained in good yield. However, alkylating reagent 65 is 
more expensive and this procedure is not convenient to scale up the reaction. Finally, 
similar results as compared to use of unsubstitued olefinic chains are obtained if 
compound 66 is prepared by allylation in the presence of potassium hydroxide with 
catalytic amounts of dibenzo-[18]-crown-6. This method presents an alternative route 
towards 66 with low cost and good yield77 (Table 2, R 9). 
 
2-(But-3-enyl)cyclododecanone (68). 
In contrast with to the good yields previously obtained (Table 2, R 8 - R 9), attempts to 
synthesize the 2-(but-3-enyl)cyclododecanone (68) using 4-bromobut-1-ene (67) in the 
presence of different bases, failed and only small amounts of 68 were obtained (Scheme 
27). As summerized in Table 3, in the presence of KOH and catalytic amounts of 
dibenzo-[18]-crown-6, the alkylation of 11 does not occur and only starting material is 
recovered (Table 3, R 10). In addition, the reaction performed in the presence of t-
BuOK and KI79 (R 11) does not offer an access to compound 68 (Table 3, R 12). 
Although in small yields the compound 68 is obtained if using LDA as base but the 
conversion is still too low (Table 3, R 12). 
 
 
Scheme 27: Synthesis 2-(but-3-enyl)cyclododecanone (68) 
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Table 3: Preparation of 2-but-3-enylcyclododecanone (68). 
R t, [h] ϑ, [°C] Reaction conditions Yield 68, [%] 
R 10 24 80 t-BuOK, KI, t-BuOH -- 
R 11 6 125 KOH, toluene, dibenzo-[18]-crown-6 -- 
R 12 16 20 LDA, THF 15 
 
In regard to these low yields obtained in R 10-R 12, the synthesis of 2-but-3-
enylcyclododecanone (68) alternatively could be run by making use of enamines as 
enolate equivalents. The 4-cyclododec-1-en-1-yl-morpholine (70) of 11 could be 
conveniently prepared by the usual azeotropic method80. Treatment of ketone 11 which 
reacts sluggishly with morpholine (69) in the presence of catalytic amounts of p-
TsOH·H2O under reflux, after 72 hours furnishes compound 70 in 85% yield (Scheme 
28, R 13). 
 
 
Scheme 28: Enamines as intermediates in the synthesis of 2-but-3-
enylcyclododecanone (68). 
 
Attempt for the alkylation of 70 is performed according to a general procedure, 
previously described by Borowitz et al.  using 4-bromo-but-1-ene (33) in the presence of 
butylmagnesiumchloride (Scheme 28). However, after hydrolysis with a solution of 
HCl, only cyclododecanone (11) is recovered (R 14).  
As an alternative method, the synthesis of 2-(but-3-enyl)cyclododecanone (68) could be 
achieved by use of ethyl 2-oxocyclododecane carboxylate(72) (Scheme 29). Following 
the Deslongchamps variant81, cyclododecanone (11) is, first treated with NaH and 
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diethylcarbonate (71), at reflux. Finally, by quenching with acetic acid, compound 72, 
after distillation of the crude mixture is obtained in 78% (R 15).  
 
 
Scheme 29: Preparation of 2-but-3-enyl-2-oxo-cyclododecane (68) 
 
Alkylation82 of β-keto esters 72, using 4-bromobut-1-ene (67) as the alkylating agent 
and t-BuOK as base, gives ethyl 1-but-3-enyl-2-oxo-cyclododecane carboxylate (73) in 
76 % yield (R 16) Finally, decarboxylation83 in the presence of NaOH in refluxing 
EtOH furnishes 2-(but-3-enyl)cyclododecanone (68) 85% yield (Scheme 29, R 17).  
 
Ethyl 1-allyl- 2-oxo-cyclododecane carboxylate (74). 
Among the suitable and compatible functional groups under hydroformylation 
conditions84, the ester function could be chosen and the preparation of β-ketoester could 
be performed. 
A general method to produce the compound 74 (Scheme 30) is the allylation of β-keto-
ester 72 with NaH and allylbromide85 (63). The product 74 is obtained in 78% yield, as 
a colorless crystalline solid, after recrystallization from n-hexane (R 18). 
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Scheme 30: Preparation of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
 
Alternatively, the β-keto-ester 72 is treated with t-BuOK in t-BuOH86 in the presence of 
allylbromide 63. A moderate improvement in yield (89% yield, Table 4) is observed and 
the product can be isolated without any further purification (R 19). 
 
Table 4: Preparation of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
OO
Base
Br
COOEt
COOEt
7472
+
63
78 - 89 %
R Base Solvent ϑ, [°C] Yield 74, [%] 
R 18 NaH THF 80 78 
R 19 t-BuOK t-BuOH 90 89 
 
Ethyl 1-(2-methyl-allyl)-2-oxo-cyclododecane carboxylate (75). 
To preapare compound 75, the starting material 72 is alkylated with 3-chloro-2-
methylprop-1-ene (64) in the presence of the HMPA-NaH system87 (Scheme 31). The 
product 75 is isolated in 76% yield after distillation of a crude mixture (R 20). 
 
 
Scheme 31: Preparation of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane 
carboxylate (75) 
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2.1.2. One-pot tandem hydroformylation aldol addition of 2-alkenyl 
cyclododecanones 
Tandem hydroformylation / aldol addition has been reported as an efficient and 
convenient method to transform cycloalkanones bearing remote olefinic side chains, 
into the corresponding aldol adducts. In these previous investigations, it has been found 
that p-toluenesulfonic acid (p-TsOH) is the most useful catalyst for performing these 
transformations. Using the BIPHEPHOS (16) (Scheme 9) ligand the hydroformylation 
proceeds with high n-selectivity generating keto aldehydes that undergo an 
intramolecular aldol reaction in a one-pot procedure. 
 
Conversion of 2-allyl-cyclododecanone (48). 
According to the reaction conditions optimized by C.Hollmann, the tandem 
hydroformylation / aldol addition of 2-allyl-cyclododecanone (48) is carried out with 
the Rh(CO)2(acac) catalyst in the presence of 5 mol % of p-TsOH and 4 mol % of 
BIPHEPHOS (16), under mild conditions of 20 bar of CO/H2, 100°C for 3 d (Scheme 
32). The reaction is observed to proceed with complete chemoselectivity giving 
exclusively aldol adduct 50 in 71% yield as a mixture of two diastereoisomers (11:1 
ratio) that could not completely be separated and assigned (Table 5, R 21).  
 
Scheme 32: Tandem hydroformylation / aldol cyclisation of 2-allyl-cyclododecanone 
(48)
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The tandem reaction conditions applied to compound 48 does not lead to the spirocyclic 
aldol adduct 49 nor to the five-fused compound 77 arising from the reversal of 
chemoselectivity. The formation of the quaternary center is avoided, probably, due to 
lower tension in the large annulated ring of 50 compared to those derived from its 
formation in the spirocyclic compound 49. 
 
Table 5: Tandem hydroformylation / aldol cyclisation of 2-allyl-cyclododecanone (48) 
R acid / base solvent dr Yield 50 [%], 
R 21 p-TsOH CH2Cl2 11:1 71 
R 22 DBU dioxane / EtOH -- -- 
 
Alternatively, the hydroformylation of 48 is performed under basic conditions in the 
presence of catalytic amounts of DBU (4 mol %) using a mixture of EtOH / dioxane 
(9:1) as solvent (Table 5, R 22). The presence of the linear aldehyde 76 (Scheme 32) as 
the only product of the reaction shows that the aldol cyclisation in the presence of 
transition metals such as Rh does not proceed in strongly coordinating solvents such as 
EtOH, THF or acetonitrile.  
 
 
Scheme 33: Different coordination of [Rh] in the presence of CH2Cl2 or EtOH 
 
This may be an indication that the mechanism of aldol addition in apolar solvents such 
as CH2Cl2, involves coordination of one or more aldehyde molecules at rhodium 
resulting in the formation of 78 (Scheme 33, pathway A) leading to an activation of the 
[Rh]+  + RCHO
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O R
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79
EtOH
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+
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carbonyl function88 whereas EtOH is known to be involved in Lewis acid / Lewis base 
adducts with the Rh-catalyst forming the complex 7989 (Scheme 33, pathway B). 
 
Conversion of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
The tandem hydroformylation / aldol addition of γ,δ-unsatured cycloalkanones bearing 
an ester function in α−position, such as β-ketoester 74, is performed w ith 
Rh(CO)2(acac) catalyst and BIPHEPHOS (16) (4% mol) in the presence of 5 mol % p-
TsOH under 20 bar CO/H2 (1:1) at 60°C (Scheme 34). Under these mild conditions, 
compound 74 is expected to react like allylated cyclododecanone 48 and indeed the 
reaction proceeds, although in low yields, with formation of compound 81 as a mixture 
of diastereoisomers in a ratio of 1.4: 3.2 detected by NMR analysis, whereas the n-
aldehyde 80 is generated in 90% isolated yield (R 23).  
 
 
Scheme 34: Tandem hydroformylation / aldol addition of ethyl 1-allyl-2-oxo-
cyclododecane carboxylate (74). 
 
The low reactivity of 1,6-ketoaldehyde 80 towards the aldol addition could be attributed 
to the presence of the α-substituent present in the starting material. Again compounds 
such as 82 resulting from attack of the aldehyde enolate, generated during the 
hydroformylation, on the ketone, are not formed.  
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Conversion of 2-(but-3-enyl)cyclododecanone (68). 
As it has been previously observed that the 2-allyl-cyclododecanone (48) affords the 
aldol adduct 50 when hydroformylated under mild conditions, the corresponding 
compound 85 is not observed and none of two other competitive intramolecular aldol 
additions occur (Scheme 32). Proceeding with the investigations of tandem 
hydroformylation / aldol addition of cycloalkanones bearing remote olefinic side chain, 
2-(but-3-enyl)cyclododecanone (68) is investigated. Hydroformylation is performed in 
the presence of 5 mol % of p-TsOH and BIPHEPHOS (16) under mild conditions (20 
bar of CO:H2, 60°C) (Scheme 35, R 24).  
 
 
Scheme 35: Hydroformylation aldol condensation of 2-(but-3-enyl)cyclododecanone 
(68) 
 
Only the n-product of hydroformylation 5-(2-oxo-cyclododecyl)pentanal (83) is 
observed in 87% yield (R 24). According to the Baldwins’ rule the 6-enol-endo-exo-trig 
compounds 84 and 85 should be favored. Besides Baldwins’ rule to the ketone 
enolate90, the formation of 8-membered ring of compound 86 could not occur because 
of low flexibility in the chain to attain the required approach angle (Bürgi-Dunitz 
trajectory91). However, the outcome of the reaction could mean that the required 
orientations of p-orbitals of the enolate do not have the correct angle of approach. 
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Conversion of ethyl 1-(but-3-enyl)-2-oxo-cyclododecane carboxylate (73). 
Similar to 2-but-3-enylcyclododecanone (68), compound 73 reacts, under the same mild 
conditions, to give the 1,7-ketoaldehyde 87 in 82 % yield (R 25). Once again, none of 
the aldol adducts is formed (Scheme 36) under these conditions. 
 
 
Scheme 36: Hydroformylation of ethyl 1-(but-3-enyl)-2-oxo-cyclododecane carboxylate 
(73). 
 
Conversion of 2-(2-methylprop-2-enyl)cyclododecanone (66). 
When compound 66 is converted with Rh(CO)2(acac) catalyst in the presence of 5 mol 
% p-TsOH using the relatively harsh hydroformylation conditions of 80 bar CO/H2, 100 
°C for 3d, is expected to react like the unsaturated cycloalkanone 48, which affords the 
desired aldol adduct 50 (Scheme 32). On the contrary the isomeric compound 2-(2-
methylprop-1-enyl)cyclododecanone (88) (R 26, Scheme 37) is generated in 93% yield, 
arising from a double-bond migration. This type of isomerization is known to be 
catalyzed by transition metal complexes92.  
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Scheme 37: Isomerization of double bond of 2-(2-methyl-1-propen)cyclododecanone 
(66). 
 
Compound 88 thus generated contain a triply substituted double bond, which if 
hydroformylated, should require the generation of quaternary centre unfavorable for 
steric and / or thermodynamic reasons93. Even the hydroformylation of the less 
substituted but hindered carbon of the double bond does not occur. According to the 
literature, this type of olefins is hydroformylated only under harsh conditions94 (high 
temperature95,  96  and pressure97) and in the presence of bulky ligands94a. The lack of 
reactivity towards a sequential tandem hydroformylation / aldol addition shows that 
cyclization to construct the bicyclic compound cannot be accomplished using this 
methodology.  
 
Conversion of ethyl 1-(2-methyl-allyl)-2-oxo-cyclododecane carboxylate (75). 
In analogy to the previous results concerning the tandem procedure applied on 
cycloalkanones bearing substituted olefinic chain ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-
cyclododecane carboxylate (75) undergoes isomerization of the double bond. Although 
the isomerization process is tried to be controlled by modifications of the reaction 
conditions (60 °C, 20 bar instead of 90°C and 80 bar) and its isomerized compound 91 
is formed, but not isolated (Scheme 38, R 27).  
 
 
 
 
 
88,  93%
OO
66
             CO / H2
     Rh(CO)2acac, p-TsOH
  41
   Results and discussion 
 
Scheme 38: Hydroformylation of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane 
carboxylate (75). 
 
Here, in contrast to the latter results both the keto ester 75 and isomerized ketoester 91 
undergo hydroformylation. Thus, a mixture of the branched aldehyde 90 and the n-
aldehyde 89 in a ratio of 1:2.7 (detected by NMR analysis) is obtained.  
It can be concluded from these results that although several substrates, as established in 
previous investigations in the sequential tandem hydroformylation / aldol addition, are 
able to form the aldol adducts, this procedure with starting materials such as compounds 
homoallylated cyclododecanone 68 and β-ketoester 73 and 66 could not satisfactorily be 
employed. Thus, in order to prepare bicyclic compounds other methods are needed. 
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2.2. Stepwise hydroformylation / aldol addition  
2.2.1. Introduction 
Alternatively, to the tandem procedures an aldol addition of preformed aldehydes is 
investigated. Regioselective hydroformylation of terminal olefins of type 92 (R=H), 
should lead to aldehydes of type 93 (R=H). While methallyl chains (R=CH3), under 
milder conditions preferably could form the linear aldehydes, hydroformylation of 
monosubstituted olefins leads to a mixture of linear and branched regioisomers and 
therefore requires additional regiocontrolling P ligands (Scheme 39).  
 
 
Scheme 39: Preparation of bicycle[9.n.1]cycloalkanone (94) 
 
Then, keto-aldehydes of type 93 are then used as the substrates in intramolecular aldol 
addition catalyzed by base or acid to give the aldol adduct of type 94. 
 
O O
O
R
O
HO
R
R
9392
   CO / H2
[Rh]/ Ligand
( )n ( )n
( )n
94
Acid or Base
 R=H, CH3
n=0,1,2...
2.2.2. Hydroformylation of 2-alkenyl-cyclododecanones and unsaturated β-
ketoesters 
Conversion of 2-allyl-cyclododecanone (48). 
For initial investigations towards the stepwise transformation, the hydroformylation of 
48 with catalytic amounts of Rh(CO)2(acac) (1 mol %) in CH2Cl2 under 20 bar of 
CO/H2 at 60°C is performed (Scheme 40). The regioselectivity of the reaction is 
achieved by use of 4 mol % of BIPHEPHOS (16) giving exclusively the n-aldehyde, 4-
(2-oxo-cyclododecyl)butanal (76) (Scheme 40). The results for different reaction times 
are shown in Table 6 
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Scheme 40: Hydroformylation of 2-allyl-cyclododecanone (48) 
 
Table 6: Variation of the reaction time in the hydroformylation of compound (48) 
O O
O
    [Rh] / BIPHEPHOS
7648
CO / H2
R t, [h] Yield 76, [%] 
R 28 24 67 
R 29 48 79 
R 30 72 91 
 
As indicated in Table 6 after increased reaction times (up to three days) a positive effect 
on the yield of compound 76 has been observed ranging from 67% in 24 hours to 91% 
in 72 hours (R 28, R 29, R 30). 
 
Conversion of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (66) 
Under the same reaction conditions, the hydroformylation of 74 proceeds in good yield 
to the give the corresponding n-aldehyde 80 is obtained in 87% yield (Scheme 41, R 
31). 
 
 
Scheme 41: Hydroformylation of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74). 
 
 
O O
O
    [Rh] / BIPHEPHOS
74 80
COOEt COOEtCO / H2
87%
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Conversion of 2-(2-methylprop-2-enyl)cyclododecanone (75) 
In contrast to the results obtained in hydroformylation of 2-allyl cyclododecanone (48), 
compound 66 (Scheme 42), with a methyl group at the double bond, when 
hydroformylated under similar reaction conditions, reacts with slightly lower 
conversion.  
 
 
Scheme 42: Hydroformylation of 2-(2-methylprop-2-enyl)cyclododecanone (66). 
 
The lower conversion of the reactions could be attributed to the lower reactivity of the 
substituted double bond of 6698.  
 
Table 7: Hydroformylation of 2-(2-methylprop-2-enyl)cyclododecanone (66) 
O O
O
9566
CO / H2
   
   [Rh]
R ϑ, [°C] t, [h] adr Yield 95, [%]
R 32 60 72 1:1.33 48 
R 33 100 24 1:1.33 47 
R 34 100 48 1:1.19 52 
R 35 100 72 1:1.1 62 
a)ratio calculated with respect to the CH3 
 
As summarized in Table 7, all yields are around 50% and 3-methyl-4-(2-oxo-
cyclododecyl)butanal (95) is obtained as a mixture of two diastereoisomers in 1:1.33 
ratio by NMR analysis (R 32). Thus, upon increasing the temperature, from 60°C (R 32) 
to 100°C (R 35, R 33, R 34) the conversions of 66 remain unaffected. Moreover, at this 
temperature, no double bond migration is observed.  
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Conversion of 1-(2-methyl-allyl)-ethyl 2-oxo-cyclododecane carboxylate (75) 
In contrast the hydroformyalation of substituted alkene 75 performed in the presence of 
Rh(I) (Scheme 43) leads to a mixture of compound 89 and 90 in the ratio of 1: 2.17 
detected by NMR analysis (R 36).  
 
O
90
O
COOEt
O
COOEtCO / H2, 20 bar (1:1)
Rh(acac)(CO)2
         CH2Cl275
O
COOEt
O
89
 
Scheme 43: Hydroformylation of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane 
carboxylate (75) 
 
Once again, the isomerization of the double bond followed by the hydroformylation of 
the internal double is observed. 
 
2.2.3. Intramolecular base and acid catalyzed aldol addition 
Conversion of 4-(2-oxo-cyclododecyl)butanal (76) 
As discussed in the introduction 1,6-ketoaldehydes of type 33 (Scheme 15) are 
intrinsically unsymmetrical and they could cyclize, depending on the reaction 
conditions, in three different ways. Moreover, under certain conditions the secondary 
alcohol 35 or tertiary alcohol 37 formed, could undergo dehydration resulting in 
α,β−unsaturated carbonyl compounds. Therefore, intramolecular aldolization of 76 is 
run under acidic and basic conditions. Again, as observed in the one-pot procedure (see 
Scheme 32), under acidic conditions the cyclization of the ketone enolate function with 
the aldehyde (Scheme 44) is favored and the bridged 7-membered ring of 12-
hydroxybicyclo[9.4.1]hexadecan-16-one (50) is formed. Treatment of ketoaldehyde 76 
with strong mineral acid leads to the formation of the bicyclic aldol 50 in very low yield 
when HCl99 is used (R 37, 20% yield) whereas the use of H2SO4100 in the aldolization is 
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not of interest because of the formation of an intractable mixture due to decomposition 
(R 38). 
 
 
Scheme 44: Aldol cyclization of 4-(2-oxo-cyclododecyl)butanal (76). 
 
Table 8: Aldol addition of 4-(2-oxo-cyclododecyl)butanal (76). 
50, (md)
O
O
O HO
76
Acid
R acid dr Yield [%], 50 
R 37 HCl 1:2.9 20 
R 38 H2SO4 -- 4 
 
In contrast to the results above, compound 76 undergo base-catalyzed aldol cyclisation, 
DBU101 in EtOH (Scheme 45), proceeds with good yield and the compound 50 is 
formed as a mixture of four diastereoisomers (R 39). 
 
 
Scheme 45: Aldol condensation of 4-(2-oxo-cyclododecyl)butanal (76) in the presence 
of DBU. 
 
 
 
 
50, (35%, md))
O
O
O
76
DBU / EtOH
HO
96, (17%)
O
+
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Conversion of ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate (80). 
The intramolecular aldol condensation of the 1,6 dicarbonyl compound 80 has been 
carried out under basic or acidic conditions for 20 hours and room temperature (Scheme 
46). 
 
 
Scheme 46: Preparation of ethyl 12-hydroxy-16-oxo-bicyclo [9.4.1]hexadecan 
carboxylate (81). 
 
Table 9: Intramolecular aldol addition of ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane 
carboxylate (80). 
81 (md)
O
O
O
80
HO
COOEt Base or Acid
COOEt
R Acid / base Solvent dr Yield, 81 [%] 
R 40 HCl(7N) Dioxane 1:6 35 
R 41 H2SO4 EtOH -- -- 
R 42 LDA THF 1:1.8 34 
aR 43 DBU EtOH 1:1:6 90 
a) 72 hours 
 
As listed in Table 9 the compound 80 reacts in the presence of HCl (7N) to afford 
product 81 in yield 35% as a mixture of two diastereoisomers in a ratio of 1:6 detected 
by NMR (R 40), whereas upon use of H2SO4102 an intractable mixture is formed 
resulting from decomposition (R 41). By replacing the mineral acids with bases such as 
LDA and DBU, the yields are significantly different. According to the results reported 
above best results are achieved (R 43) in the intramolecular aldol condensation if 
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DBU103 in EtOH at room temperature is used whereas use of LDA furnish the 
compound 81 in only low yield (34% yield, R 42) 
Applying the best conditions reported above, the ethyl 2-oxo-1-(5-oxo-pentyl)-
cyclododecane carboxylate (87) bearing a longer side chain treated with DBU for 20 
hours at room temperature (Scheme 47) does not give any aldol addition product (R 44). 
 
 
Scheme 47: Attempted cyclization of ethyl 2-oxo-1-(5-oxo-pentyl)-cyclododecane 
carboxylate (87) with DBU 
 
Conversion of 3-methyl-4-(2-oxo-cyclododecyl)butanal (95) 
Confirming the results obtained as with 1,6 ketoaldehyde 76 (Scheme 44) containing 
nonbranched chain, upon acid catalysis with a solution of HCl (7N) the aldol reaction of 
the 2-substituted aldehyde 95 proceeds with poor yield exclusively towards the 
formation of compound 97 as a mixture of diastereoisomers (Table 10, R 46). If H2SO4 
is used, the reaction does not occur and decomposition is again observed (Table 10, R 
47, Scheme 48).  
 
 
 
 
O
87
O
HO HO
O
84 86
COOEt
CHO
DBU, EtOH COOEt
COOEt
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97, 63% (md)
O
O
O HO
98, not observed
O
95
+acid or base
 
Scheme 48: Aldol addition under basic or acidic conditions of 3-methyl-4-(2-oxo-
cyclododecyl)butanal (95). 
 
Then, in order to test basic conditions for the preparation of 12-hydroxy-14-
methylbicyclo[9.4.1]hexadecan-16-one (97), conversion of ketoaldehyde 95 under 
identical conditions (DBU in ethanol), proceeds with good yield (Table 10, R 45) 
whereas, as observed from NMR analysis of the crude mixture, no signal is present in 
the olefinic region indicating the absence of the β,γ−unsaturated carbonyl compound 98. 
 
Table 10: Aldol addition of 3-methyl-4-(2-oxo-cyclododecyl)butanal (95). 
R Acid / Base solvent adr Yield 97, [%] 
R 45 DBU EtOH 1:2.3:1.5:1.5 63 
R 46 HCl dioxane 1:2.8 15 
R 47 H2SO4 dioxane -- -- 
a) ratio calculated with respect to the CH3 
 
In conclusion, aldol addition base-catalyzed can be employed to achieve the formation 
of bridged system where the one-pot procedurefailed, whereas stepwise acid-catalysized 
aldol reaction proceeds with lower yield or with decomposition. Unfortunately, as 
observed in the reaction performed in the presence of DBU (Scheme 32), these basic 
conditions, are often incompatible in combination with transition-metal catalyzed 
hydroformylation. Once again, other methods of activation are necessary to be 
employed such as one-pot sequential hydroformylation / Mukaiyama aldol addition of 
preformed silyl enol ethers. 
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2.3. Sequential hydroformylation / aldol addition of enol ethers 
2.3.1. The rhodium-catalyzed Mukaiyama aldol addition 
2.3.1.1. Introduction 
In order to circumvent the chemoselectivity problems in cross-aldol reaction, synthetic 
procedures have been developed by Wittig and Heme104 using lithium derivatives of 
imines. In addition, House and coworkers105 reported the use of lithium enolates and 
metal salts in the aldol condensation reaction. Prior to House, Mukaiyama106,107 and 
shortly thereafter House108, published a general method to accomplish the cross-aldol 
addition products starting silyl enol ethers of various carbonyl compounds which react 
with aldehydes and ketones in the presence of titanium tetrachloride under mild 
conditions (Scheme 49). Titanium tetrachloride is found to be a powerfully activator of 
the carbonyl carbon for nucleophilic reactions 
 
 
Scheme 49 : The Mukaiyama aldol addition reaction of enolsilanes with aldehydes or 
ketones. 
 
Silyl enol ether 99 readily attacks a carbonyl compound 100 activated by titanium 
tetrachloride (101) in a nucleophilic fashion to form trimethylsilyl chloride (103) and an 
intermediate chelate 104 (Scheme 49). Hydrolysis of this intermediate should then 
afford aldol 105. In order to follow the interest in tandem reactions which combine the 
R1 C CR2R3
O
Si(CH3)3
+ TiCl4
-(CH3)3SiCl
R4 R5
O
R4 CR2R3
O
CR4R5
O
TiCl3
+H2O
R4 CR2R3
O
CR4R5
OH
99 100
104 105
R1
C
R3R2C
O
Si(CH3)3
OC
R5 R4102
(101)
(103)
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two reaction steps described above in an efficient one-pot procedure, the application of 
a Rh-catalyzed Mukaiyama aldol reaction of preformed enol silyl ethers was 
investigated. The first example of aldol reactions between trimethylsilyl enol ethers and 
aldehydes by the aid of rhodium complex has been reported in 1986 by Matsuda58. 
Following these first results, Reetz el al.59 observed that intermediate rhodium enolates 
may be formed which in turn undergo aldol additions. Extensive investigations 
concerning the mechanism of the rhodium(I) catalysed Mukaiyama aldol reaction have 
been made by Heathcock60 and co-workers who proposed rhodium enolate and aldolate 
intermediates with a final intermolecular transfer of the silyl fragment to generate the O-
siIylated aldols (Scheme 50). Four important features must be incorporated into this 
catalytic process: (1) the rhodium enolate must be sufficiently nucleophilic to condense 
with aldehydes, (2) the rhodium aldolate complexes must be resistant to significant 
competing irreversible decomposition under the reaction conditions, (3) the rhodium-
oxygen bond in the rhodium complexes must be reactive toward the organic enol 
derivatives, and (4) the enol source and the aldehyde must not condense without the 
catalyst109.  
 
 
Scheme 50: Generalization of a rhodium-catalyzed aldol reaction 
 
According to the mechanism proposed, the formation of the rhodium enolate 106 occurs 
via transmetalation of the enolsilane, which adds to the aldehyde 107. This addition 
resulting in the formation of rhodium enolate 108 can stereoselectively be incorporated 
R1
O[Rh]
106 R
2CHO
R1 R2
O O[Rh]
R1
OSiR3
R1 R2
O OSiR3
108
107
109
110
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into the reaction by using enolsilane of a fixed geometry. Finally, a transfer of the silyl 
moiety from another enolsilane 109 follows, resulting in the formation of the final 
adduct 110 with regeneration of the reactive rhodium enolate. In previous investigations 
using [Rh(cod)Cl]2 as catalyst110, starting from unsaturated silyl enol ethers of type 111 
five membered rings of type 112 are generated, as depicted in the Scheme 51. The 
reaction proceeds with high selectivity by converting only one of two different double 
bonds to form the intermediate aldehyde.  
 
 
 
Scheme 51: Silyl enol ether in intramolecular aldol addition  
 
Using this protocol, silylated spiro compound of type 114 are obtainable if the enol silyl 
ethers 113, obtained under thermodynamical control, is used as starting materials. The 
intramolecular aldol addition proceeds with satisfying selectivities (Scheme 52). 
 
 
Scheme 52: Intramolecular aldol addition of trimethyl silyl ether 113 of 2-allyl-
cyclohexanone 
 
If starting from the silyl enol ether 115, formed under kinetic control, again, the 
spirocyclic aldol product 114 was obtained. Here obviously a rhodium catalyzed 
isomerisation of the silyl enol ether double bond to form the thermodynamically favored 
species is involved (Scheme 53). 
 
R
OTMS CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2
R
O OTMS
111 112
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2113 114
OTMS O
OTMS
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Scheme 53: Intramolecular aldol addition of trimethyl silyl ether 115  
 
At first, to investigate this procedure on the starting materials described above, a 
number of enolsilane have been prepared. Finally, the hydroformylation of these enol 
silyl ethers have been performed. 
 
115
OTMS
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2 114
O
OTMS
2.3.1.2. Preparation of trimethylsilyl enol ethers of cyclododecanones and β-
ketoesters 
A general preparative method for the synthesis of silyl enol ethers involves treatment of 
ketones with bases of sufficient strength to convert the ketones completely into their 
enolate anions. Subsequent reaction of the enolate anion(s) with excess of trimethylsilyl 
chloride produces the O-silylated product. The preparation of enolates of unsymmetrical 
ketones, such as 2-alkenyl-cyclododecanones (52) (Scheme 21) could be achieved by 
control of the reaction conditions. House and co-workers111 reported that silyl enol 
ethers, under kinetic control, are very selectively formed from ketones by using first 
lithium diisopropylamide to generate the lithium enolate at low temperarure and then O-
silylating with chlorotrimethylsilane. Paterson and al. 112 find that the method can be 
improved by generating the lithium enolate at —78° and by avoiding the aqueous work-
up to give in high yields and regioselectivities.House et al. found that silyl enol ethers, 
under thermodynamic control, are best prepared by equilibrating the mixture of silyl 
enol ethers formed by treating the ketone with triethylamine and chlorotrimethylsilane 
in dimethylformamide. The equilibration is done simply by heating the reaction mixture 
under reflux for hours or days. 
Following these observations and taking into account the investigations proposed here, 
the silyl enol ethers, under kinetic control, has to be prepared. If starting from 2-(2-
methylprop-2-enyl)-cyclododecanone (66), the required compounds 116 is synthesized 
by using TMSCl (103) and LDA, at -78°C for 4 hours (Scheme 54, R48).  
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Scheme 54: Preparation of silyl enol ethers 116 of 2-(2-methylprop-2-enyl)-
cyclododecanone (66). 
 
Upon the same reaction conditions the β-ketoester 74 and 75 with TMSCl (103) are 
converted in the silyl enol ether 116 in 79 % yield, after filtration through a short pad of 
neutral alumina. 
 
 
Scheme 55: Preparation silyl enol ethers 117 and 118 of β-ketoester. 
 
Table 11: Synthesis of silyl enol ethers 117 and 118 
OTMSO
TMSCl
66
103
+
LDA
THF
79%
116
O
TMSCl
COOEt
OTMS
COOEt
R
R=H,     74
R=CH3, 75
103
+ LDA
THF
R=H,     117
R=CH3, 118
R
Entry R Compounds Yield [%] 
R 49 H 117 78 
R 50 CH3 118 74 
 
Both reactions proceed with high yield and the compounds 117 and 118 are isolated 
after filtration of LiCl through a short pad of neutral alumina (Table 11, R 49, R 50). 
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2.3.1.3. Hydroformylation of trimethylsilyl enol ethers 
As described above, stereoselectivity can be achieved by using enolsilanes of fixed 
geometry. If starting from cyclic ketones, only E(O)-enolates are formed due to the 
geometrical requirements of the ring systems, which would cause higher strain in the Z 
(O) enolates113. In order to evaluate the behavior of these enol silyl ethers towards the 
Mukaiyama aldol addition, compound 116 is subjected to the standard conditions, 
previously optimezed . In contrast to the open chain substrates upon these conditions, 
the aldol addition of 116 does not take place and the keto aldehyde 95 is isolated after 
distillation of crude mixture (R 51, Scheme 56). 
 
 
Scheme 56: Hydroformylation of trimethyl-[12-(2-methyl-allyl)-1-cyclododece-1-
enyloxyl]-silane (116). 
 
Obviously, the trimethylsilyl enol ether is too labile under these conditions and 
decomposes under the hydroformylation conditions, thus not permitting the formation 
of rhodium enolate. 
Similar results are obtained if using 1-(2-methyl-allyl)-2-trimethylsilanoxy-cyclododec-
2-enecarboxylic acid ethyl ester (119). As can be seen in Scheme 57, under standard 
conditions for Rh-catalyzed Mukaiyama aldol addition again a desilylation process 
occurs (R 52) and the ketoester 75 is isolated as a sole product.  
 
OTMS
116
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2
    56%
O
95
CHO
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Scheme 57: Attempted hydroformylation of 1-(2-methyl-allyl)-2-trimethylsilanoxy-
cyclododec-2-enecarboxylic acid ethyl ester (118) 
 
In contrast to the substates with substituted olefinic chain 116 and 118 the O-silylated 
compound 117 (R 53) under similar conditions leads to the n-aldehyde 119 is isolated 
without hydrolyzing the silyl enolate (Scheme 58). 
 
 
Scheme 58: Hydroformylation of silyl enol ethers 117. 
 
However, by appling Mukaiyama’s aldol conditions, ethyl 1-(4-oxo-butyl)-2-
trimethylsilanoxy-cyclododec-2-ene carboxylate (119) if treated with an equimolecular 
amount of TiCl4 in CH2Cl2 at room temperature (R 54, Scheme 59) gives a 
diastereomeric mixture of compound 81 is formed whereas compound 120 is not 
observed. 
 
 
 
 
 
 
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2
    94% 75
O
COOEt
118
OTMS
COOEt
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2
     93%
OTMS
117
COOEt
OTMS
119
COOEt
CHO
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OTMS
119
COOEt CHO
TiCl4(101)
81 (md)
O
COOEt
HO
O
COOEt
TMSO
120
 
Scheme 59: Aldol addition of compound 119 under Mukaiyama conditions.  
 
Further investigations in one-pot Rh-catalyzed hydroformylation /alol addition have 
been conduct performing the reactions in the presence of more stable TBDMS-
enolsilane. 
 
2.3.1.4. Preparation of TBDM-silyl enol ethers 
Under the conditions applied for the preparation of TMS-enol silyl ether, allylated 
cyclododecanone 66 is treated with LDA and TBDMSCl (121). Unfortunately, the 
formation of O-silylated compound 122 is not observed (Scheme 60, R 55). 
 
 
Scheme 60: Attempted preparation of silyl enol ethers 122 of 2-(2-methylprop-2-enyl)-
cyclododecanone (66). 
 
In contrast, as indicated in Table 12 the reaction of compound 74 with TBDMSCl (121) 
proceeds with good yield to give the silyl compounds 123, whereas the compound 75 
leads to the silyl enol ether 124 (34% conversion detected by GC-analysis) (Scheme 
61). 
OTBDMSO
TBDMSCl
66 121
+
LDA
THF
122
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Scheme 61: Preparation of silyl enol ethers 123 and 124  
 
Table 12: Synthesis of silyl enol ethers 123 and 124  
O
TBDMSCl
COOEt
OTBDMS
COOEt
R
R=H,    74
R=CH3,75
121
+
LDA
THF
R=H,     123
R=CH3, 124
R
Entry R Compounds Yield, % 
R 56 H 123 78 
R 57 CH3 124 34a
a) Conversion detected by GC analysis. 
 
The problems met into the separation of the crude mixture do not allow the employment 
of starting compound 124 in the following investigations. 
 
2.3.1.5. Hydroformylation of TBDM-silyl enol ethers 
Results similar to TMS-enol ether reaction (Scheme 58) are observed if compound 123 
is treated with 1 mol % of [Rh(cod)Cl]2 under 80 bar of CO/H2 at 90 °C for 2d, leading 
to n-aldehyde 125. Again, no Mukaiyama aldol adducts are obtained, indicating that the 
trans-metallation of the enolsilane by the active Rh-catalyst does not occur (R 58, 
Scheme 62). 
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Scheme 62: Hydroformylation of silyl enol ethers 123. 
 
It can be concluded that the one-pot intramolecular aldol addition under Mukaiyama 
conditions proceeds with satisfying results with various types of enolsilanes , whereas 
cyclododecane derivatives appear to be unable to generate bicyclic compounds. 
Therefore, if considering the difficulties met using these procedures, an alternative 
method of enolization of ketones, followed by sequential hydroformylation / aldol 
addition has to be investigated. 
Boron enolates are highly reactive, are used as important intermediates in organic 
synthesis114 and are useful reagents for directed stereo controlled aldol reactions115. 
 
CO /H2 (1:1)
80bar, 90°C, 2d
[Rh(cod)Cl]2
CH2Cl2
    87%
OTBDMS
123
COOEt
OTBDMS
125
COOEt
CHO
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2.3.2. Enolboration / hydrofomylation / aldol addition  
2.3.2.1. Introduction 
One of the methodologies towards the preparation of boron enolates involves the 
reaction of ketone with a suitable organoboron derivative, R2BX, having a good leaving 
group, in the presence of a suitable tertiary amine. Dialkylboron chlorides in the 
presence of tertiary amines rapidly and quantitatively convert ketones into the 
corresponding enol borinates116. In fact, the poor Lewis acidity of (cy-hex)2BCl, 
combined with the relatively large steric requirements of the cyclohexyl groups, may 
contributet to prevent the non-complexation of the amines used as base. As the result, 
(cy-hex)2BCl becomes a versatile reagent which can effect the enolization in the 
presence of a wide variety of tertiary amines of variable steric requirements. In the case 
of smaller amines, such as Me2EtN, instead of abstracting the α-proton of the ketone 
leading to enolization, the amine preferentially reacts with the organoboron reagent 
forming a strong complex, resulting in a low yield. On the other hand, in the case of 
strongly sterically hindered amines, such as i-Pr2NH, the large steric requirements of the 
amine must play a major role in the observed poor yield. Only moderately hindered 
tertiary amines are efficient for quantitative enolboration.  Moreover, the R2BCl 
reagents greatly influence the stereochemistry of the enol borinate formed, making it 
possible to produce preferentially either Z(O)-or E(O)-boron enolates117 (Scheme 63). 
Indeed dicyclohexylchloroborane (cy-hex)2BCl, produces E enol borinates either 
exclusively or predominantly from various ketones118. 
 
 
Scheme 63: General preparation of Z(O)-or E(O)-boron enolates 127 and 128 
 
R1
O
R2BX, Et3N
0°C, CH2Cl2
126
R1
R2BO
R1
R2BO
Et3N HX
127 128 129
Z(O)-boron enolate E(O)-boron enolate
and / or +
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It was also observed the steric requirements of the amine influence the stereoselectivity. 
Brown119 in a systematic study to achieve an understanding of the various effects 
influencing the stereochemistry of the enolboration process, observed smaller amines 
favor formation of kinetic enolates (E(O)-boron enolate), while bulkier amines favor 
formation of thermodynamic enolates (Z(O)-boron enolate), regardless of the ketone as 
well as the organoboron reagent used. Then, the boron enolates derived from these 
acyclic ketones undergo aldol condensation. Fenzl and Koster120 demonstrated that 
boron enolate additions are highly stereoselective with the Z (O)-or E (O)-boron 
enolates giving syn (131) and anti (132) aldols, respectively (Scheme 64). 
 
 
Scheme 64: Boron enolates in aldol addition reaction. 
 
In 1957, in conjunction with a stereochemical study of the Ivanov and Reformatsky 
reactions, Zimmerman and Traxler accounted for the observed aldol diastereoselection 
by advancing the hypothesis that the reaction proceeded via a preferred chair-like 
transition state involving cooperative metal ion ligation of both the enolate and carbonyl 
substrates121. 
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Scheme 65: Different transition states for (Z) - and (E)-enolates 
 
As shown in Scheme 65 four possible transition state A, B, C, D, reflecting the different 
orientations of the enolates with respect to the aldehyde 130 as well as the (E/Z) 
geometry of the enolates 127 and 128
For trans enolates transition state B is destabilized relative to A owing to Rl↔R2 
interactions whereas for cis-enolate the transition state D is stabilized relative to C. 
Then, the syn aldol adduct (erythro) 134 is formed for the cis-enolate and anti product 
133 is observed for the trans enolate.  
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Moreover, the conversion of a number of cyclic ketones into pure (E)-enol borinates, 
required by their cyclic structures, provided aldols which analyzed predominantly or 
exclusively for the anti aldol products. Brown et al  observed excellent stereoselection 
with cyclic ketones Exclusively E enol borinates have been obtained from 
cyclopentanone (100%), cyclohexanone (98%), cycloheptanone (97%), and 
cyclooctanone (100%), confirmed by the essentially exclusive formation of anti aldols 
in the reaction of benzaldehyde at -78 °C. Excellent regioselectivities have been 
achieved with substituted cyclohexanones. In the case of 2-methylcyclohexanone, the 
kinetic enolate 136 has been obtained exclusively (Scheme 66). 
 
 
Scheme 66: Boron enolates of cyclohexanone (135). 
 
In a preliminary investigation122 concerning the suitability of rhodium catalyzed 
hydroformylation combined with aldol addition of enolborinates, it has been observed 
that a sequential enolboration / hydroformylation / aldol addition could offers an 
efficient method for preparations of aldol adducts similar to bridged system of type 54 .  
 
 
 
 
O OBR2 OBR2
R2BX, Et3N
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Et3N
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Scheme 67: Enol borinates of cyclododecanone derivatives 52 in one-pot 
hydroformylation / aldol addition 
 
Therefore, several cyclic ketones such as compounds 52 (Scheme 67) have been chosen 
as starting materials in order to test whether they are able to undergo this one-pot 
procedure. 
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2.3.2.2. Enolboration / hydroformylation / aldol addition of 2-alkenyl 
cyclododecanones 
Starting from 2-alkenyl-cyclododecanone, the boron enolate is smoothly generated in 
situ by treating of cyclic ketones with NEt3, as the base, and (cy-hex)2BCl at 0°C, under 
argon atmosphere. After approximately 40 minutes the Rh-catalyst is added and the 
reaction is carried out under 80 bar of CO/ H2 (1:1) for 24 hours at 90°C (Scheme 68). 
 
 
Scheme 68: Enolboration hydroformylation / aldol addition of 2-alkenyl-
cyclododecanone 48 and 66. 
O
R=H,     50,  20% 
R=CH3, 97
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HO
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             CO / H2
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R
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After oxidative workup of the crude reaction mixture, containing the boron chelate and 
ammonium salts under neutral conditions, aldol adducts are isolated. The regulation of 
the pH by using a pH 7 phosphate buffer is necessary to avoid the retro-aldol reaction. 
The results are summarized in Table 13. 
 
Table 13 Enolboration hydroformylation / aldol addition of 2-alkenyl-cyclododecanone 
48 and 66 
Entry R Compounds Yield, % 
R 59 H 50 20 
R 60 CH3 97 --a
a) ratio of 2.48:1 of compound  97: 66 (calculated by NMR analysis). 
 
Under these conditions, aldol additions of enolates are obtained from both cyclic 
ketones under kinetic control. The reactions proceed with high chemoselectivity but low 
yields. In contrast to the one-pot procedure under acidic conditions, the reaction of 2-
allyl-cyclododecanone (48) proceeds with drastic decrease of yield (71% to 20%). On 
the other side, the compound 66 leads to the bicycle 97 whereas the one-pot acid-
catalyzed method failed. The crude mixture analyzed by 1H-NMR analysis contains the 
bicyclic compound 97 and compound 66 in 2.48: 1 ratio (NMR calculated). Both 
reactions proceed with high degree of diastereoselectivity furnishing only one 
diastereoisomer. 
 
2.3.2.3. Enolboration / hydroformylation / aldol addition of unsaturated β-
ketoesters 
If applying the optimized reaction conditions of enolboration /hydroformylation to β-
ketoester possessing a C-3 olefinic chain in α-position, again, the bicyclic compounds 
are obtained (Scheme 69). As listed in Table 14, ethyl 1-allyl-2-oxo-cyclododecane 
carboxylate (74) reacts to form a mixture of compound 81, as a single diastereoisomer, 
and linear aldehyde 80 in 75 % and 25% yield respectively (NMR calculated) (R 62, 
Table 14). As expected the aldol addition is observed to occur in the α’-position. 
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Scheme 69: Sequential enolboration /hydroformylation / aldol addition of β-ketoester 
74 and 75 
 
Table 14: Enolboration /hydroformylation / aldol addition of β-ketoester 74 and 75 
Entry R Compounds Yield, [%] 
R 61 H 81 a75 
R 62 CH3 139 --b
a) NMR yield, b) ratio of 2:1 of compound 139: 75 (calculated by NMR analysis). 
 
With compound 75 (R 62, Table 14), although, the reaction is successful, its conversion 
proceeds to afford the corresponding aldol adduct 139 in slighly lower yield, 
presumably due to lower reactivity of the substituted double bond. Both reactions once 
again lead to the formation of only one diastereoisomers and the syn-aldol would be 
predicted. 
The suitability of this cascade reaction to form differently functionalized bicycles is 
tested starting from β-keto-ester 72. The allylation reaction in the α´-position of the  72 
is performed in the presence of 2 eq. of LDA and allylbromide (63)123 (Scheme 70, R 
63). The ethyl 3-allyl-2-oxo-cyclododecane carboxylate (140) is obtained in 87 % yield 
after purification by distillation of the crude mixture as colorless crystals. 
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Scheme 70: Sequential enolboration /hydroformylation / aldol addition of allylated β-
ketoester 140 
 
The conversion of compound 140 under the reaction conditions of enolboration / 
hydroformylation leads, once again, to the formation of the bicyclic cyclic ketone 142 
(R 64) 58% yield (calculated by NMR-analysis). The reaction proceeds with high 
degree of chemo- and regio-selectivity and only one diastereoisomer is detected 
confirming again the high diastereoselectivity of the whole process. 
In conclusion, bicyclic compounds with control of chemo- and diastereoselectivity are 
easily accessible from cyclododecanone derivatives via enolboration / hydroformylation 
/ aldol addition. This convenient and efficient one-pot method allows variations of the 
substitutents leading to cyclisation products with the same substitution patterns. 
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2.4. Michael addition / aldol reaction 
2.4.1. Introduction 
Following interest in tandem reactions, which combines multiple transformations in an 
efficient one-pot procedure, the sequential hydroformylation / aldol addition of α-vinyl 
cycloalkanones could be investigated. As depicted in Scheme 71, cyclododecanone (11) 
is chosen as starting material and the vinyl group could be introduced by a number of 
methods as discussed later. The preparation of β-hydroxy ketones of type 146 should be 
accomplished by application of 2-vinyl cyclododecanone 144 in tandem 
hydroformylation / aldol addition. 
 
Scheme 71: Preparation of β-hydroxybicyclo[9.3.1]pentadecane-15-one of type 146 
 
Moreover by analyzing the skeleton of compound 147 depicted in the Scheme 72, such 
compound (n=0) appear to be a key intermediates towards the preparation of 15-
hydroxy[9]metacyclophane 150 as well as the bicyclo[9.4.l]hexadecan-16-one (n=1) 
could be considered as an effective intermediate in the preparation of 2,7-
nonamethylene bridged tropone 149124(Scheme 72). These compounds belonging to the 
class of cyclophanes125 or bridged aromatics tropones126 are fascinating compounds due 
to their unique physical and chemical properties. The territory of "phanes"127 includes 
heterocyclophanes and bridged nonbenzenoid aromatics128. 
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Scheme 72: Nonamethylene-bridged phenols (150) and tropones (149) 
 
Recent syntheses of systems 147 or 148 are elaborated in numerous steps, while an 
approach to such compounds involving the one-pot procedure described above, 
consequently could afford the compounds 149 and 150 more easily.  
Beginning with the preparation of 2-vinyl-cyclododecanone (144), starting material 11 
could be allylated by a number of methods reported in literature. In contrast to the easily 
accessible 2-allylcyclododecanone (48), α-vinylation reactions of cycloalkanones are 
not well developed in organic synthesis. Among the most general is the α-alkenylation 
of ketones with 1-alkynes of type 153, such as phenylacetylene (R2=Ph) in the presence 
of SnCl4 (152), Bu3N and TMSCl (103), which provides a certain range of β-enones 
with acidic α-protons129 (Scheme 73). 
 
 
 
 
 
 
 
 
 
O
148
( )n
n=0,1
O
OH
n=1
n=0
150
149
O
147
HO
( )n
  70
   Results and discussion 
R1
O
R1
O
SnCl3
R1
O
R2
Cl3
Sn
R1
O
R2
SnCl4( 152)-Bu3N R2 SnCl3
154, β-enone
α-stannyl ketone α-stannyl α-enone
TMSCl,
then HCl aq151
(153)
 
Scheme 73: α-alkenylation of ketones (151) with 1-alkynes (152). 
 
The preparation of 2-vinyl-cycloalkanones of type of 144 could be accomplished in the 
preparation of 1,2 divinyl cycloalkanols130 (159) (Scheme 74).  
 
 
Scheme 74: α-alkenylation of Cl-ketones (155) via 1,2 divinyl cycloalkanols 159 
 
In fact, α-chloro-cycloalkanones (155) could react with vinylmagnesium chloride (156) 
131,132 to afford the chlorohydrin (157) which smoothly undergoes 1,2-migration of the 
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vinyl group to afford the 2-vinylcycloalkanone (158) when its magnesium salts of 
heated131,132,133,134,135  
Recently, M. Yamaguchi et al.136 developed an ethenylation reaction of cyclic ketones  
and β-dicarbonyl compounds with trimethylsilylethyne in the presence of GaCl3137. The 
reaction converts silyl enol ethers of type 160 into a α-ethenylated products 161 in one 
step. This novel ethenylation reaction has a wide applicability and provides not only 
ketones with a quaternary α-carbon but also enolizable products trimethylsilylethyne in 
high yields .  
 
 
Scheme 75: α-alkenylation of silyl enol ethers with trimethylsilylethyne 
 
A limitation of the method, however, is that cyclic ketones with relatively small ring 
number such as cyclohexanone and cycloheptanone gives considerable amounts of the 
conjugated α-enones. In the presence of GaCl3, silyl enol ethers derived from α-
substituted-β-ketoesters or malonates are ethenylated at the α-carbon atom with 
Problems in the preparation of α-vinyl cycloalkanones are caused by the high cost of 
the reagents such as GaCl3 and the multi-step approach. Besides these considerations, 
analysis of the aldehyde 163 revealed that these products could also be obtained in a 
more straightforward route. In fact, the 1,5-dicarbonyl compound of type 163 should be 
obtained if starting from cyclododecanone or its derivatives of type 162 by a Michael 
addition employing α,β-unsaturated aldehydes such as acrolein (Scheme 76). 
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Scheme 76: Stepwise Michael reaction and aldol addition  
 
An aldol addition of preformed keto-aldehyde of type 163 could be performed as well as 
ae one-pot Michael addition / aldol reaction  
O
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2.5. Stepwise Michael addition / aldol cyclysation of cyclododecanone 
2.5.1. Preparation of 12-hydroxy-bicyclo[9.3.1]pentadecan-15-one  
Michael addition has attracted enormous attention as one of the most important carbon-
carbon bond forming reactions in organic synthesis138. In general, Michael additions are 
conjugate additions of enolates to α, β-unsaturated carbonyl compounds affording 1,5-
dioxo compounds and are generally carried out under strongly basic conditions139. 
However, such base-catalyzed methods are sometimes detrimental140 to base sensitive 
functionalities and often lead to side reactions like autooxidation or retro-Michael type 
condensation . 
In order to circumvent this problem considerable attention has been directed towards the 
search for more convenient methods141. Preformed enamines or silyl enol ethers, for 
example, constitute an important class of Michael donors that have been utilized142 
under milder conditions. However, a literature survey revealed that in comparison to 
enolates, the use of enamines as Michael donors is significantly less common. The 
major disadvantage associated with enamines is their susceptibility to hydrolysis143, 
causing restrictions to their general use in Michael addition reactions. Consequently, 
further developments in the use of enamines for an efficient Michael addition offers 
advantages and remain a challenging problem to organic chemistry.  
Then, to begin this route towards the preparation of bicyclo[9.3.1]pentadecane 
derivatives of type 164, the preparation of silyl enol ether from cyclododecanone with 
TMSCl (103) has to be conducted (Scheme 77), whereas the synthesis of 4-cyclododec-
1-en-1-ylmorpholine (70) is accomplished starting from 11 in the presence of 
morpholine (69) and catalytic amount of p-TsOH·H2O (see R 13). The silyl enolization 
via electron-transfer mechanism144 by treatment of cyclododecanone (11) with Mg-
turnings, trimethychlorosilane, (103), in N,N-dimethylformammide at RT145 does not 
give any conversion (Table 15, R 65).  
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Scheme 77: Preparation of cyclododec-1-enyloxy-trimethyl-silane (165). 
 
Table 15: Preparation of cyclododec-1-enyloxy-trimethyl-silane (165). 
O TMSO
16511
+ TMSCl
103
Solvent
R Reaction conditions ϑ, [°C] t,[h] Yield 165, [%] 
R 65 Mg, DMF 5-7 18 -- 
R 66 NaI, NEt3, CH3CN 20 12 38 
R 67 LDA, THF -78 6 78 
 
Following the procedure reported by Dunogues et al.146 the reaction of cyclododecanone 
(11) in the presence of Me3SiCl-NaI-Et3N as the reagent proceeds at room temperature 
and the corresponding silyl enol ether 165 is obtained in 38% yield (Table 15, R 66). 
Finally, best results are achieved if the reaction is performed with the LDA as base. As 
compiled in Table 15 (R 67) compound 165, after distillation, is obtained in 78% yield. 
To obtain the compound 145 (Scheme 78), the Michael addition reaction of silyl enol 
ethers is carried out with acrolein (166) proceeding smoothly to afford the 
corresponding adducts in 78% yield (Table 16, R 68). On the other hand, if the reaction 
is performed starting from 4-cyclododec-1-en-1-ylmorpholine (70), treated with 
acrolein (166) (Scheme 78), the results depend on the reaction conditions applied as 
presented in Table 16. 
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Scheme 78: Preparation 3-(2-oxo-cyclododecyl)propanal (145) as intermediate in aldol 
addition 
 
In the presence of dioxane147, Michael addition reaction at 90°C does not occur and 
after hydrolysis with a solution of HCl, only cyclododecanone is recovered (11) (R 69). 
 
Table 16: Preparation 3-(2-oxo-cyclododecyl)propanal (145) 
N
O
O
O
TMSO
O
O
O
70
Solvent
165
(166)
145
DBU
72%
167
168
HO
HCl O
167,
, 53% (md)
42%
R Starting material Solvent ϑ, [°C] t, [h] Yield 145, [%] 
R 68 165 CH2Cl2 -78 9 78 
R 69 70 dioxane 90 66 -- 
R 70 70 MeOH 20 25 -- 
R 71 70 MeOH 80 25 -- 
R 72 70 Et2O 0 25 96 
 
Same results are observed if the reactions are carried out with in MeOH148 either at 
room temperature (R 70), or at reflux temperature MeOH (R 71). In contrast, by 
replacing MeOH with Et2O and decreasing temperature to 0°C the Michael adduct 145 
is isolated after distillation in 96% yield (R 72).  
  76
   Results and discussion 
Intramolecular aldol cyclisation of the ketoaldehyde 145 (Scheme 78) is performed 
under both acidic and basic conditions. Via a basic approach, using DBU in EtOH149 (R 
73), the reaction affords the desired α,β-unsaturated ketone 167 in 72% yield. Under 
acidic conditions, in the presence of HCl (7N) 98 (R 74), a mixture of aldol adduct 168 
(53% yield, mixture of diastereoisomers in a ratio 1:2.38, detected by 1HNMR with 
respect to the CHOH) and the corresponding dehydrated compound 167 (42% yield) is 
obtained. 
In conclusion, Michael addition, starting from activated cyclododecanone (70) to give 
compound 145 proceeds with acrolein (166) in high yields if low temperatures and Et2O 
are employed. An aldol condensation occurs under both acidic and basic aldol addition 
furnishing the aldol adduct 168 and the enone 167 (Scheme 78).  
Since β-keto esters are important classes of compounds for the construction of 
substituted bicyclic skeletons Michael additions can also be extended to these substates.  
 
2.5.2. Stepwise Michael addition / aldol cyclisation of β-keto esters 
2.5.2.1. Preparation of ethyl 2-oxo-1-(3-oxo-propyl)cyclododecane 
carboxylate  
Traditionally, Michael addition reactions of β-keto esters are catalyzed by very strong 
bases such as alkali metal alkoxides. Several undesirable side reactions can be caused 
by these strongly basic catalysts150, including rearrangements, secondary condensations, 
isomerizations, polymerizations, bis additions, and transesterifications. Recently, phase-
transfer catalysis has been utilized to circumvent some of these problems with 
α,β−unsaturated aldehydes151 or mild conditions using alumina152 as catalyst without 
any solvent are reported. Following the previous observations, several attempts of 
introducing the aldehyde chain, including the more classical, have been performed. The 
results from these investigations are presented in Table 17 (Scheme 79). In the absence 
of a solvent, ethyl 2-oxo-cyclododecane carboxylate (72) does not react with acrolein 
(166) in the presence of Al2O3153 (activated at 100°C for 2 hours prior to use) (R 75). 
Furthermore, the failures of the reaction by using of Na2 3CO 154 in toluene (R 76) or 
piperidine155 (R 77) indicate that both are not sufficiently strong bases for the Michael 
additions. 
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Scheme 79: Michael addition / aldol reaction of ethyl 2-oxo-cyclododecane carboxylate 
(72). 
 
In attempts to convert the compound 72 into the Michael-addition adduct molecular 
sieves156 turned out to be poor catalyst in terms of yield for the reaction (R 78). Indeed, 
after filtration on a short pad of Celite the crude mixture analyzed by GS-analysis shows 
only 10% conversion; this result is not in accordance with the general observations from 
literature of the crucial action of molecular sieves as an initiator for the Michael 
addition. 
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Table 17: Michael addition of β-dicarbonyl compounds 72 
a)Unless otherwise noted, all reactions are performed at room temperature; b) isolated yield; c) refluxing 
toluene; d) detected by GC analisys; e) mixture of diastereoisomers in ratio calculated with respect to the 
methyl group 
 
However, NEt3 in DMF proved to be a superior base in the Michael addition. Indeed, in 
the presence of catalytic amounts of base at room temperature157 the reaction afforded 
the expected ethyl 2-oxo-1-(3-oxo-propyl)cyclododecan carboxylate (171) in 83% yield, 
isolated by distillation (R 79). In contrast, under the same reaction conditions the 
reaction of 72 performed with compound 169 and 170 proceeds with good selectivity in 
favor of the corresponding substituted hydroxy substituted bicyclic adducts 175 and 
176, respectively (R 80, R 81) as a mixture of diastereoisomers. 
 
R Base and /or catalyst Solventa Acceptors t,[h] Michael adducts [%]b
R 75 Al2O3 -- 166 20 -- 
R 76 Na2CO3 toluene 166 24 -- 
R 77 Piperidine THF 166 72 -- 
R 78 Molecular sieves toluenec 166 12 171[10]d
R 79 NEt3 DMF 166 20 171[83] 
R 80 NEt3 DMF 169 16 175 [61] (1:1:1)e
R 81 NEt3 DMF 170 16 176 [54] (1:1.4:1.1)e
2.5.2.2. Intramolecular aldol addition of ethyl 2-oxo-1-(3-oxo-
propyl)cyclododecane carboxylate. 
Based on the results observed in intramolecular acid or base – catalyzed aldol addition 
of 1,6 keto-aldehyde 76 (Scheme 38) attempts to utilize this methodology to convert the 
Michael adducts into β-hydroxy bicyclic compounds of type 164 (Scheme 76) have 
been investigated. All results obtained are listed in Table 18. These results reveal that 
the formation of aldol adduct 174 in 82% is exclusively observed when HCl is used (R 
82, whereas an aldol condensation occurs under all other conditions used. 
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Scheme 80: Aldol addition and / or condensation of compound 171 
 
By replacing the strong mineral acid with a Lewis acid such as BF3·OEt2 the reaction 
proceeds at room temperature with high yield resulting in compound 177 in 81 % yield 
(R 83).  
 
Table 18: Aldol cyclisation and condensation of ethyl 2-oxo-1-(3-oxo-
propyl)cyclododecan carboxylate (171). 
a) Mixture of diastereoisomers in ratio calculated by 1HNMR analysis with respect to the ester groups 
 
As shown in Table 18, the aldol condensation performed in the presence of NaOH as 
base is dependent on reaction time. When the conversion of compound 171 is carried 
out at 80°C for 72 h (R 85) a convenient one-pot aldol condensation-decarboxylation 
reaction occur furnishing α,β-unsaturated ketone 167 whereas compound 177 has been 
obtained with high yield under the same conditions with shorter reaction times (R 84).  
 
 
O
COOEt
Solvent
Base or  acid
O
OO
HO
O
COOEt COOEt
167174 177171
+ +
R Base /or acid Solvent ϑ, [°C] t [h] Products [%] 
R 82 HCl Dioxane 20 16 174 [82] (1:1.6)a
R 83 BF3·OEt2 CH2Cl2 20 20 177 [81] 
R 84 NaOH EtOH 80 24 177 [86] 
R 85 NaOH EtOH 80 72 167 [97] 
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2.5.3. One-pot Michael addition / aldol reaction 1,3-dicarbonyl compounds 
2.5.3.1. Introduction 
In the course of the study on the stereoselective synthesis of the naturally occurring 
Prelog-Djerassi lactone, Rodriguez et al.158found a very useful base-catalyzed 
diastereoselective three centre Michael addition of chiral β-ketoester (178) to α, β-
unsaturated carbonyl compounds 179. In addition to these results, they described a mild 
and general one-pot high yield preparations of synthetically valuable β-hydroxy 
bicyclo[3.2.1]octanones 180 by a slight modification of their initial conditions for the 
Michael addition159. These bicyclic derivatives are involved as intermediates in the ring 
expansion of cyclopentanones to seven-membered ring160 such as compound 181. The 
one-pot condensation-cyclisation takes place under very mild conditions with α, β-
unsaturated aldehydes of type 179 in acetone at room temperature in the presence of 1.5 
eq. of K2CO3 (Scheme 81). Moreover, if compound 180 is treated with K2CO3 in the 
presence of MeOH or EtOH, they smoothly undergo a reverse-Dieckmann reaction161to 
the corresponding substituted cycloheptane derivatives 181162. 
 
 
Scheme 81: Base-catalyzed two carbon ring expansion of cyclopentanones 178 
 
In 1997, Filippini et al163 reported an base-induced anionic sequence involving five 
different reactions starting from 178 by replacing acetone with MeOH or EtOH. The 
overall transformation, named MARDi cascade, involved a Michael addition, an 
intramolecular aldol addition, a retro-Dieckmann reaction followed by dehydration, and 
chemoselective ester saponification. The result is the facile one-pot disatereoselective 
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formation of highly functionalized and synthetically valuable cycloheptanes 171 bearing 
two stereogenic centres and two chemically differentiated carboxylic groups (Scheme 
81). The applicability of this procedure on β-ketoester 72 will be investigated by the use 
of different bases and solvents in the presence of α,β-unsaturated enals. 
 
 
2.5.3.2. Michael addition / aldol reaction of 1,3-dicarbonyl compounds. 
The initial studies of the MARDi cascade of β-ketoester begin with the screening of the 
reactions in the presence of K2CO3 as base in acetone or MeOH with variation of 
reaction time and temperature. The results from these investigations are presented in 
Table 19. In contrast to the results observed by Filippini et al.  with cyclopentanone 
derivatives, starting material 72 does not lead to the substituted pentadecane. The 
expected one-pot expansion does neither take place in EtOH in the presence of catalytic 
amount of K2CO3 at room temperature nor in refluxing solvent (Scheme 82). 
 
 
Scheme 82: Base-promoted one-pot Michael addition aldol cyclisation of ethyl 2-oxo-
cyclododecane carboxylate (72). 
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If the reaction is performed in the presence of acrolein (166), via an aldol addition the 
compound 174 is obtained in good yield (R 86, R 87, R 88) whereas an aldol 
condensation occurs if the reaction is carried out for prolonged reaction time (72 hours) 
at refluxing EtOH (R 89) furnishing compound 177 in 67% yield.  
 
Table 19: One-pot Michael addition / aldol cyclisation of β-ketoester 72 in the presence 
of K2CO3
a) isolated yield; b) yield analyzed by 1HNMR calculated with respect to CHO/CH-OH; c) 
diastereoisomeric ratio calculated by 1HNMR with respect to CHOH; d) ratio analyzed by 1HNMR 
calculated with respect to C=CH/CH-OH, e) ratio analyzed by 1HNMR calculated with respect to 
aldehydic group, f) ratio analyzed by 1HNMR calculated with respect to methyl group 
 
Moreover, in contrast to the the results observed by Rodriguez  in the preparation of 
bicyclic β-hydroxy compounds, Michael adduct 171 is exclusively isolated in 78% yield 
R Solvent t,[h] ϑ, [°C] Acceptors Products [%]a
R 86 EtOH 18 20 166 174 [61] 
R 87 EtOH 72 20 166 174 [58], (1:1)c
R 88 EtOH 18 80 166 174[56] (1:1.09)c
R 89 EtOH 72 80 166 177 [67] 
R 90 Acetone 18 20 166 171 [78] 
R 91 Acetone 72 20 166 174 [67] 
R 92 EtOH 18 20 169 175 [58] 
R 93 EtOH 72 20 169 175 (30), 182 (35), (175 1:1.33)f
R 94 EtOH 18 80 169 175 [43], (1:1.68:1.37)f
R 95 EtOH 72 80 169 175 (37.5)d, 182 (62)d, (175 1:1)f
R 96 Acetone 18 20 169 172 [85] (1:1.6)e
R 97 Acetone 72 20 169 175(61), 172 (33) (175 1:2:1)f
R 98 EtOH 18 20 170 176 [53] (1:1.15)f
R 99 EtOH 72 80 170 183 [76] 
R 100 Acetone 18 20 170 173 [84] (1:2.8)e
R 101 Acetone 72 20 170 176 [57] 
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(R 90) after 18 hours if the reaction of 72 with 166 is carried out in the presence of 1.5 
eq. of K2CO3 in acetone, while aldol adduct 174 is observed in 67% after a period of 72 
h (R 91). 
Based on the above results Michael addition / aldol reaction is also observed if starting 
from β-ketoester 72 and methacrolein (169). In contrast to the unsubtituted aldehyde 
166, if the reaction is carried out with methacrolein (169) in EtOH for a period of 72 h 
an aldol condensation takes place and a mixture of aldol adduct 175 and α,β-
unsaturated ketoester 182 is obtained at room temperature (R 93) as well as in refluxing 
solvent (R 95). Using shorter reaction time (R 92, R 94), however, the aldol adduct 175 
is exclusively formed. The reactions of β-ketoester 72 and methacrolein  (169) in the 
presence of K2CO3 in acetone show similar trends as observed for acrolein (R 96). 
Nevertheless, the reaction carried out for 72 hours, proceeds with formation of a 
mixture of aldol products 175 and unsaturated β-ketoester 172 (R 97). 
The Michael addition / aldol addition of crotonic aldehyde (170) to the ketoester 72 is 
also dependent of the conditions. Again, for longer reaction times (72 hours), under 
refluxing conditions and employing EtOH as solvent, an aldol condensation takes place 
and the enone 183 is isolated (R 99). Shorter reaction time (20 hours) at room 
temperature furnishes the aldol adduct 176 as the only product (R 98). As previously 
observed, treatment of β-ketoester 72 with crotonic aldehyde (170) in the presence of 
K2CO3 in acetone furnishes the corresponding β-hydroxy ketone 176 only if the reaction 
is run for a period of 72 hours (R 101) whereas shorter reaction time leads to the 
Michael adduct 173 as a misture of diastereoisomers (R 100). In conclusion, the 
reactions using K2CO3, regardless of the solvent and the α,β-unsaturated aldehydes 
employed proceed with formation of the aldol adducts. Furthermore an aldol 
condensation occurs if the reaction is conducted for longer reaction times at high 
temperatures. 
Proceeding in searching for an efficient base/solvent system for performing the MARDi 
cascade NaOH / ROH (R=Me or Et) is investigated (Scheme 83). All results are listed 
in Table 20. 
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Scheme 83: Aldol condensation of β-ketoester (72) in the presence of NaOH / EtOH. 
 
First, the conversions are performed with of acrolein (166). In contrast to the results 
observed in the presence of sodium carbonate with NaOH, all reactions proceed with an 
aldol condensation resulting in the formation of α,β-unsaturated ketoester 177 or 184 
dependent of solvent used (R 102, R 103). Moreover, higher temperature favors the 
decarboxylation process furnishing compound 167 as main product (R 104). On the 
other hand, prolonged reaction time results in lower yield owing to degradation and the 
compound 167 is obtained in only 7 %.(R 105). 
 
Table 20: Effects of the temperature and reaction time in the aldol reactions of β-
ketoester 72 in the presence of NaOH. 
 
O
COOR
O
COOEt
72
NaOH
OROH
+
R1 R1
O
R1=H        166
R1=CH3,  170
R1
R1= H, R=Et,       177
R1= H, R=Me ,    184
R1=CH3, R=Et,    183
R1=H ,      167
R1=CH3 ,  185
R=Me, Et
R t, [h] ϑ, [°C] Acceptors Solvent Aldol adducts [%] 
R 102 18 20 166 EtOH 177 (63) 
R 103 72 20 166 MeOH 184 (72) 
R 104 18 80 166 EtOH 177 (18), 167(63) 
R 105 72 80 166 EtOH 167 (7) 
R 106 18 20 170 EtOH 183 (23) 
R 107 72 20 170 EtOH 183 (71) 
R 108 18 80 170 EtOH 185 (51) 
R 109 72 80 170 EtOH 185 (21) 
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According to the previous results, the reactions performed in the presence of crotonic 
aldehyde (170) show similar trends. At higher temperature aldol condensation followed 
by decarboxylation is observed either for a period of 24 h or longer leading to the β-
enone 185 in 51% (R 108) and 21% yield (R 109). At room temperature, if the reaction 
is run for 72 hours the compound 183 is exclusively formed in 71% yield (R 107) 
whereas lower yield is observed for a reaction carried out in a period of 24 hours (R 
106). 
These results suggest that the selectivity of condensations could be controlled by the 
modification of temperature and the base. Indeed, while in all case an aldol 
condensation occurs, further decarboxylation is observed only with NaOH at high 
temperature regardless the reaction time. 
In continuation of the investigation concerning the applicability of MARDi cascade, an 
amidine such as 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU) is employed. Moreover, in 
order to test the overall process on larger cycloalkanoness the preparation of ethyl 2-
oxo-cyclotridecane carboxylate (186) is performed in the presence of boron trifluoride 
etherate with ethyl diazoacetate (187) in diethylether (R 110, Scheme 84). 
 
 
Scheme 84: Preparation of ethyl 2-oxo-cyclotridecane carboxylate (186). 
 
The sequential Michael addition-intramolecular aldolization between 1 equiv of β-
ketoester 72 and 186 with 1 equiv of enals 166, 169 and 170 are carried out in the 
presence of DBU as base in ROH (R=Me or Et) with variation of temperature (Scheme 
85). The results are summarized in Table 21.  
 
O
90%
Et2O
11
O
COOEt
BF3OEt2
N2CHCOOEt
186
+
187
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Scheme 85: Aldol condensation of β-ketoester 72 and 186 in the presence of DBU / 
EtOH. 
 
The reaction of β-ketoester 72 with acrolein (166) proceeded very smoothly giving the 
corresponding bicyclic compound 174 in 72% yield as a mixture of two 
diastereoisomers. Only one diastereoisomers is isolated in 32% yield after 
recrystallization from Et2O (R 111) and in addition as an oil a mixture of two epimers 
due to the different orientation of 12-hydroxy group is obtained. According to the 
results observed with NaOH condensation reaction between 72 and 166 occurs under 
refluxing conditions furnishing compound 177. Furthermore, prolonged reaction time 
does not favour decarboxylation. Regardless of the solvent employed, only higher yield 
in the α,β-unsaturated ketoester is obtained after prolonged reaction times (R 112, R 
113). 
 
 
 
O
COOR
O
COOEt
n=1,   72
n=2, 186
DBU
ROH
+
( )n
O
R1=R2= H,          166
R1=H, R2=CH3,  169
R1=CH3, R
2=H,  170
R2
R1
O
R1=R2= H, R=Et,           174 
R1=H, R2=CH3, R=Et,    175
R1=H, R
2=CH3, R=Me,  188
R1=CH3, R
2=H, R=Me , 189
R1=R2= H, R=Et,           190
R1=H, R2=CH3, R=Me,  191
R1=CH3, R
2=H, R=Me,  192
O
COOR
R=Me, Et
HO
R2
R1
COOR
HO
R2
R1
R1
R1= H, R=Et,      177
R1=CH3, R=Me, 184
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Table 21: Effects of the temperature and reaction time in the aldol reactions of β-
ketoester 72 and 186 in the presence of DBU. 
a) ratio of diastereoisomers calculated with respect to CH3, b) ratio for the compound 188, c) ratio of 
diastereoisomers calculated with respect to CH2CH3. 
 
The reaction of methacrolein (169) with compound 72 in MeOH proceeds with the 
formation of aldol adducts 175, 188 (R 114). The presence of compound 188 is 
attributed to the use of MeOH as solvent; indeed a transesterification takes place under 
these reaction conditions. Both aldol adducts 175, 188 are present as a mixture of two 
diasteroisomers which are not separable. 
The use of crotonic aldehyde (170) in MeOH in Michael addition / aldol reaction of 72 
gives the aldol adduct 189 in slightly lower yield (62%, R 115) as a mixture of two 
diastereoisomers. As observed above one diastereoisomer is isolated in 49% yield after 
recrystallization from Et2O and again, in addition a mixture of both epimers due to 
different orientations of 12-hydroxy and / or methyl group is obtained. 
As expected on the base of these results, in all reactions of ethyl 2-oxo-cyclotridecane 
carboxylate (186) with α,β-unsaturated aldehydes in the presence of DBU, a Michael 
addition / aldol reaction takes place. Indeed, regardless the solvent used, the DBU-
mediated reaction proceeds smoothly giving the corresponding alcohols 190-192 in 
good yield (R 116, R 117, R 118). Finally, attempts for performing the MARDi cascade 
are investigated by the reaction carried out in the presence of NaOR. Reactions have 
R n Acceptors t, [h] ϑ, [°C] Solvent Aldol adducts, [%] dr 
R 111 166 18 20 EtOH 174 (72) 1:1.8 
R 112 166 18 80 EtOH 177 (41) -- 
R 113 166 72 80 EtOH 177 (73) -- 
R 114 169 18 20 MeOH 175(10), 188(71%), 1:1.5a,b
R 115 
1 
170 18 20 MeOH 189 (62) 1:1.33a
R 116 166 18 20 EtOH 190 (78) 1:1.25c
R 117 169 18 20 MeOH 191 (68) 1:3:8:2a
R 118 
2 
170 18 20 MeOH 192 (62) 1:1.37a
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been conducted at room temperature for 20 hours and the results are compiled in Table 
22. 
 
 
Scheme 86: Aldol reaction of β-ketoester (72) in the presence of NaOR. 
 
In contrast to the results above observed, Michael addition / aldol condensation occurs 
even at room temperature(R 119, R 121). 
 
Table 22: Effects of the temperature and reaction time in the aldol reactions of β-
ketoester 72 in the presence of NaOR 
a) Isolated yield, b)NMR-yieldcalculated with respect CH=C /CHOH 
 
Furthermore, if the reaction is performed with acrolein (166) a mixture of aldol product 
174 and corresponding α,β-unsaturated ketoester 177 is formed in 56% and 30 % yield, 
respectively (R 119). Same result is observed if the reaction is carried out with 
methacrolein (169) leading, again, to a mixture of aldol product 188 and corresponding 
α,β-unsaturated ketoester 193 (R120) 
From all these results, stereochemical differences could be assumed responsible for 
isolation of bicycles β-hydroxy cycloalkanones whereas the analogous product from 
O
COOR
NaOR
R2
R1
O
COOR
R2
R1HO
O
COOEt
72
+
O
R1=R2= H,          166
R1=H, R2=CH3,  169
R1=CH3, R
2=H,  170
R2
R1
R1=R2= H, R=Et            174
R1=H, R2=CH3,  R=Et,   175
R1=H, R2=CH3,  R=Me,  188
R1=CH3, R
2=H, R=Et     176
R1=R2= H, R=Et,           177
R1=H, R2=CH3,R=Me,  193
R1=CH3, R
2=H,   R=Et, 183
R=Me, Et
R t, [h] ϑ, [°C] Acceptor Solvent Aldol adducts[%]a
R 119 18 20 166 EtOH 174 (56%), 177 (30%) 
R 120 18 20 169 MeOH 188 (46)b, 193 (54)b
R 121 18 20 170 EtOH 183 (68) 
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cyclopentanone is not isolated since further conversion via retro-Dieckman 
condensation readily occurred (cfr Scheme 81). Then, in order to attribute a 
stereochemistry two crystals probes of compound 174 and 176 an analysis by X-ray is 
required. As could be observed from the crystal structure, an asymmetric unit of ethyl 
rac-(1R, 11S, 12R)-12-hydroxy-15-oxo-bicyclo[9.4.1]pentadecan carboxylate164(174) 
contains conformers molecules, which are described as a trans-fused bicyclic system. 
The carbonyl group lies on the same as the carbetoxy function, while the OH is in the 
opposite site. The six-membered rings have a chair conformation and the conformations 
of the twelve-membered rings are similar in the two molecules. Four molecules linked 
via H-bond and a centrosymmetric center sixteen-membered heterocycle with four O-
H…O hydrogen bond plus six atoms from two six-membered rings is formed. These four 
molecules are separated by Van der Waals interactions from their surroundings (Scheme 
87).  
 
 
Scheme 87: Crystal structure of ethyl rac-(1R, 11S, 12R) 12-hydroxy-15-oxo-
bicyclo[9.4.1]pentadecan carboxylate (174). 
 
As it is shown in the crystal structure, methyl rac-(1R, 11S, 12R) - 12-hydroxy-14-
metyl-15-oxo-bicyclo[9.4.1]pentadecan carboxylate165 (189) is also described as a 
O
O
O
HO
H
174
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trans-fused bicyclic system. The carbonyl group lies on the same side as the 
methoxycarbonyl group, while the OH group is on the opposite side. In contrast to the 
previous structure, the six-membered ring has a twist formed conformation, presumably 
due to the presence of the methyl group next to a bulky methoxycarbonyl group 
(Scheme 88).  
Scheme 88: Crystal structure of methyl rac-(1R, 11S, 12R)-12-hydroxy-14-metyl-15-
oxo-bicyclo[9.4.1]pentadecan carboxylate (189). 
 
In conclusion, the failure of the MARDi cascade could be explained if considering the 
observed tran-fused stereochemistry of the products, whereas the analogous products 
formed from cyclopentanone is the cis-fused compound . 
The lack of reactivity of such compounds towards the formation of macrocycles 
requires to investigate alternative procedures. As stated in the introduction of the project 
presented here ring-enlargement methods involving the cleavage of the keto-bridge in 
the presence of other functional groups in appropriate positions could be applied. 
O
HO
COOMeH
189
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2.6. Preparation of tricyclic compounds  
2.6.1. Introduction 
 
Although the results reported above concerning attempts to perform the MARDi 
cascade show the impossibility to accomplish the synthesis of pentadecane derivatives, 
compounds such as β-ketoester 184 or enone 167 appear to be interesting intermediates 
in the preparation of tricyclic compound. Indeed, as shown in Scheme 89, compounds 
of type 194 involve the disconnection C14-C15, which can be built up by means of a 1, 
4 conjugate addition to α,β-unsaturated cyclic ketoester 184 or 167, followed by 
sequential hydroformylation / aldol condensation.  
 
 
Scheme 89: Preparation of tricyclic compounds of type 194 
 
Therefore, in order to test methods of formation of such compounds under 
hydroformylation conditions, an allyl or vinyl chain is needed to be introduced. 
 
O O
RR
O
R
194
HO
195 R1=H, R=COOMe, 184
R1=H, R=H,            167
1,4-addition
Aldol 
addition
hydroformylation
14
117
16
15
11
18
R1
2.6.2. Preparation of 12-alkenyl-bicyclo[9.3.1]pentadecan-15-one 
The allyl chain could be inserted in the compounds 184 or 167, readily available, via a 
Sakurai reaction166 in which Lewis acids promote 1,4-addition of allylsilanes with 
enones. Keith et al.167 reported a method involving α,β-unsaturated cycloalkanones with 
allyltrimethylsilane in the presence of TiCl4 (Scheme 90). Compound 197 in 96% yield 
isolated without any purification (R 122).  
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Scheme 90: Preparation of methyl 12-allyl-15-oxo-bicyclo[9.3.1]pentadecan 
carboxylate (197). 
 
Alternatively, by replacing the allyl chain with vinylic chain an 1,4-conjugate addition 
using organocopper reagents could be performed. Proceeding from β-enone 167 and β -
ketoester 184 the results of the reactions are shown in Scheme 91. Both reactions 
proceeding with decomposition of starting materials upon the conditions applied, 
affording an intractable mixture (R 123, R 124). 
 
Scheme 91: Attempted for vinyl-chain introduction. 
 
 
 
 
 
O
COOMe
O
COOMe
SiMe3
184
            TiCl4 (101)
           CH2Cl2
197
96%
+
62
O
R
O
R
ClMg CuI
R=COOMe,  184
R=H,             167
198
+
R=COOMe,  200
R=H,             199
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2.6.3. Hydroformylation of methyl 12-alkenyl-bicyclo[9.3.1]pentadecan-15-one 
carboxylate  
For the initial investigation into tandem hydroformylation / aldol addition the compound 
197 is hydroformylated under acidic conditions with a catalytic amount of p-TsOH (5 
mol %) Rh (I) (1 mol %) of Rh(acac)(CO)2 and 4 mol % of BIPHEPHOS (16) in 
CH2Cl2 under 20 bar CO / H2 (1:1) at 60° for 3d. Only cyclized product 201 is observed 
and after recrystallization from diethylether one diastereoisomer is isolated in 43% yield 
(R 125) (Scheme 92). 
 
 
Scheme 92: Preparation of methyl rac-(1R, 11R, 14S, 18R)18-hxdroxy-19-oxo-
tricyclo[9.7.1.01.14]nonadecane-11-carboxylate (201). 
 
Owing to the complex tricyclic structure of methyl rac-(1R, 11R, 14S, 18R)18-hxdroxy-
19-oxo-tricyclo[9.7.1.01.14]nonadecane-11-carboxylate (201) bearing four stereogenic 
centres, an X-ray analysis has been performed.  
 
 
 
 
 
 
 
 
 
O
COOMe
O
COOMe
HOCO / H2
   [Rh]
    43%
197 201
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O
201
MeOOC
OH
H
 
Scheme 93: Crystal structure methyl 18-hxdroxy-19-oxo-tricyclo[9.7.1.01.14]nonadecan-
11-carboxylate (201) 
 
The structure shows a cis-fused decaline system attached to the cyclododecanone in the 
position α,α’ to its carbonyl168 group. Thus, the Michael reaction and the subsequent 
hydroformylation /aldol addition occur from the side of the carbonyl group of the 
bicyclic starting compound, whereas the OH group is at the opposite side. Both six-
membered rings have a chair conformation. Four molecules linked via two O-H…O 
hydrogen bonds and a centrosymmetric sixteen-membered heterocycle containing four 
hydrogen bonds is formed. 
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2.7. Fragmentation reactions and ring expansion methods 
2.7.1. Introduction 
As stated in the introduction, the ultimate aim of this work is to perform a general way 
to synthesize macrocycles via ring expansion. As illustrated in Scheme 94 it could be 
useful to envisage ring-enlargement methods involving the cleavage of the keto-bridge 
in the presence of other functional groups in appropriate positions. 
 
 
Scheme 94: Macrocycles accomplished via ring expansion 
 
Along this line, an oxidative approach, such as Baeyer-Villiger (BV) oxidation followed 
by lactone hydrolysis could be valid approach. Alternatively, the base-promoted Grob 
fragmentation169 of tosylates of bicyclo[9.4.1]hexadecane 50170 will be investigated 
whereas the retro-Dieckmann failed. 
 
 
R3,R2
R1
( )n
R=R1=H 50
O
R
HO
R1=H, CH3
61
R1
( )n
R
R=H,COOEt, NO2,CN
58
2.7.2. Baeyer-Villiger oxidation 
2.7.2.1. Introduction 
The Baeyer-Villiger oxidation of ketones with organic peroxy acid, hydrogen peroxide 
or alkyl hydroxyperoxide to give esters / lactones is of considerable synthetic use as a 
component of methods for converting carbocycles to hetero-cycles and opening cyclic 
array to prepare functionalized chains and/or rings. 
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In a recent asymmetric synthesis of morphine reported from White et al.171 ring 
expansion and ring fragmentation products were synthesized from pentacyclic ketone 
202 via Baeyer-Villiger oxidation followed by opening of the lactone ring of 203. 
Indeed, exposure of 202 to m-chloroperbenzoic acid led smoothly to δ-lactone 203 
resulting from migration of the more highly substituted carbon172 (Scheme 95). Next, 
basic hydrolysis of lactone followed by acidification and then treatment of the resultant 
hydroxy acid with diazomethane, produced methyl ester 204. 
 
 
Scheme 95: Ring expansion and ring fragmentation via Baeyer-Villiger oxidation of 
ketone 201 
 
In 2000, Buono et al.173 in connection with studies on transition - metal - catalyzed 
cyclizations towards natural product targets reported a straightforward route to 
functionalized cycloheptanols from cyclopentanones. The key reaction involves a Pd-
catalyzed bicyclic annulation and a two-carbon-atom ring expansion sequence based on 
Baeyer-Villiger oxidation followed by reductive lactone opening (Scheme 96). 
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N
( )n Pd(OAc)2/PPh3 cat.
RO
OR
R=Ac, COOMe
O
206 n=1-4
1. Bayer-Villiger
2. LiAlH4
( )n
( )n
207n=1,2
OH
OH
205
 
Scheme 96: Preparation of stereodefined functionalized cycloheptanols and 
cyclooctanols 207 
 
Baeyer-Villiger oxidation174 of bicyclic ketones with peracetic acid in the presence of 
Na2CO3 occurred smoothly yielding the corresponding lactones in excellent yields. 
Reductive lactone ring opening was performed at room temperature using LiAlH4 (two 
equiv.) in ether, affording 3-methylene-cis-5-hydroxymethylcycloheptanols 207 in good 
yields as single diastereoisomer.  
Following these results bicycles of type 58 (Scheme 97), synthesized as previously 
described could be employed as starting material in Baeyer-Villiger oxidation giving 
lactones of type 208 and / or 209.  
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Scheme 97: Ring expansion and fragmentation of compound 58 via Baeyer-Villiger 
oxidation 
 
The ring expansion could be performed using this mixture of compounds and the 
corresponding triols 210 and / or 211 could be prepared if LiAlH4 is used as reductive 
agent.  
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2.7.2.2. Baeyer-Villiger oxidation of bicyclo[9.4.1]hexadecan-16-one 
derivatives. 
For initial investigation into applicability of Baeyer-Villiger oxidation, the simplest 
starting material 50 is subjected to the standard reaction conditions (Scheme 98).  
 
 
Scheme 98: Attempted Baeyer-Villiger oxidation of 12-
hydroxybicyclo[9.4.1]hexadecan-16-one (50). 
 
In the case of β-hydroxy ketone 50, the oxidation reactions to produce lactones 213 and 
/or 214 were unsuccessful regardless of the reaction conditions and the starting material 
is recovered upon workup. The reaction, performed in the presence of m-CPBA (212) 
CH2C12 at 0°C for 16 hours175, proceeds without any conversion of compound 50 (R 
126). The addition of NaHCO3176 was not effective for accelerating the rate of the 
reaction of 50 with m-CPBA  (212) in CH2 2C1  (R 127). This inertess of 50 could be 
explained in terms of the steric hindrance to the carbonyl face. Bulky undecane ring and 
hydroxylic groups covered both faces of the carbonyl group, thus preventing 
nucleophilic attack of m-CPBA. In fact it has been reported that the oxidation reaction 
of the ketone having a bulky group adjacent to the carbonyl requires a longer reaction 
times177,178. The rate of the Baeyer-Villiger reaction depends on the size of substituents 
adjacent to the carbonyl group. 
Based on these results Baeyer-Villiger oxidation of β-hydroxy ketone 50 is not suitable 
for obtaining the intermediate lactones on which to test the ring opening for the 
preparation of substituted cyclopentadecane 210 and 211 (Scheme 97). In further the 
use of symmetric ketones in the Baeyer-Villiger oxidations was examined. Moreover, 
O
HO HO
O
O
HO
O
Om-CPBA (212)
     NaHCO3
   CH3Cl
T= 0-20°C
t=16-18h
213 21450
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using such starting materials seemed very useful when regioselectivity problems are 
considered. 
To begin the route for the preparation of saturated ketone 215 has to be accomplished 
(Scheme 99). The most obvious method is to carry out the hydrogenation reaction of the 
compound 96, which could be prepared by means of dehydration reaction under acidic 
or basic conditions. The results are listed in Table 23. 
 
 
Scheme 99: Attempted Baeyer-Villiger oxidation of bicyclo[9.4.1]hexadecan-16-one 
(215) 
 
When a mixture of secondary alcohol 50 in the presence of CuSO4/SiO2 in toluene179 is 
heated at 120°C, no conversion into unsaturated ketone 96 is observed. Indeed, upon 
inspection of the crude mixture after filtration through a short pad of alumina only 
starting material is recovered (R 131). However, attempts to prepare the compound 96 
are carried out under acidic conditions by use of H2SO4 in toluene to give the desired 
compound in only 15% yield (R 128) due to a decomposition of the starting material. 
Again, low yields are obtained when the reactions are performed in the presence of p-
TsOH (35%, R 129) in toluene and SOCl2 (25%, R 130) in pyridine180. Finally, high 
yields are obtained when the reaction is performed in the presence of P2O512 in toluene 
O
HO
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O
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-H2O
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  conditions
O
215
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O
216
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64%
H2
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(73%, R 132). Alternative reaction conditions need to be employed if considering 
difficulties to isolate the compound 96 from the crude mixture. Thus, DBU-EtOH181 
turns out to be an efficient system towards the preparation of bicyclo[9.4.1]hexadec-12-
en-16-one (96) in high yield (85%) after acidic workup (R 133). 
 
Table 23: Preparation of bicyclo[9.4.1]hexadec-12-en-16-one (96). 
R Acid / Base Solvent t, [h] ϑ, [°C] 96, [%] 
R 128 H2SO4 toluene 20 20 15 
R 129 p-TsOH toluene 20 20 35 
R 130 SOCl2 pyridine 12 20 25a
R 131 CuSO4/SiO2 toluene 20 120 -- 
R 132 P2O5 toluene 18 120 73 
R 133 DBU EtOH 16 80 85 
a) conversion detected by GC analysis. 
 
Hydrogenation of compound 96 was carried out in the presence of Pd/C in AcEt182 (R 
134) to furnish compound 215 in 64% as a single diastereoisomer (Scheme 99). 
Saturated ketone 215 was then treated with oxidative agent such as peracetic acid 
(PAA) (217) and m-CPBA (212) under different conditions as listed in Table 24. 
 
Table 24: Baeyer-Villiger on bicyclo[9.4.1]hexadecan-16-one (215) 
R Oxidant Catalyst Solvent t, [h] ϑ, [°C] 216, [%]
R 135 PAA NaHCO3 CH2C12 10 0 -- 
R 136 m-CPBA NaHCO3 CHC13 20 20 -- 
R 137 m-CPBA NaHCO3 CHC13 48 80 -- 
R 138 PAA BF3·OEt2 CH3CC13 120 50 -- 
 
The reaction conducted with PAA in the presence of NaHCO3 as buffering agent at 0°C  
(R 135) does not lead to the lacton 216. The outcome of the reaction does not change by 
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replacing PAA (217) with m-CPBA (212) (R 136) or in refluxing chloroform (R 137) 
and again starting material is recovered. Moreover, reaction of compound 96 with an 
excess of PAA (217) in CH3CCl3 and catalytic amount of BF3·OEt2 at high temperature 
(50°C) failed (R 138). 
Proceeding with investigations of Baeyer-Villiger oxidation the 
bicyclo[9.3.1]pentadecan-15-one (218) and β-ketoester 219 are chosen as starting 
materials (Scheme 100). Such compounds are synthesized in high yield via analogous 
hydrogenation of compound preparated above, by treating in the presence of Pd/C in 
AcEt at room temperature. Both compounds 218 and 219 are isolated as white solids 
after recristallization from cyclohexane (R 139, R 141).  
Toda et al183 have observed a remarkable acceleration in the rate of the Baeyer-Villiger 
reaction for sterically congested ketones by the addition of powdered sodium 
bicarbonate under solvent-free conditions184. According to the procedure reported by 
Yakura et al.185 the reaction is carried out dissolving the solid reactants 218 and 219 in 
CHC13 and after immediate evaporation of the solvent, starting the reaction. After 
workup, the lactones 220 and 221 are not detected and only starting material are 
recovered (R 140, R 142). 
 
 
Scheme 100: Attempted Baeyer-Villiger oxidation of bicyclo[9.3.1]pentadecan-15-one 
(218)  
 
From all these results, it could be concluded that the preparation of macrocycles could 
not accomplished by means of the Baeyer-Villiger oxidation and an alternative 
procedure has to be investigated.  
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2.7.3. Fragmentation reactions of bridged compounds 
2.7.3.1. Introduction 
System containing a function with a negative charge or an unshared electron pair and a 
leaving group in 1,4-relationship are known to undergo heterolytic fragmentation 
process. In extension 1,3-diol derivatives may undergo concerted base-promoted 
fragmentations to give a carbonyl compound (Y=oxygen), an alkene and an anion as 
shown in Scheme 101. 
 
 
Scheme 101: Basic mechanismus of fragmentation  
 
The one-step synchronous fragmentation is allowed only when the compound can adopt 
a conformation where the leaving group X as well as the electron pair of the electrofuge 
Y is antiperiplanar to the C2-C3 bond. 
Effective examples to demonstrate the synthetic power of these methods are shown by 
the preparation of Exaltone and Muscone via Eschenmoser-type fragmentation186. 
Starting from the α,β-unsaturated ketones (222) and proceeding via the epoxy ketones 
(223) the tosylhydrazone 224 is cleaved to give the cycloalkanones such as Exaltone 
and Muscone after hydrogenation of compound 226 (Scheme 102). 
 
 
 
 
 
 
 
 
C3 C2
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Y
X
+Y + + X-
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Scheme 102: Preparation of Exaltone and Muscone via Eschenmoser-type 
fragmentation 
 
The versatile utility of fragmentation, especially those of 1,3-diol monosulfonate, for 
the construction of functionalized medium-sized cycloalkenes was demonstrated by 
Wharton187,188 by applying Grob’s observations189. Stereochemical arrangement has 
been investigated by Wharton  for the four stereoisomeric tosylates (Scheme 103). 
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Scheme 103: Stereochemical arrangement in the fragmentation reaction 
 
Compounds such as 227, 229 and 232 show the crucial bond to be anti, and in these 
cases fragmentation to the cyclododecenone 228 and 231 occurs in 90% yield . The 
stereochemistry of C-C bond forming the double bond is strictly retained (227, 229 
gives 228; 232 gives 231). The isomer 230, having the bonds which may undergo 
cleavage in a gauche orientation remains largely unchanged. On the other hand, it has 
been found that the synperiplanar relationship between breaking bonds is required for 
facile fragmentation in a bridged bicyclic system190. 
An alternative procedure under acetalization condition has been reported by Sakai et al. 
191. Here cyclopentanone and cyclohexanone of type 232 with carbonyl functions in an 
appropriate position in a side chain undergo facile ring cleavage to construct a new ring. 
Particularly useful is the reaction sequence starting from a cyclopentanone with 
carbonyl function at the C-3 position of the α-position side chain (Scheme 104).  
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Scheme 104: Unusual Grob fragmentation via acetalization conditions (Sakai’s 
investigations). 
 
After aldol addition and acetalization a fragmentation takes place, which may be 
considered as one of the unusual cases of the Grob fragmentation . This ring expansion 
has been applied to the synthesis of bulnesol . Similarly, bicyclo[m.n.0]alkanes are 
converted to spirocyclic skeletons . 
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2.7.3.2. Attempted fragmentation under acetalization conditions  
As above reported, by treatment with BF3·OEt2/ethyleneglycol, cyclopentanones with 
carbonyl function at the exposition of α-side chain undergo the ring cleavage to build 
up the seven membered rings. The expected ring enlargement to fourteen membered 
ring would involved the following three steps; a) aldol condensation, b) acetalization, c) 
ring enlargement due to the cleavage of the five membered ring as shown in Scheme 
104.  
Following the procedure reported by Tanaka at al. , treatment of the ketoaldehyde 145 
under the acetalization conditions at room temperature, for 16 hours, furnishes the β-
hydroxy ketone 168 in 63% yield (Scheme 105) whereas the desired half ethyleneglycol 
ester 123 is not observed (R 143). 
 
 
Scheme 105: Preparation of 12-hydroxy bicyclo[9.3.1]pentadecan-16-one (145) 
 
Thus, it is likely that the aldehyde is too reactive and an aldol addition occurs before the 
acetalization could take place and then this reaction could be not applied for the ring 
transformation. 
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2.7.3.3. Grob fragmentation of bicyclo[9.4.1]hexadecan-16-one derivatives 
An alternative method for preparation of 14-, 15-membered ring via fragmentation 
reaction of bridged rings could be accomplished by means of macrocyclic compound of 
type 239. 
Synthesis of a fragmentable bicyclic precursor (Scheme 106) from β-hydroxy ketone 50 
requires stereoselective conversion into of keto tosylate 238, which has to bear the 
equatorial leaving group in order to satisfy the rigorous anti-periplanar geometry 
required of the breaking bonds in the transition state192 (Scheme 106). 
Treatment of the crude mixture of 50, with 1 equiv. of tosyl chloride (237), in 
pyridine193 for 72 hours at room temperature, furnishes the keto tosylate 238 in 87% 
yield as a white solid (R 144).  
 
 
Scheme 106: Preparation of 1-cyclopentadec-5-enyl-methanol (239) 
 
The fragmentation of tosylate 238 employed lithium aluminum hydride as a combined 
basic initiator and reducing agent furnishes, as expected, 1-cyclopentadec-5-enyl-
methanol (239) in 88% yield (R 145). 
Although, the most widely used leaving group in heterolytic fragmentation process is 
the tosylate or mesylate group, no study has been performed to provide data on how the 
rate of fragmentation vary as a function of the leaving group. Alternatively, iodine could 
be employed if comparing the reaction time of both reaction for the formation of 
intermediates 238 and 241 (R 144 and R 146). A rapid and convenient procedure for the 
preparation of iodide ketone 241 is the application of Appel reaction194, described by 
Gottardo et al.195 employing the PPh3/I2/imidazole combination in dichlorometane 
solvent (R 146). 
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Scheme 107: Preparation of 1-cyclopentadec-5-enyl-methanol (247)  
 
The reaction is carried out at room temperature for a period of 16 hours and after 
filtration on a pad of silica gel furnishes the compound 241 in 85% yield (R 146). 
According to the previous results, the fragmentation step is performed in the presence of 
LiAlH4 under refluxing conditions and, as expected, the reaction proceeds with the 
formation of 1-cyclopentadec-5-enyl-methanol (242) (R 147). In an approach to the 
substituted fourteen-membered ring ethyl rac-(1R*, 11S*, 12R*)-12-hydroxy-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (174) is chosen as starting material. According to 
the previous procedure, compound 243 is prepared via the Appel reaction  from the 
corresponding alcohol 174 (R148).  
 
 
Scheme 108: Attempted fragmentation reaction of ethyl 15-oxo-12-iodo-
bicyclo[9.3.1]pentadecan carboxylate (243). 
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Conversion of 174 with iodine and PPh3 occurs via a nucleophilyc substitution and 
according to reaction mechanism the result proceeds with an inversion of the 
configuration at C-12 (Scheme 108). In order to confirm the stereochemistry of the 
compound 243 an X-Ray analysis is required. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 109: Crystal structure of ethyl rac-(1R*, 11S*, 12S*)-15-oxo-12-iodo-
bicyclo[9.3.1]pentadecan carboxylate (243) 
 
 
Ethyl rac-(1R*, 11S*, 12S*)-15-oxo-12-iodo-bicyclo[9.3.1]pentadecan carboxylate 
(243) is described as a trans-fused bicyclic system196 (Scheme 109). The carbonyl group 
lies on the same side as the carbethoxy function and iodine. The six membered rings 
have a chair conformation. The axial iodide bicyclic β-ketoester 243 does not undergo 
fragmentation process. The outcome of the reaction is in contrast with the previously 
results (Scheme 14). The compound 243 reacts differently toward LiAlH4. Indeed, the 
reaction carried out in the presence of LiAlH4 (R 149) proceeds with high yield into 
formation of 1-hydroxymethyl-bicyclo[9.3.1]pentadecane-15-ol (244) and the difference 
could be attributed to stereoeletronic effects. The presence of bridgehead ester group is 
crucial to the fragmentation of axial iodide. In fact, in the system without the ester 
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group, the keto tosylates 239 or iodide 241 is found to fragment whereas the axial 
iodide 243 undergoes reduction and elimination. An X-ray analysis is investigated for 
the compound 244.  
 
 
Scheme 110: Crystal structure of 1-hydroxymethyl-bicyclo[9.3.1]pentadecane-15-ol 
(244)197
 
The investigated crystal is described as a bicyclic trans - system. Both hydroxy groups 
lie on the same side, whereas the six-membered rings has a distorted-chair lies in the 
opposite side. 
From all these results, although the last investigation is not the desired fourteen-
membered ring, the method could be considered an important method because it 
represent a net chemoselective fragmentation of equatorial 1,3-diol derivatives.  
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3. Conclusion and outlook 
In this work an investigation on the ring expansion methods involved in the preparation 
of fourteen-, fifteen-membered rings towards the construction of Exaltone and Muscone 
via bridged compounds was conducted. Following preliminary results observed by 
Hollmann concerning the sequential hydroformylation / aldol addition, a variety of 
unsaturated ketones or ketoester have been chosen as starting materials as depicted in 
Scheme 111. 
 
 
Scheme 111: Sequential hydroformylation / aldol addition of unsaturated substrates. 
 
First the sequential hydroformylation / aldol addition was tested for 2-alkenyl-
cyclododecanone 48, 66 and 68 are employed (Scheme 112). Preliminary studies have 
shown that the one-pot sequence proceeds with the formation of a bicyclic compound if 
2-allylcyclododecanone (R=H, n=1, 48) is employed giving the compound 50 in high 
yield (71%). Under the same conditions, the substituted allyl chain (R=CH3, n=1, 66) 
and homologated allyl chain (R=H, n=2, 68) do not allow the formation of bridged 
system.  
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Scheme 112: Reactivity of 2-alkenyl-cyclododecanone (48, 66 and 68) under tandem 
hydroformylation / aldol cyclisation  
 
For the compound 68 only the n-product resulting from simple hydroformylation 50 is 
obtained in 87% yield, whereas compound 66 with substituted chain undergoes 
isomerizzation of the double bond (88). 
Proceeding with these investigations the sequential tandem hydroformylation / aldol 
addition were tested with the keto ester 74, 75 and 73, as depicted in Scheme 113. 
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Scheme 113: Reactivity of ethyl 2-alkenyl-cyclododecanone carboxylate (74, 75 and 
73) under tandem hydroformylation / aldol cyclisation. 
 
Although the aldol addition is observed in low yield when compound 74 is used, upon 
hydroformylation in the presence of mild acid catalysis the α-substitued ketoester 
designed for the preparation of macrocycle derivatives gave no aldol products. As an 
alternative various Z(O)-silyl enol ethers of the unsaturated ketones 117 and ketoesters 
118 and 119 were similarly converted. 
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Scheme 114: Attempted synthesis of bridged compounds via hydroformylation 
 /Mukaiyama aldol additions 
 
This method allowed access to the aldehyde 119 if starting from enolsilane 116 in 93% 
yield. For the others enolsilanes 116 and 118 under the same hydroformylation 
conditions only the desilylation process was observed. Once again, the directed 
preparation of the bicyclic compounds could not be accomplished via this methodology.  
Finally, a cascade reaction via enolboration / hydroformylation / aldol addition was 
investigated accomplishing the formation of bridged system in all cases.  
The reactions proceed with good yields, unless when 2-allyl-cyclododecanone (48) gave 
compound 50 is isolated in 20% yield.  
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Scheme 115: Preparation of bridged compounds via enoboration /hydroformylation / 
aldol additions of 2-alkenyl-cyclododecanone 
 
On the other hand, for trisubstituted olefin in subtrates as compound 66 and 75 the 
reactions proceed with good yield into the formation of bicycles 97 and 139, 
respectively. No isomerization process of the double bond is observed. 
 
 
Scheme 116: Synthesis of bridged compounds via enoboration/hydroformylation / aldol 
additions of β-keto ester. 
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Moreover, a control of stereoselectivity could be achieved. The reaction cascade of the 
substrate 140 that bears more than one enolizable site, proceeds with formation of the 
more sterically hindered aldol adduct 142.  
Proceeding in the studies towards the preparation of bridged systems, the conversion of 
the β-ketoester 72 into β-hydroxy[9.3.1]pentadecan-15-one could be performed starting 
from cyclododecanone or its derivatives by a Michael reaction employing the α,β-
unsaturated aldehydes (166, 169, 179). All investigations suggest that the selectivity of 
condensation could be controlled by the modification of temperature, time and base 
(Scheme 117). While, an aldol addition occurs to give compounds of type 174-176 
regardless the base used (K2CO3, NaOH, DBU and Na/EtOH), only Michael addition is 
observed if K2CO3 in acetone is used at room temperature for 24 hours furnishing 
compound 171-173. 
 
 
Scheme 117: Study of reactivity of β-ketoester 72 with variation of reaction conditions 
 
An aldol condensation furnishing unsaturated β-ketoester 177, 183 and 193 takes place 
if K2CO3 or DBU in EtOH is used and the reactions are carried out under refluxing 
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solvent and long reaction time. Furthermore, NaOH in EtOH or NaOR are able to 
undergo the aldol condensation even at room temperature in a period of 24 hours. 
Moreover, although in low yield a sequential Michael addition / aldol condensation / 
decarboxylation is observed in the presence of NaOH / EtOH under refluxing conditions 
for a period of 72 hours and the β-enones 167, 185 are isolated in 7 % and 21 % yield, 
respectively.  
A preliminary investigation towards the preparation of tricyclic system (Scheme 118) 
was attempted via sequential hydroformylation / aldol addition starting from 
compounds compound 197. Using this method, the cyclized product 201 is obtained in 
43% yield.  
 
 
Scheme 118: Preparation of methyl 18-hxdroxy-19-oxo-
tricyclo[9.7.10.1.14]nonadecan-11-carboxylate (201). 
 
In completion of this work, the synthesis of macrocycles involved in the preparation of 
musk compounds was attempted. While the bridged system 238 and 241 could smoothly 
undergo Grob fragmentation furnishing the fifteen-membered rings 239 and 242 in 
excellent yield (Scheme 119), a failure of the method is observed if the reaction is 
carried out with compound 174. Instead, only the compound 244 resulting from a 
reduction is isolated in 75 % yield (Scheme 119). 
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Scheme 119: Bridged system involved in fragmentation reaction. 
 
At present, until further optimizations are successful, the fragmentation procedure is a 
fast and high-yielding approach for the preparation of fifteen-membered rings, as 
potential intermediates of odour musk or its derivatives. 
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4. Experimental Part 
4.1. General Aspects 
 
Reagent, solvents and synthesized catalyst  
All reagents were purchased from commercial sources and were used withouth further 
purification unless otherwise stated. THF and Et2O were distilled over sodium metal 
and benzophenone, while CH2Cl2 and triethylamine were distilled over CaH2.  
The [Rh(cod)Cl]2 catalyst used in hydroformylation was prepared via the method of 
Crabtree198, while the Rh(CO)2(acac) hydroformylation catalyst and RhCl·3H2O were 
donated by Degussa AG, Düsseldorf. 
 
Spectroscopic and analytical methods 
1H and 13C NMR spectra were recorded on Bruker DRX 400, 500 instruments. CDC13 
was used as the solvent, and both proton and carbon spectra were referenced to CHCl3 
(δ 7.25 and δ 77.00). The assignment of the signals in most cases is based on H,H-, 
C,H- und long range C,H-correlation spectroscopy. All 1D-NMR spectra were Fourier 
transformed using Bruker WINNMR software and plotted using the ACDLABS 
SpecMan software suite. IR spectra were acquired using Nicolet Impact 400 D using 
neat compounds or thin films in CDCl3 between KBr. High resolution analytical mass 
spectra HR-FABMS and HR-EIMS were recorded on JEOLJMS-SX 102 A and 
Finnigan MS 8200, respectively Elemental analysis were recorded with a Leco CHNS-
932. Melting points (mp) were determined using Büchi melting point apparatus B-540 
and are not corrected.  
 
Chromatoghraphic / purification methods 
Analytical gas chromatography was carried out on a Fisons 8130 gas chromatograph 
with 25 m CP-sil-5(CB) capillaries. Detection was accomplished via a flame-ionization 
detector. TLC was performed exclusively on aluminium-backed Merck F254 silica gel 
60 plates, with the appropriate running solvents. Column chromatography was 
performed using gel silica 60 (size 0.063-0.200 nm). Filtration subsequent to 
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hydroformylation in order to remove residue were performed with Merck alumina, 
neutral activity. 
 
Working methods. 
Reactions are performed in normal laboratory glassware with round glass joints, and 
reactions requiring an inert atmosphere were run under positive pressure of argon. 
Pressure reactions have been carried in autoclaves (250 ml, type A, PTFE-insert) from 
Berghof, Eningen, Germany, and similar autoclaves (70 ml, stainless steel). 
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4.2. One-pot hydroformylation / aldol addition of 2-alkenyl 
cyclododecanones and unsaturated β-ketoesters 
4.2.1. Preparation of starting materials 
Preparation of 2-allyl-cyclododecanone (48). 
R 1:  To 50.0 ml of abs. methanol containing 5.0 g (27.0 mmol) of cyclododecanone 
(11) and 6.9 ml (5.0 g, 44.0 mmol) of allytrimethylsilane (62), 4.5 g (82.0 mmol) of 
CAN are added. The orange mixture is stirred at room temperature until the color 
disappeared. After 16h, the solvent is removed under reduced pressure. The residue is 
dissolved in 30 ml of diethylether and washed with water (3 x 30 ml). The combined 
organic layers are dried over anhydrous MgSO4 and the solvent is removed in vacuum. 
The residue is purified by column chromatography on silica gel using a mixture of 
cyclohexane-MTBE (20:1) as eluent to give 3.5 g (15.6 mmol, 58 % yield) of 2-allyl-
cyclododecanone (48) (C15H26O, 222.37 g / mol) as a colorless oil. Its spectroscopic 
data are consistent with those reported in ref. 71. 
 
 
R 2:  A solution of 22.0 ml (3.54 g, 55.0 mmol) of a solution of n-butyllithium (2.5 M 
in n-hexane) is added dropwise over a period of 30 min. to a cold (0°C) solution of 7.6 
ml (5.54 g, 55 mmol) of freshly distilled of diisopropylamine in THF. After 20 min 10.0 
g (55.0 mmol) of cyclododecanone (11) is added and the mixture is stirred for 30 min. 
5.9 ml (7.9 g, 66.0 mmol) of 3-bromo-1-propene (63) in THF is added dropwise. The 
reaction mixture is maintained at 0°C for 45 min. and gradually warmed to room 
temperature and is maintained at room temperature for 16 hours. Then, 30 ml of a 
solution of HCl (5 %) is added, and the aqueous layer is extracted three times with 
diethylether (3 x 40 ml). The organic layer is washed once with 30 ml of a solution of 
HCl (5 %) and once with brine and dried over anhydrous MgSO4. The solvent is 
removed in vacuum giving a crude product. Distillation of the resulting mixture under 
reduced pressure (3 x 10-2 mbar) at 90°C gives 5.2 g of 2-allyl-cyclododecanone (48) 
(23.5 mmol, 87 % yield) (C15H26O, 222.37 g / mol) as a colorless oil. Its spectroscopic 
data are consistent with those reported in ref. 71. 
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R 3:  To a solution containing 2.0 g (10.9 mmol) of cyclododecanone (11) in 45 ml of 
THF, under argon, is added at 0°C a solution of 4.5 ml (0.6 g, 10.9 mmol) of n-
butyllithium (solution in n-hexane 2.5 M). The mixture is stirred for 1h, then, 1.1 ml 
(1.56 g, 13.0 mmol) of 3-bromo-1-propene (63) is added at 0°C. The temperature is 
increased to 20°C and the solution is stirred for 16h. Then, 30 ml of water is added and 
the aqueous layer is extracted with diethylether (3 x 30 ml). The combined organic 
layers are dried with MgSO4 and the solvent is removed in vacuum. Distillation under 
reduced pressure (2 x 10-2 mbar) at 90°C gives 1.5 g (6.8 mmol, 63 % yield) of 2-allyl-
cyclododecanone (48) (C15H26O, 222.37 g / mol). Its spectroscopic data are consistent 
with those reported in ref. 71. 
 
 
R 4:  A mixture of 50.0 ml of abs. methanol containing 2.0 g (10.9 mmol) of 
cyclododecanone (11) and 1.52 g (10.9 mmol) of K2CO3 is stirred for 1h, then, 1.6 ml 
(1.56 g, 13.0 mmol) of 3-bromo-1-propene (63) is added and the solution is stirred at 
80°C for 16h. After cooling, the solvent is removed under reduced pressure. The residue 
is dissolved in 40 ml of diethylether and washed with water (3 x 30 ml). The combined 
organic layers are dried over anhydrous MgSO4 and the solvent is removed in vacuum. 
Starting material is recovered. 
 
 
R 5:  A mixture of 10.0 g (55.0 mmol) of cyclododecanone (11), 6.5 ml (7.9 g, 66 
mmol) of 3-bromo-1-propene (63) in 80 ml of abs. toluene is heated with 6.0 g (105 
mmol) of finely ground potassium hydroxide in the presence of 40.0 mg (1 mol %) of 
the catalyst phase transfer dibenzo-[18]-crown-6 for 4 hours. The reaction mixture is 
poured into 50 ml of water, and the organic layer is separated, washed with water (3 x 
20 ml), and dried over anhydrous MgSO4. After removing of solvent the crude product 
is distilled under vacuum 90°C (4.5 x 10-2 mbar) to give 9.6 g (43.4 mmol, 79 % yield) 
of 2-allyl-cyclododecanone (48) (C15H26O, 222.37 g / mol) as a colorless oil. Its 
spectroscopic data are consistent with those reported in ref. 71. 
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Preparation of 2-(2-methylprop-2-enyl)-cyclododecanone (66) 
R 6:  A solution of 30.0 g (164.0 mmol) of cyclododecanone (11) in 80 ml of abs. 
THF is added dropwise over 30 min. to a suspension of 8.8 g of NaH (382 mmol, 60 % 
suspension in mineral oil) in 120 ml of abs. THF containing 66.3 ml (16.6 g, 382 mmol) 
of HMPA at RT under Argon. The reaction mixture is heated to reflux for 30 min, then, 
16.6 ml (14.8 g, 164 mmol) of 3-chloro-2-methylprop-1-ene (64) in abs. THF is added 
dropwise. The reaction mixture is heated to reflux for 16 hours and poured into 150 ml 
of diethylether. The organic layer is washed with a solution of sodium thiosulfate 
solution (5 %, 200 ml) and once with water (100 ml). The aqueous layer is extracted 
three times with diethylether, dried over MgSO4 and filtrated. After removing of solvent 
the crude product is distilled under vacuum 90°C (4.5 x 10-2 mbar) to give 38.0 g (161 
mmol, 98 % yield) of 2-(2-methylprop-2-enyl)-cyclododecanone (66) (C16H28O, 236.40 
g / mol) as a colorless oil. Its spectroscopic data are consistent with those reported in 
ref. 78. 
 
 
R 7 Amounts: 
  30.0 g   (164 mmol)  cyclododecanone (11) 
  14.8 g   (164 mmol)  3-chloro-2-methylprop-1-ene (64) 
  11.5 g   (180 mmol)  n-BuLi 
  18.8 g   (180 mmol)  diisopropylamine 
  150 ml    abs. THF 
Procedure: Analogously to R 2 
Starting material is recovered as a crude product. 
 
 
R 8 Amounts: 
  30.0 g    (164.0 mol)  cyclododecanone (11) 
  22.14 g  (164.0 mol.)  3-bromo-2-methylprop-1-ene (65) 
  11.52 g  (180.0 mmol) n-BuLi 
  18.8 g    (180.0 mmol) diisopropylamine 
  150 ml    abs. THF 
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Procedure: Analogously to R 2, 18h, 20°C. 
After removing of solvent the crude product is distilled under vacuum 90°C (4.5 x 10-2 
mbar) to give 33.0 g (139 mmol, 85 % yield) of 2-(2-methylprop-2-enyl)-
cyclododecanone (66) (C16H28O, 236.40 g / mol) as a colorless oil. Its spectroscopic 
data are consistent with those reported in lit. 78. 
 
 
R 9 Amounts: 
  10.0 g    (55.0 mmol)  cyclododecanone (11) 
  6.0 g    (66.0 mmol)  3-chloro-2-methylprop-1-ene (64) 
  14.7 g    (105 mmol)  potassium hydroxide 
  36.0 mg  (1 mol %)  dibenzo-[18]-crown-6 
  150 ml    abs. toluene 
Procedure: Analogously to R 5, 64 h, refluxing toluene. 
After removing of solvent the crude product is distilled under vacuum 80-90°C  
(4.5 x 10-2 mbar) to give 9.3 g (39 mmol, 71 % yield) of 2-(2-methylprop-2-enyl)-
cyclododecanone (66) (C16H28O, 236.40 g / mol) as a colorless oil. Its spectroscopic 
data are consistent with those reported in lit 78. 
 
 
Preparation of 2-(but-3-enyl)-cyclododecanone (68) 
R 10:  A solution of 2.0 ml (4.0 g, 30 mmol) of 4-bromobut-1-ene (67) in 15 ml of t-
butanol is added dropwise to a stirred solution of 5.0 g (55 mmol) of cyclododecanone 
(11), 3.4 g (30.1 mmol) of potassium t-butoxide in 50 ml of t-butanol. 262.0 mg of KI 
are added under stirring at room temperature. The mixture is stirred at room temperature 
for 2h. Then, the reaction mixture is stirred at 80°C on oil bath for 22 hours. The cooled 
reaction mixture is diluted with 40 ml of water, extracted with diethylether (3 x 40 ml), 
and after removing of solvent under reduced pressure starting material is recovered. 
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R 11 Amounts: 
  10.0 g   (55.0 mmol)  cyclododecanone (11) 
  8.9 g   (66.0 mmol)  4-bromobut-1-ene (67) 
  14.7 g   (105.0 mmol) potassiumhydroxide 
  36.0 mg  (1 mol %)  dibenzo-[18]-crown-6 
  150 ml    abs. toluene 
Procedure: Analogously to R 5. 
Starting material is recovered. 
 
 
R 12 Amounts: 
 5.0 g (27.0 mmol)  cyclododecanone (11) 
 3.7 g (27.0 mmol)  4-bromobut-1-ene (67) 
 1.9 g (29.7 mmol)  n-BuLi 
 2.9 g (29.7 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2, 18h, 20°C. 
After removing of solvent the crude product is distilled under vacuum 95°C (5.2 x 10-2 
mbar) to give 0.9 g (4.0 mmol, 15 % yield) of 2-but-3-enylcyclododecanone (68) 
(C16H28O, 236.40 g / mol) as a colorless oil. 
 
 
R 13:  To a solution of 10.0 g (109.0 mmol) of cyclododecanone (11) in 60 ml of 
toluene are added 22.0 ml (21.0 g, 250 mmol) of morpholine (69) and 
1.5 g (7.45 mmol) of p-TsOH (5 mol %). The mixture is stirred at 
reflux temperature for 48 hours. Then, the solution is allowed to cool at 
room temperature and the solvent removed under reduced pressure. 
The crude product is purified by bulb to bulb distillation at 85°C (4 x 
10-2 mbar) giving 23.2 g (92.6 mmol, 85 % yield) of 4-cyclododec-1-
en-1-yl-morpholine (70) (C16H29NO, 251.41 g / mol) as a colorless 
liquid. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ  [ppm] = 
4.32 (t, 1H, 3J = 7.7 Hz, CH), 3.67 (m, 4H, CH2), 2.71 (m, 4H, CH2), 
   Experimental part 
2.17 (t, 2H, 3J = 7.0 Hz, CH2), 2.06 (m, 2H, CH2), 1.47-1.24 (m, 16H, CH2). 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 148.23 (CH=C), 106.17 (CH=C), 67.17 (2 x CH2), 
49.28 (2 x CH2), 28.60 (CH2), 25.22 (CH2), 25.14 (CH2), 24.74 (CH2), 24.54 (CH2), 
23.64 (CH2), 23.07 (CH2), 22.67 (CH2), 22.48 (CH2), 22.17 (CH2).  
 
 
R 14: A solution of 5.0 g (2.0 mmol) of 4-cyclododec-1-en-1-yl-morpholine (70) in 50 
ml of abs. THF is added to 2.4 ml (2.3 g, 20 mmol) of butylmagnesiumchloride in abs. 
THF and the mixture is heated to reflux for 2 hours and cooled. 2.0 ml (2.7 g, 20 mmol) 
of 4-bromobut-1-ene (67) in 15 ml of abs. THF is added slowly and the resulting 
mixture is heated at reflux for 15 hours and cooled. After hydrolysis with 30 ml of a 
solution of HCl (10 %) at reflux for 20 h, the mixture is extracted with diethylether (3 x 
40 ml). The organic layer is washed with 30 ml of a solution of NaHCO3, dried and the 
solvent removed. Starting material is recovered. 
 
 
R 15:  In a three-necked flask, equipped with a reflux condenser and dropping funnel, 
are placed 24.0 g (0.5 mmol, 60 % suspension in mineral oil) of NaH in 80.0 ml of abs. 
THF. 35.7 ml (47.5 g, 0.4 mmol) of diethylcarbonate (71) in 80 ml of abs. THF are 
added dropwise with stirring. A solution 38.5 g (0.2 mmol) of cyclododecanone (11) in 
120.0 ml of THF is added dropwise over a period of one hour. After the addition is 
completed, the reaction is stirred at 120°C for 24 hours. Then the mixture is cooled to 
0°C and a solution of acetic acid and water (3:1) is added carefully. The organic phase 
is separated, and the aqueous layer is extracted with Et2O (3 x 30 ml). The combined 
organic layers are washed with 30 ml of a solution of NaHCO3; the organic layer is 
separated and dried over MgSO4. After removing of the solvent, distillation of the 
resulting mixture under reduced pressure (3 x 10-2 mbar) at 90°C gives 39.6 g (156 
mmol, 78 % yield) of ethyl 2-oxo-cyclododecane carboxylate (72) (C15H26O3, 254.37 g / 
mol) as a colorless oil. Its spectroscopic data are consistent with those in ref.82 
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R 16 Amounts: 
 10.0 g (38.7 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 5.8 g (60.4 mmol)  4-bromobut-1-ene (67) 
 4.8 g (38.7 mmol)  t-BuOK 
 0.3 g (3 mol %)  KI 
 150.0 ml   t-BuOH 
Procedure: Analogously to R 10 
After removing of solvent the crude product is distilled under vacuum 90°C (4.5 x 10-2 
mbar) to furnish 9.0 g (29.4 mmol, 76 % yield) of ethyl 1-but-3-enyl-2-oxo-
cyclododecane carboxylate (73) (C19H32O3, 308.46 g / mol) as a colorless oil.  
Spectroscopic data: 1H-NMR (500 MHz, 
CDCl3): δ [ppm] = 5.74 (tdd, 1H, 3J = 16.9 Hz, 3J = 10.2 
Hz, 3J = 6.23 Hz, CH=CH2), 4.99 (dd, 1H, 3J = 16.9 Hz, 
Jgem = 1.7 Hz, CH=CHH), 4.90 (dd, 1H, 3J = 10.2 Hz, Jgem 
= 1.7 Hz, CH=CHH), 4.14 (q, 2H, 3J = 7.2 Hz, CH2CH3), 
2.90-2.87 (dd, 0.5H, 3J = 17.9 Hz, 3J = 2.4 Hz, CH2), 2.86-
2.80 (dd, 0.5H, 3J = 17.9 Hz, 3J = 2.2 Hz, CH2), 2.17–1.95 (m, 8H, CH2), 1.90–1.70 (m, 
4H, CH2), 1.23 (t, 3H, 3J = 7.2 Hz, CH2CH3), 1.31-1.17 (m, 8H, CH2), 0.83 (m, 2H, 
CH2). 13C-NMR (125 MHz, CDCl3): δ [ppm]= 206.95 (CO), 172.78 (CO), 137.79 
(CH=CH2), 114.70 (CH=CH2), 63.10 (Cq), 61.02 (CH2CH3), 33.93 (CH2), 29.33 (CH2), 
28.49 (CH2), 28.16 (CH2), 26.49 (CH2), 26.31 (CH2), 23.44 (CH2), 22.62 (CH2), 21.92 
(CH2), 21.79 (CH2), 21.46 (CH2), 18.86 (CH2), 13.99 (CH2CH3). IR (KBr/film), ν [cm-
1] = 3076 (w), 2923 (s), 2864 (s), 2852 (s), 1746 (s), 1712 (s), 1635 (m), 1464 (m), 1376 
(m). LR-MS (EI, 70 eV): m/z (%) 308 (M+, 19.89), 267 (46.76), 254 (26.04), 109 
(39.67), 95 (66.19), 81 (69.20), 67 (50.64), 55 (100), 41 (76.77). HR-MS (EI, 70 eV): 
Calcd 308.2352, Found 308.2377. 
 
 
R 17:  A solution of 3.0 g (9.7 mmol) of ethyl 1-but-3-enyl-2-oxo-cyclododecane 
carboxylate (73) is decarboxylated by refluxing under argon for 12 hours in 80 ml of an 
aqueous ethanolic solution (2:1) and 1.6 g (29 mmol) of KOH. After cooling, the 
solvent is removed under reduced pressure. The aqueous layers is extracted with 
O
73
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diethylether (3 x 30 ml), the solution is dried over MgSO4 and evaporated. 1.9 g (8.2 
mmol, 85 % yield) of 2-but-3-enylcyclododecanone (68) is isolated by distillation (4 x 
10-2 mbar, 110°C), (C16H28O, 236.40 g / mol) as colorless oil. Spectroscopic data: 1H-
NMR (500 MHz, CDCl3): δ [ppm] = 5.73 (ddd, 1H, 3J = 16.7 Hz, 3J = 10.2  Hz, 3J = 
6.4 Hz, CH=CHH), 4.99 (dd, 1H, 3J = 16.7 Hz, Jgem = 1.50 Hz, CH=CHH), 4.90 (dd, 
1H, 3J = 10.2 Hz, Jgem = 1.5 Hz, CH=CH2), 2.60–2.53 (m, 
2H, CH2), 2.45–2.35 (m, 1H, CH2), 2.04-1.94 (m, 2H, 
CH2), 1.76–1.61 (m, 5H, CH2), 1.59–1.52 (m, 1H, CH2), 
1.43–1.36 (m, 1H, CH2), 1.26–1.15 (m, 7H, CH2), 0.84 (m, 
6H, CH2).  13C-NMR (125 MHz, CDCl3): δ [ppm] = 
214.55 (CO), 138.04 (CH=CH2), 114.93 (CH=CH2), 51.19 
(CH), 37.21 (CH2), 31.65 (CH2), 30.19 (CH2), 29.46 
(CH2), 26.07 (CH2), 25.70 (CH2), 24.02 (CH2), 23.70 (CH2), 23.41 (CH2), 22.51 (CH2), 
22.17 (CH2), 21.85 (CH2). IR (KBr/Film): ν [cm-1] = 3075 (m), 2928 (s), 2864 (m), 
2852 (s), 2721 (w), 1709 (s), 1641 (m), 1468 (m), 1414 (w), 1241 (w), 910 (w). LR-MS 
(EI, 70 eV): m/z (%) = 236 (M+, 18.55), 221 (7.39), 182 (61.69), 125 (16.63), 109 
(30.90), 98 (33.38), 81 (63.29), 67 (51.17), 55 (100), 41 (72.96), 29 (23.10). HR-MS 
(EI, 70 eV): Calcd: 236.2140, Found: 237.5127. 
 
 
Preparation of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
R 18:  A solution of 37.0 ml (5.16 g, 43.0 mmol) of 3-bromo-1-propene (63) in 20 ml 
of abs. THF is added dropwise to a stirred solution of 10.0 g (39.0 mmol) of ethyl 2-
oxo-cyclododecane carboxylate (72) in 45 ml of abs. THF and 1.8 g (78.0 mmol, 60 % 
suspension in mineral oil) of NaH in 15 ml of abs. THF at reflux temperature over a 
period of 30 min. Then, the mixture is stirred at 80°C on oil bath for 22 h. Then, the 
mixture is cooled to 0°C and a solution of acetic acid and water (3:1) is added carefully. 
The organic phase is separated, and the aqueous layer is extracted with Et2O (3 x 30 
ml). The combined organic layers are washed with a solution of NaHCO3; the organic 
layer is separated and dried with magnesium sulfate. After removing the solvent, 
distillation of the resulting mixture under reduced pressure (3 x 10-2 mbar) at 125 °C 
gives 8.5 g (29 mmol, 78 % yield) of ethyl 1-allyl-2-oxo-cyclododecane carboxylate 
O
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(74) (C18H30O3, 294.43 g / mol) as colorless crystals. Melting point: 56-58°C. Its 
spectroscopic data are consistent with those reported in ref 87. 
 
 
R 19 Amounts:  
 10.0 g (67 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 5.3 g (44.0 mmol)  3-bromo-1-butene (63) 
 5.0 g (44.0 mmol)  t-BuOK 
 150 ml    t-BuOH 
Procedure: Analogously to R 10, 90°C. 
After removing the solvent, distillation of the resulting crude mixture under reduced 
pressure (3 x 10-2 mbar) at 125 °C gives 17.5 g (59 mmol, 89 % yield) of ethyl 1-allyl- 
2-oxo-cyclododecane carboxylate (74) (C18H30O3, 294.43 g / mol) as white crystals. 
Melting point: 56-58°C. Its spectroscopic data are consistent with those reported in ref 
87. 
 
 
Preparation of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane carboxylate 
(75) 
R 20 Amounts: 
 10.0 g (67 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 6.9 g (77.4 mmol)  3-chloro-2-methylprop-1-ene (64) 
 1.0 g (38.7 mmol)  NaH 
 6.9 g (38.7 mmol)  HMPA 
 150 ml    abs. THF 
Procedure: Analogously to R 6 
After removing the solvent, the crude product is distilled under vacuum 85°C (4 x 10-2 
mbar) to afford 15.7 g (51 mmol, 76 % yield) of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-
cyclododecane carboxylate (75) (C19H32O3, 308.46 g / mol) as a colorless oil. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ  [ppm] = 4.78 (d, 1H, Jgem = 1.0 
Hz, CHH=C), 4.67 (s, 1H, CHH=C), 4.14 (q, 2H, 3J = 6.9 Hz, CH2CH3), 2.92-2.86 (m, 
2H, CH2), 2.60 (s, 3H, CH3), 2.16-2.02 (m, 6H), 1.84-1.78 (m, 2H, CH2), 1.23 (t, 3H, 3J 
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= 6.9 Hz, CH2CH3), 1.51-1.10 (m, 9H, CH2), 0.84-0.81 (m, 3H, CH2). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 206.42 (CO), 173.14 (CO), 
141.47 (CH=CH2), 114.51 (CH=CH2), 62.97 (Cq), 61.10 
(CH2CH3), 38.06 (CH2), 33.79 (CH2), 32.09 (CH2), 29.18 
(CH2), 26.63 (CH2), 26.34 (CH2), 23.44 (CH2), 23.21 (CH3), 
22.63 (CH2), 22.14 (CH2), 21.98 (CH2), 21.46 (CH2), 13.87 
(CH2CH3). IR (KBr/film), ν  [cm-1] = 3436 (w), 2977 (s), 
2930 (s), 2861 (s), 1741 (s), 1711 (vs), 1643 (w), 1469 (m), 
1445 (m), 1366 (m), 1241 (m), 1182 (m), 1128 (m), 1030 (m), 724 (m), 917 (m). LR-
MS (EI, 70 eV):  m/z (%) = 308 (M+, 32.72), 262 (28.10), 221 (66.47), 142 (56.61), 
101 (100), 77 (59.33), 55 (15.14), 41 (19.48), 29 (12.70). HR-MS (EI, 70 eV): Calcd: 
308.2351, Found: 308.2328. 
 
 
O
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4.2.2. One-pot tandem hydroformylation / aldol addition 
Preparation of 12-hydroxy-bicyclo[9.4.1]hexadecane-16-one (50) 
R 21: A solution of 3.0 g (13.5 mmol) of 2-allyl-cyclododecanone (48), 35 mg (1 mol 
%) of Rh(CO)2(acac), 0.5 g (4 mol %) of BIPHEPHOS (16) and 129.0 mg (5 mol %) p-
TsOH in 100 ml anhydrous CH2Cl2 is placed in an autoclave. After flushing with argon, 
the reactor is pressurized with 20 bar CO/H2 (1:1) magnetically stirred and heated to 60 
°C for 24 hours. Then the autoclave is allowed to cool to room temperature. After 
removing the syn gas, the remaining solution is filtered through alumina N (III) using 
MTBE as eluent. The solvent is removed by rotary evaporation and the residue is 
analyzed by gas chromatography. The crude mixture is filtered through a pad of alumina 
N (III), using cyclohexane / Et2O (3:1). 12-
hydroxybicyclo[9.4.1]hexadecane-16-one (50) (2.4 g, 9.7 mmol, 
71 % yield) (C16H28O2, 252.39 g / mol) is isolated as a mixture of 
two diastereoisomers in a ratio of 11:1 (calculated by NMR 
analysis from OH) as a white solid. Spectroscopic data: 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 3.75, 3.73 (s, 1H, OH), 3.68 (m, 
1H, CH), 3.31-3.24 (m, 2H, CH), 2.79 (td, 1H, 3J = 11.2 Hz, 3J = 
O
50
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2.49 Hz, CH), 2.37-2.31 (m, 2H, CH2), 2.24-2.19 (m, 1H, CH2), 2.13-2.07 (m, 3H, 
CH2), 2.02-1.91 (m, 5H, CH2), 1.84-1.01 (m, approx. 12H, CH2). 13C-NMR (125 MHz, 
CDCl3): δ [ppm] = Mixture of diastereoisomers: 218.51, 218.46, 218.29 (CO), 74.95, 
74.45, 72.15, 71.55 (CH), 55.68, 64.68, 58.93, 55.92 (CH), 52.81, 51.75, 48.79, 45.89 
(CH), 37.13, 37.38, 38.57, 40.03 (CH2), 31.50, 31.70, 31.73, 31.79 (CH2), 29.55 (CH2), 
27.27, 27.30, 27.41, 27.53 (2 x CH2), 26.78, 26.75, 26.81, 26.86 (CH2), 23.75, 23.84, 
24.04, 23.99 (CH2), 23.12, 23.55, 23.58, 23.33, (CH2), 22.88 (CH2), 21.72, 21.75 (CH2), 
21.47, 21.53, 21.56, 21.61 (CH2), 19.66 (CH2). IR (neat): ν  [cm-1] = 3466 (bs), 3413 
(bs), 2928 (s), 2862 (s), 2849 (s), 1692 (s), 1471 (m), 1461 (m), 1448 (m), 1236 (m), 
1136 (m), 1088 (m), 914 (m). Spectroscopic characteristics are consistent with those 
previously reported by C. Hollmann. 
 
 
Hydroformylation of 2-allyl-cyclododecanone (48) 
R 22 Amounts: 
 3.0 g     (13.5 mmol) 2-allyl-cyclododecanone (48) 
 35.0 mg   (1 mol %)  Rh(CO)2(acac)  
 400 mg    (4 mol %)  BIPHEPHOS (16) 
 29.0 mg   (5 mol %)  DBU 
 100 ml    abs. EtOH / dioxane (9:1) 
Procedure: Analogously to R 21. 
The products are then separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1) furnishing 2.1 g (8.2 mmol, 61 %) of 4-(2-oxo-
cyclododecyl)butanal (76) (C16H28O2, 252.39 g / mol) as a colorless oil. Spectroscopic 
data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 9.71 (t, 1H, 3J = 1.2 Hz, CHO), 2.61-
2.49 (ddd, 2H, 3J = 17.0 Hz, 3J = 8.7 Hz, 3J = 3.5 Hz, CH2), 2.40 (td, 2H,  3J = 1.2 Hz, 3J 
= 7.0 Hz, CH2), 1.73-1.46 (m, approx. 12H, CH2), 1.39-
1.04 (m, approx. 11H, CH2). 13C-NMR (100 MHz, 
CDCl3): δ  [ppm] = 214.28 (CO), 202.11 (CHO), 51.93 
(CH), 43.74 (CH2), 36.93 (CH2), 30.22 (CH2), 29.41 
(CH2), 26.05 (CH2), 25.73 (CH2), 23.91 (CH2), 23.47 
(CH2), 23.11 (CH2), 22.22 (CH2), 22.07 (CH2), 21.73 
O
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(CH2), 20.04 (CH2). IR (KBr/film): ν  [cm-1] = 2932 (s), 2864 (s), 2849 (s), 2712 (m), 
1705 (s), 1704 (s), 1469 (m), 1119 (m). LR-MS (EI, 70 eV): m/z (%) = 251 (M-H, 
2.89), 222 (8.54), 182 (40.48), 98 (44.46), 81 (100), 67 (25.71), 55 (66.60), 41 (67.61), 
29 (55.39). 
 
 
Tandem hydroformylation / aldol addition of ethyl 1-allyl-2-oxo-cyclododecane 
carboxylate (74) 
R 23 Amounts: 
 1.0 g   (3.4 mmol) ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
 12 mg   (1 mol %) Rh(CO)2(acac) 
 70 mg   (4 mol %) BIPHEPHOS (16) 
 45.0 mg (5 mol %) p-TsOH 
 20 ml   abs. CH2Cl2 
Procedure: Analogously to R 21 
The products are separated by column chromatography on alumina N (III) with 
cyclohexane / Et2O (2:1) to give 110 mg (0.34 mmol, 10 % yield) of ethyl 12-hydroxy-
16-oxo-bicyclo[9.4.1]hexadecan carboxylate (81) (C19H30O3, 324.45 g / mol) as a 
colorless solid and 990 mg (3.0 mmol, 90 % yield) of ethyl 2-oxo-1-(4-oxo-butyl)-
cyclododecane carboxylate (80) (C19H32O4, 324.45 g / mol) as a colorless oil. The 
compound 81 is obtained as a mixture of diastereoisomers in a ratio of 1.4: 3.2 (detected 
by NMR analysis from CH2CH3). Spectroscopic data of ethyl 2-oxo-1-(4-oxo-butyl)-
cyclododecane carboxylate (80): 1H-NMR (400 MHz, CDCl3): δ  [ppm] = 9.71 (t, 1H, 
3J = 1.2 Hz, CHO), 4.10 (q, 2H, 3J = 6.9 Hz, CH2CH3), 2.82 (ddd, 2H, 3J = 9.9 Hz, 3J = 
3.4 Hz, Jgem = 1.99 Hz, CH2), 2.32 (t, 2H, 3J = 7.2 Hz, 
CH2), 1.90 (m, 4H, CH2), 1.70 (m, 3H, CH2), 1.40 (m, 
1H, CH2), 1.23 (t, 3H, 3J = 6.9 Hz, CH2CH3), 1.31-1.29 
(m, 14H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] 
= 206.95 (CO), 203.03 (CHO), 169.53 (CO), 64.75 (Cq), 
62.63 (CH2CH3), 45.29 (CH2), 35.38 (CH2), 31.09 (CH2), 
29.96 (CH2), 27.92 (CH2), 27.75 (CH2), 24.88 (CH2), 24.04 (CH2), 23.37 (CH2), 23.22 
(CH2), 22.90 (CH2), 20.29 (CH2), 18.03 (CH2), 15.43 (CH2CH3). IR (KBr/film): 
O
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 ν  [cm-1] = 3431 (w), 2930 (s), 2865 (s), 2720 (w), 1739 (s), 1724 (s), 1708 (s), 1468 
(m), 1445 (m), 1365 (w), 1258 (m), 1236 (m), 1127 (m), 1080 (w), 1055 (w), 1031 (w), 
801 (m). GC-MS (EI, 70 eV): m/z (%) = 324 (M+, 3), 321 (48), 293 (3), 229 (5), 254 
(16), 236 (4), 109 (14), 96 (14), 84 (100), 71 (32), 55 (28). 
Spectroscopic data of ethyl 12-hydroxy-16-oxo-bicyclo[9.4.1]hexadecan carboxylate 
(81): 1H-NMR (500 MHz, CDCl3): δ [ppm] = 4.15 (q, 4H, 3J = 7.2 Hz, CH2CH3), 3.84 
(m, 1H, CH), 3.26 (dd, 1H, 3J = 11.9 Hz, 3J = 3.2 Hz, CH), 3.14 (dd, 2H, 3J = 8.4 Hz, 3J 
= 3.2 Hz, CH), 2.16–2.10 (m, 3H, CH2), 2.09–2.01 (m, 5H, CH2), 2.00–1.93 (m, 5H, 
CH2), 1.87-1.34 (m, 8H, CH2), 1.19 (t, 6H, 3J = 7.2 Hz, 
CH2CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 210.86 
(CO), 172.23 (CO), 73.83, 72.56 (CH), 65.81, 63.78 (Cq), 
60.74, 60.64 (CH2CH3), 52.70, 50.84 (CH), 38.19 (CH2), 
37.58 (CH2), 37.32 (CH2), 36.58 (CH2), 35.62 (CH2), 27.84 
(CH2), 27.10, 27.07 (CH2), 27.00, 26.97 (CH2), 23.73, 23.70 
(CH2), 23.64, 23.38 (CH2), 22.36, 22.25 (CH2), 21.81 (CH2), 14.09, 14.05 (CH2CH3). 
IR (neat): ν  [cm-1] = 3507 (s), 2928 (s), 2864 (s), 1731 (s), 1712 (s), 1469 (m), 1454 
(m), 1445 (s), 1252 (m), 1227 (m), 1189 (w), 1122 (m), 735 (m). LR-MS (EI, 70 eV): 
m/z (%) = 324 (M+, 21.72), 306 (10), 278 (35.66), 109 (29.01), 95 (53.15), 81 (71.71), 
55 (100), 29 (76.09). HR-MS (EI, 70 eV): Calcd: 324.2301, Found: 324.2276. 
 
 
Preparation of 5-(2-oxo-cyclododecyl)-pentanal (83) 
R 24 Amounts: 
 2.0 g     (8.0 mmol)  2-but-3-enylcyclododecanone (68) 
 20.16 mg (1 mol %)  Rh(CO)2(acac) 
 16.3 mg   (4 mol %)  BIPHEPHOS (16) 
 24.7 mg   (5 mol %)  p-TsOH 
 50 ml    abs. CH2Cl2
Procedure: Analogously to R 21 
The crude mixture is filtered on alumina N (III) using cyclohexane / Et2O (2:1) as 
eluent. 1.8 g (7 mmol, 87 % yield) are isolated of 5-(2-oxo-cyclododecyl)-pentanal (83) 
(C17H30O2, 266.42 g / mol) as a colorless oil.  
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Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 9.69 (t, 1H, 3J = 1.7 Hz, 
CHO), 2.58 (dd, 2H, 3J = 8.5 Hz, 3J = 3.5 Hz, CH2), 
2.40 (td, 2H,  3J = 1.7 Hz, 3J = 7.0 Hz, CH2), 1.66–
1.46 (m, approx. 12H, CH2), 1.27–1.04 (m, approx. 
13H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] 
= 215.18 (CO), 202.04 (CHO), 50.38 (CH), 42.35 
(CH2), 35.66 (CH2), 29.32 (CH2), 28.11 (CH2), 27.75 
(CH2), 24.64 (CH2), 24.03 (CH2), 22.62 (CH2), 22.18 (CH2), 22.01 (CH2), 21.13 (CH2), 
20.983 (CH2), 20.63 (CH2), 18.95 (CH2). IR (KBr/film): ν [cm-1] = 3432 (w), 2929 (s), 
2862 (s), 2849 (s), 2715 (m), 1707 (s), 1703 (s). 
 
 
Hydroformylation of ethyl 1-(but-3-enyl)-2-oxo-cyclododecane carboxylate (73) 
R 25 Amounts: 
 2.0 g   (6.5 mmol)  ethyl 1-(but-3-enyl)-2-oxo-cyclododecane   
     carboxylate (73) 
 24.0 mg (1 mol %)  Rh(CO)2(acac) 
 70.0 mg (4 mol %)  BIPHEPHOS (16) 
 90.0 mg (5 mol %)  p-TsOH  
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 21 
The crude mixture is filtered by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1). 1.8 g (5.3 mmol, 82 % yield) of ethyl 2-oxo-1-(5-oxo-
penthyl)-cyclododecane carboxylate (87) (C20H34O4, 
338.49 g / mol) are obtained as a colorless oil. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 9.67 (t,  1H, 3J = 1.7 Hz, CHO), 4.10 (q, 
2H, 3J = 6.9 Hz, CH2CH3), 2.80 (dd, 2H, 3J = 10.2 
Hz, 3J = 2.4 Hz, CH2), 2.36 (t, 2H, 3J = 7.2 Hz, 3J = 
1.7 Hz, CH2), 2.12-1.95 (m, 4H, CH2), 1.82-1.73 (m, 
4H, CH2), 1.53-1.45 (m, 1H, CH2), 1.27-1.04 (m, approx. 14H, CH2), 1.23 (t, 3H, 3J = 
6.9 Hz, CH2CH3), 0.79 (m, 1H, CH2). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 206.85 
O
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(CO), 201.56 (CHO), 172.523 (CO), 63.25 (Cq), 61.13 (CH2CH3), 43.79 (CH2), 33.88 
(CH2), 29.58 (CH2), 28.46 (CH2), 26.22 (CH2), 26.75 (CH2), 23.37 (CH2), 22.54 (CH2), 
21.85 (CH2), 21.70 (CH2), 21.38 (CH2), 20.29 (CH2), 18.79 (CH2), 16.51 (CH2), 13.93 
(CH2CH3). IR (KBr/film): ν   [cm-1] = 3501 (w), 2931 (s), 2864 (s), 2705 (w), 1738 (s), 
1708 (s), 1468 (m), 1454 (m), 1366 (w), 1233 (m), 1176 (m), 1129 (m), 1029 (m), 1024 
(m), 1031 (w), 916 (m), 713 (s). LR-MS (EI, 70 eV): m/z (%) = 339 (M++1, 12), 292 
(58.04), 264 (31.64), 236 (12.74), 208 (17), 98 (100), 84 (82.14), 55 (97.87), 41 (88.29), 
29 (60.09). 
 
 
Isomerization of 2-(2-methylprop-2-enyl)-cyclododecanone (66) 
R 26 Amounts: 
 3.0 g  (12.7 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 32 mg   (1 mol %)  Rh(CO)2(acac) 
 129 mg (5 mol %)  p-TsOH 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21 
The crude mixture is filtered on a pad of alumina N (III) using cyclohexane / Et2O (2:1) 
as eluent giving 2.8 g (11.8 mmol, 93% yield) of 2-(2-methyl-propenyl)-
cyclododecanone (88) (C16H28O2, 236.40 g / mol) as a colorless oil. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 5.04 (dd, 0.5H, 3J = 9.2 
Hz, 4J = 1.2 Hz, CH), 5.00 (dd, 0.5H, 3J = 9.2 Hz, 4J = 1.2 Hz, CH), 3.48, (m, 1H), 2.39 
(m, 2H, CH2), 1.68 (d, 3H, 4J = 1.00 Hz, CH3), 1.65 (d, 3H, 
4J = 1.0 Hz, CH3), 1.96 (m, 3H, CH2), 1.55-1.13 (m, approx. 
14H, CH2), 0.86 (m, 1H, CH2). 13C-NMR (100 MHz, 
CDCl3): δ [ppm] = 212.93 (CO), 134.43 (CH=C), 123.18 
(CH=C), 50.85 (CH), 37.88 (CH2), 30.88 (CH2), 26.86 
(CH2), 25.77 (2 x CH3), 25.47 (CH2), 24.90 (CH2), 24.51 
(CH2), 24.30 (CH2), 24.19 (CH2), 23.29 (CH2), 22.21 (CH2). IR (KBr/film): ν [cm-1] = 
3076 (m), 2941 (s), 2869 (m), 2721 (w), 1708 (s), 1640 (m), 1469, 1443 (m), 913 (m). 
LR-MS (EI, 70 eV): m/z (%) = 236 (M+, 24.85), 95 (31.17), 81 (30.70), 67 (57.13), 55 
(57.06), 41 (100), 29 (32.74). HR-MS (EI, 70 eV): Calcd: 236.2140, Found: 236.2105. 
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Hydroformylation of ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane 
carboxylate (75) 
R 27 Amounts: 
 1.0 g  (3.2 mmol)  ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-  
     cyclododecane carboxylate (75) 
 10 mg  (1 mol %)  Rh(CO)2(acac) 
 40 mg   (5 mol %)  p-TsOH 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 21 
A mixture of 439 mg (1.3 mmol, 40%) ethyl 1-(1-oxo-isopropyl)-2-oxo-cyclododecane 
carboxylate (90) and ethyl 1-(4-oxo-2-methyl-butyl)-2-oxo-cyclododecane carboxylate 
(89) (C20H34O4, 338.49 g / mol) is obtained in the ratio 1:1.27 from 1H-NMR (from 
CHaO). Both aldehydes are present as a mixture of diastereoisomers: the compound 89 
is present in a ratio of 1:4 from 1H-NMR (from CHaO); the compound 90 is present as a 
mixture of two diastereoisomers in a ratio of 1:1.1 from 1H-NMR (from CHbO). 
Spectroscopic data of mixture of 
compound 89 and 90: 1H-NMR (500 
MHz, CDCl3): δ [ppm] = 9.70 (t, 1H, 3J 
= 1.7 Hz, CHaO), 9.68 (t, 1H, 3J = 1.7 Hz, 
CHaO), 9.64 (d, 1H, 3J = 1.5 Hz, CHbO), 
9.63 (d, 1H, 3J = 1.2 Hz, CHbO), 4.10 (m, 
6H, CH2CH3), 2.87 (dd, 2H, 3J = 18.2 Hz, 
3J = 3.49 Hz, CH), 2.84 (dd, 2H, 3J = 18.2 
Hz, 3J = 2.74 Hz, CH), 2.38 (dd, 1H, 3J = 1.5 Hz, 3J = 5.7 Hz, CH), 2.35 (dd, 1H, 3J = 
1.5 Hz, 3J = 5.9 Hz, CH), 2.31 (m, 2H), 2.16-1.95 (m, 4H, CH2), 1.91-1.74 (m, 6H, 
CH2), 1.23 (m, CH2CH3), 1.31-1.29 (m, CH2), 0.93 (d, 6H, 3J = 6.7 Hz, CH3 a’/b’), 0.79 
(d, 6H, 3J = 6.4 Hz, CH3 b’/ a’). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 206.69 (CO), 
206.26 (CO), 202.19 (CO), 201.89 (CO), 173.66 (CO), 173.26 (CO), 62.74, 62.26 (Cq), 
61.29, 61.19 (CH2CH3), 61.05, 60.99 (CH2CH3), 52.49 (CH2), 50.69 (CH2), 45.25, 
45.22 (CH), 36.81 (CH2), 36.38 (CH2), 33.88 (CH2), 33.40 (CH2), 29.87, 29.35 (CH2), 
28.67, 28.65 (CH2), 26.52 (CH2), 26.26 (CH2), 24.42, 24.08 (CH), 23.41, 23.36 (CH2), 
22.60, 22.56 (CH2), 21.96 (CH2), 21.91 (CH3), 21.81, 21.76 (CH2), 21.47, 21.41 (CH2), 
90
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19.47 (CH3), 19.14, 19.08 (CH3), 13.84, 13.79 (CH2CH3). LR-MS (EI, 70 eV): m/z 
(%) = 338 (M+, 0.86), 309 (25.76), 292 (100), 266 (2.92), 18 (0.94). 
 
 
4.3. Stepwise hydroformylation aldol reactions 
4.3.1. Hydroformylation reactions 
Preparation of 4-(2-oxo-cyclododecyl)butanal (76) 
R 28 Amounts: 
 3.0 g    (13.5 mmol)  2-allyl-cyclododecanone (48) 
 35.0 mg (1 mol %)  Rh(CO)2(acac) 
 0.5 g  (4 mol %)  BIPHEPHOS (16) 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21, 20 bar CO/H2 (1:1), 24 hours, 60°C 
The crude mixture is filtered on a pad of alumina N (III) using cyclohexane / Et2O (2:1) 
as eluent furnishing 2.3 g (9.0 mmol, 67 % yield) of 4-(2-oxo-cyclododecyl)butanal (76) 
(C16H28O2, 252.40 g / mol) as a colorless oil. Its spectroscopic characteristics are 
consistent with those reported in R 22. 
 
 
R 29 Amounts: 
 3.0 g    13.5 mmol)  2-allyl-cyclododecanone (48) 
 35.0 mg (1 mol %)  Rh(CO)2(acac) 
 0.5 g   (4 mol %)  BIPHEPHOS (16) 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 21, 20 bar CO/H2 (1:1), 48 hours, 60°C 
The products are then separated by column chromatography on alumina N (III) using a 
mixture of cyclohexane / Et2O (2:1) obtaining 2.7 g (10.7 mmol, 79 % yield) of 4-(2-
oxo-cyclododecyl)butanal (76) (C16H28O2, 252.40 g / mol). Its spectroscopic 
characteristics are consistent with those reported in R 22. 
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R 30 Amounts: 
 3.0 g   (13.5 mmol)  2-allyl-cyclododecanone (48) 
 35.0 mg (1 mol %)  Rh(CO)2(acac) 
 0.5 g      (4 mol %)  BIPHEPHOS (16) 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21, bar CO/H2 (1:1), 72 hours, 60°C 
The products are then separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1) giving 3.1 g (12.3 mmol, 91 %) of 4-(2-oxo-
cyclododecyl)butanal (76) (C16H28O2, 252.40 g / mol). Its spectroscopic characteristics 
are consistent with those reported in R 22. 
 
 
Hydroformylation of ethyl 1-allyl-2-oxo-cyclododecane carboxylate (74) 
R 31 Amounts: 
 2.0 g    (6.8 mmol)  ethyl 1-allyl-2-oxo-cyclododecane carboxylate  
     (74) 
 24.0 mg   (1 mol %)  Rh(CO)2(acac) 
 140.0 mg (4 mol %)  BIPHEPHOS (16) 
 40 ml    abs. CH2Cl2 
Procedure: Analogously to R 21 
The products are separated by column chromatography on alumina N (III), cyclohexane 
/ Et2O (2:1) furnishing 1.9 g (5.9 mmol, 87 % yield) of ethyl 2-oxo-1-(4-oxo-butyl)-
cyclododecane carboxylate (80) (C19H32O4, 324.43 g / mol) as a colorless oil. Its 
spectroscopic data are consistent with those reported in R 23. 
 
 
Preparation of 3-methyl-4-(2-oxo-cyclododecyl)-butunal (95) 
R 32 Amounts: 
 3.0 g    (12.7 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 32.0 mg (1 mol %)  Rh(CO)2(acac) 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21, 20 bar CO/H2 (1:1), 72 hours, 60°C 
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The products are separated by column chromatography on alumina N (III), cyclohexane 
/ AcEt (10:1). 1.62 g (6.0 mmol, 48 % yield) of 3-methyl-4-(2oxo-cyclododecyl)-
butanal (95) (C17H30O2, 266.42 g / mol) are isolated as colorless oil as a mixture of two 
diastereoisomers in a ratio of 1:1.33 identified by NMR analysis (ratio calculated with 
respect to the CH3). Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 
9.69 (t, 1H, 3J = 1.7 Hz, CHO), 2.61-2.51 (m, 3H, CH2), 2.46-2.33 (m, 2H, CH2), 2.30 
(dd, 2H, 3J = 6.2 Hz, 3J = 1.7 Hz, CH2), 2.24-2.20 (m, 3H, CH), 2.04-1.88 (m, 2H, CH), 
1.77-1.46 (m, 8H, CH2), 1.35-1.06 (m, 6H, CH2), 0.91 
(d, 3H, 3J = 6.5 Hz, CH3). Diasteroisomers 1 / 2: 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 214.16, 214.12 
(CO), 202.27, 202.24 (CHO), 51.25, 50.93 (CH2), 
50.05, 49.37 (CH), 37.95 (CH2), 37.34 (CH2), 36.76, 
36.66 (CH2), 36.24 (CH2), 30.25 (CH2), 28.98 (CH2), 
26.20 (CH2), 26.07, 25.85 (CH), 26.03 (CH2), 25.91, 25.70 (CH2), 23.85 (CH2), 23.44 
(CH2), 23.19 (CH2), 23.05 (CH2), 22.76 (CH2), 22.08, 22.02 (CH2), 22.30 (CH2), 21.73 
(CH2), 21.6 (CH2), 19.88, 19.76 (CH3). IR (KBr/film): ν [cm-1] = 3432 (w), 2929 (s), 
2862 (s), 2849 (s), 2715 (m), 1707 (s), 1703 (s). LR-MS (EI, 70 eV): m/z (%) = 266 
(M+, 1.85), 249 (2.14), 222 (1.97), 195 (2.33), 182 (7.35), 135 (2.33), 109 (7.29), 95 
(16.30), 81 (33.88), 67 (30.94), 55 (80.61), 41 (100), 29 (31.16). HR-MS (EI, 70 eV): 
Calcd. 266.2246, Found: 266.2264. 
 
 
R 33 Amounts:  
 3.0 g    (12.7 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 32.0 mg (1 mol %)  Rh(CO)2(acac) 
 20 ml    abs.CH2Cl2
Procedure: Analogously to R 21, 80 bar CO/H2 (1:1), 24 hours, 100°C. 
The products are separated by column chromatography on alumina N (III), cyclohexane 
/ Et2O (3:1) furnishing 1.6 g (6.1 mmol, 47 % yield) of 3-methyl-4-(2-oxo-
cyclododecyl)butanal (95) (C17H30O2, 266.42 g / mol) as a colorless oil as a mixture of 
two diastereoisomers in ratio of 1:1.33 identified by NMR analysis  (ratio calculated 
O
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with respect to the CH3). Its spectroscopic characteristics are consistent with those 
reported in R 32. 
 
 
R 34 Amounts:  
 3.0 g   (12.7 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 32.0 mg (1 mol %)  Rh(CO)2(acac) 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21, 80 bar CO/H2 (1:1), 48 hours, 100°C 
The products are separated by column chromatography on alumina N (III), cyclohexane 
/ Et2O (3:1) giving 1.7 g (6.6 mmol, 52 % yield) of 3-methyl-4-(2-oxo-
cyclododecyl)butanal (95) (C17H30O2, 266.42 g / mol) as a colorless oil as a mixture of 
two diastereoisomers in a ratio of 1:1.19 as identified by 1H-NMR (ratio calculated with 
respect to the CH3). Its spectroscopic characteristics are consistent with those reported 
in R 32. 
 
 
R 35 Amounts: 
 1.5 g    (6.4 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 16.0 mg (1 mol %)  Rh(CO)2(acac) 
 20 ml    abs. CH2Cl2
Procedure: Analogously to R 21, 80 bar CO/H2 (1:1), 72 hours, 100°C. 
The products are then separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (3:1). 1.1 g (3.9 mmol, 62 % yield) of 3-methyl-4-(2-oxo-
cyclododecyl)butanal (95) (C17H30O2, 266.42 g / mol) is obtained as a mixture of two 
diastereoisomers as a ratio of 1:1.1 identified by 1H-NMR (ratio calculated with respect 
to the CH3). Its spectroscopic characteristics are consistent with those reported in R 32. 
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Hydroformylation of 1-(2-methyl-allyl)-ethyl 2-oxo-cyclododecane carboxylate (75) 
R 36 Amounts: 
 2.0 g (6.5 mmol)  ethyl 1-(2-methyl-allyl)-2-    
     oxocyclododecane carboxylate (75) 
 16 mg  (1 mol %)  Rh(CO)2(acac)
 40 ml    abs. CH2Cl2 
Procedure: Analogously to R 21 
A mixture of ethyl 1-(1-oxo-isopropyl)-2-oxo-cyclododecane carboxylate (90) and ethyl 
1-(4-oxo-2-methyl-butyl)-2-oxo-cyclododecane carboxylate (89) (C20H34O4, 338.49 g / 
mol) is obtained in a ratio of 1:2.7 detected by 1H-NMR analysis (from CH2CH3). The 
compound 90 is present as a mixture of two diastereoisomers in a ratio of 1: 0.7 as 
detected by 1H-NMR (from CH2CH3). Spectroscopic data are consistent with those 
reported in R 27. 
 
 
4.3.2. Intramolecular aldol addition  
Preparation of 12-hydroxybicyclo[9.4.1]hexadecane-16-one (50) 
R 37: To a solution of 1.5 g (6.6 mmol) of 4-(2-oxo-cyclododecyl)butanal (76) in 10 
ml of dioxane is added dropwise 70 ml (7N) HCl and the mixture is stirred for 18 hours 
at room temperature. Then, the solution is cautiously neutralized with a solution of 
NaHCO3 (5 %) and the aqueous layer is extracted with diethylether. The combined 
organic phases are dried over anhydrous MgSO4, filtered, and concentrated in vacuum. 
The product is separated by column chromatography on alumina N (III), cyclohexane / 
Et2O (3:1). 330 mg (1.3 mmol, 20 % yield) of 12-hydroxybicyclo[9.4.1]hexadecan-16-
one (50) as a mixture of two diastereoisomers in a ratio of 1: 2.9 as detected by NMR 
analysis are isolated. Its spectroscopic characteristics are consistent with those 
previously reported in R 21. 
 
 
R 38:  To a solution of 1.5 g (6.6 mmol) of 4-(2-oxo-cyclododecyl)butanal (76) in 10 
ml of dioxane are added dropwise 30.0 ml H2SO4 (conc.) and the mixture is stirred for 
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18 hours at room temperature. Then, the solution is cautiously neutralized with a 
solution of NaHCO3 (5 %) and the aqueous layer is extracted with diehylether. The 
combined organic phases are dried over anhydrous MgSO4, filtered, and concentrated in 
vacuum. The products are separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (3:1) to give 66 mg (0.26 mmol, 4 % yield) of 12-
hydroxybicyclo[9.4.1]hexadecan-16-one (50) (C16H30O2, 252.21 g / mol) as a white 
solid. Its spectroscopic characteristics are consistent with those previously reported in R 
21. 
 
 
Aldol condensation of 4-(2-oxo-cyclododecyl)butanal (76) 
R 39:  To a solution of 6.0 g (23.8 mmol) of 4-(2-oxo-cyclododecyl)butanal (76) in 40 
ml of  EtOH are added 3.6 ml (23.8 mmol) DBU in 20 ml of EtOH, and the mixture is 
stirred for 20 at room temperature. Then, the solvent is first eliminated under reduced 
pressure, the residue is dissolved in Et2O, acidified with a solution of HCl (5 %) and the 
aqueous layer is extracted with Et2O (3 x 30 ml). The combined organic phases are 
filtered, dried over anhydrous MgSO4. Evaporation of the solvent under reduced 
pressure gives the crude compound. The products are separated by column 
chromatography on alumina N (III), cyclohexane / Et2O (3:1) to give 2.4 g (8.3 mmol, 
35 % yield) of 12-hydroxybicyclo[9.4.1]hexadecan-16-one (50) as mixture of four 
diastereoisomers in a ratio of 3:1:1:1 (detected by NMR) and 900 mg (4.0 mmol, 17 % 
yield) of bicyclo[9.4.1]hexadec-12-en-16-one (96) (C16H26O, 234.38 g / mol) as a white 
solid compound. Spectroscopic data of compound 96: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 5.55 (ddd, 1H, 3J = 11.4 Hz, 3J = 3.26 Hz, 3J = 2.76 Hz, 
CH), 5.14 (m, 1H, CH), 2.30 (m, 4H, CH2), 2.1-1.96 (m, 5H, CH2), 
1.79-1.55 (m, 6H, CH2), 1.35-0.98 (m, 9H, CH2). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 211.23 (CO), 130.42 (CH2), 129.51 
(CH2), 56.00 (CH), 42.09 (CH), 31.03 (CH2), 29.84 (CH2), 28.46 
(CH2), 27.50 (CH2), 26.87 (CH2), 26.42 (CH2), 23.62 (CH2), 22.85 
(2 x CH2), 22.60 (CH2), 21.51 (CH2). IR (neat): ν  [cm-1] = 3054 (w), 3022 (w), 2927 
(s), 2858 (s), 1708 (s), 1632 (w), 1604 (w), 1467 (m), 1445 (m), 1138 (w), 729 (m). 
GC-MS (70 eV): m/z (%) = 234 (M+, 78), 207 (38), 191 (17), 149 (25), 121 (44), 107 
O
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(38), 95 (52), 81 (58), 67 (99), 55 (100). Spectroscopic characteristics of compound 
50 are consistent with those previously reported in R 21. 
 
 
Aldol addition of ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate (80) 
R 40 Amounts: 
 1.3 g (6.6 mmol) ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate  
    (80) 
 70.0 ml  HCl (7N) 
 80.0 ml  dioxane 
Procedure: Analogously to R 37 
The products are separated by column chromatography on alumina N(III), cyclohexane / 
Et2O (3:1) giving 784 mg (2.3 mmol, 35 % yield) of ethyl 12-hydroxy-16-oxo-
bicyclo[9.4.1]hexadecan carboxylate (81) (C19H30O3, 324.21 g / mol) as a mixture of 
two diastereoisomers in a ratio of 1:6 detected by NMR analysis as a white solid. Its 
spectroscopic data are consistent with those reported in R 23. 
 
 
R 41 Amounts: 
 1.3 g (6.6 mmol) ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate  
    (80) 
 40 ml   H2SO4 (conc.) 
 80 ml   EtOH 
Procedure: Analogously to R 38 
Decomposition of starting material is observed. 
 
 
R 42:  A solution of 2.2 ml n-butyllithium (2.5 M in n-hexane solution, 341.0 mg, 5.32 
mmol) is added dropwise over a period of 30 min. to a cold (0°C) solution of 0.8ml of 
diisopropylamine (freshly distilled, 538.0 mg, 5.32 mmol) in 30 ml of abs. THF. After 
20 min. a solution of 0.7 g of ethyl 2-oxo-1-(4-oxo-butyl)cyclododecane carboxylate 
(80) (1.78 mmol) in 25 ml of abs. THF is added and the mixture was stirred for 30’ min. 
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The reaction mixture is maintained at 0°C for 45 min. and gradually warmed to room 
temperature, 40 ml of a solution of HCl (5 %) is added, and the aqueous layer is 
extracted (3 x 40 ml) with diethylether. The organic layer is washed once with 20 ml of 
HCl (5 %) and once with 30 ml of brine, separated and dried over magnesium sulfate. 
The solvent is removed in vacuum giving a crude mixture. The product is purified by 
column chromatography on alumina N (III), cyclohexane / EtAc (3:1). 200 mg (0.6 
mmol, 34 % yield) is obtained of ethyl 12-hydroxy-16-oxo-bicyclo[9.4.1]hexadecan 
carboxylate (81) (C19H30O3, 324.21 g / mol) as a mixture of two diastereoisomers in a 
ratio of 1:1.8 as a white solid. Its spectroscopic data are consistent with those reported 
in R 23. 
 
 
R 43 Amounts: 
 1.3 g (6.6 mmol) ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate  
    (80) 
 0.6 g (6.6 mmol) DBU 
 80 ml   EtOH 
Procedure: Analogously to R 39 
The products are separated by column chromatography on alumina N (III), cyclohexane 
/ Et2O (3:1) affording 1.9 g (5.9 mmol, 90 % yield) of ethyl 12-hydroxy-16-oxo-
bicyclo[9.4.1]hexadecan carboxylate (81) (C19H30O3, 324.21 g / mol) as a mixture of 
two diastereoisomers in a ratio of 1:1:6 detected by NMR analysis. Its spectroscopic 
data are consistent with those reported in R 23. 
 
 
Aldol addition of ethyl 2-oxo-1-(5-oxo-penthyl)-cyclododecane carboxylate (87) 
R 44 Amounts: 
 1.0 g   (6.6 mmol)  ethyl 2-oxo-1-(5-oxo-pentyl)-cyclododecane  
     carboxylate (87) 
 456 mg (6.6 mmol)  DBU 
 80 ml    EtOH 
Procedure: Analogously to R 39 
  146
   Experimental part 
Starting material is recovered. 
 
 
Preparation of 12-hydroxy-14-methylbicyclo[9.4.1]hexadecan-16-one (97) 
R 45 Amounts:  
 1.0 g (3.8 mmol) 3-methyl-4-(2-oxo-cyclododecyl)butanal (95) 
 0.6 g (3.8l mmol) DBU 
 80 ml   EtOH 
Procedure: Analogously to R 39 
The products are purified by column chromatography on alumina N (III), cyclohexane / 
Et2O (3:1) to give 636 mg (2.4 mmol, 63 % yield) of 12-hydroxy-14-
methylbicyclo[9.4.1]hexadecane-16-one (97) (C17H30O2, 266.42 g / mol) as a mixture of 
diastereoisomers in a ratio of 1:2.3:1.5:1.5 detected by 1HNMR analysis (ratio 
calculated with respect to the CH3). Spectroscopic data: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 3.75 (m, 1H, CH), 3.37-3.05 (m, 3H, CH), 3.02-2.97 (m, 1H, CH), 3.24-3.18 
(m, 2H, CH2), 2.98-2.82 (m, 2H, CH), 2.46-2.20 (m, 3H, CH), 
2.03-1.91 (m, 6H, CH2), 1.44–1.07 (m, 8H, CH2), 0.89 (d, 3H, 
3J = 6.78 Hz, CH3). Mixture of diastereoisomers 13C-NMR 
(125 MHz, CDCl3): δ [ppm] = 218.51 (CO), 75.97, 75.63, 
76.03, 773.23 (CH), 56.51, 65.68, 66.47, 62.70 (CH), 50.46, 
46.32, 42.32, 35.12 (CH), 37.13, 37.38, 38.57, 40.03 (CH2), 
31.50, 31.70, 31.73, 31.79 (CH2), 29.63, 28.64,27.63, 26.66 
(CH), 27.31, 27.30, 27.43, 27.29 (CH2), 26.76, 26.71, 26.83, 26.85 (CH2), 23.77, 23.82, 
24.00, 23.89 (CH2), 23.11, 23.48, 23.56, 23.29 (CH2), 22.01 (CH2), 21.69, 21.71 (CH2), 
21.87, 21.85, 21.01, 20.58 (CH3), 21.44, 21.49, 21.51, 21.55 (CH2), 19.71 (CH2).  IR 
(neat): ν [cm-1] = 3466 (bs), 2928 (s), 2862 (s), 2849 (s), 1703 (s), 1650.5 (m), 1469 
(m), 1445 (m), 1365 (m), 1253 (m), 1122 (m), 1082 (m), 873 (m). LR-MS (EI, 70 eV): 
m/z (%) = 266 (M+, 66.0), 248 (52.86), 113 (45.67), 95 (66.16), 81 (73.85), 67 (60.50), 
55 (100), 41 (79.78), 29 (29.28), 18 (17.13). HR-MS (EI, 70 eV): Calcd. 266.2246, 
Found: 266.2234. Melting point: 107°C 
 
 
O
HO
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R 46 Amounts: 
 1.5 g (5.6 mmol) 3-methyl-4-(2-oxo-cyclododecyl)butanal (95) 
 70 ml   HCl (7N) 
 80 ml   dioxane 
Procedure: Analogously to R 37 
The products are separated by column chromatography on alumina N (III), cyclohexane 
/ Et2O (3:1). 224 mg (0.8 mmol, 15 % yield) of 12-hydroxy-14-
methylbicyclo[9.4.1]hexadecan-16-one (97) (C17H30O2, 266.42 g / mol) are isolated as a 
mixture of diastereoisomers in a ratio of 1:2.8 as detected by NMR. Its spectroscopic 
characteristics are consistent with those reported in R 45. 
 
 
R 47 Amounts: 
 1.0  g (3.8 mmol) 3-methyl-4-(2-oxo-cyclododecyl)butanal (95) 
 30   ml   H2SO4 (conc.) 
 80   ml   dioxane 
Procedure: Analogously to R 38 
After filtration, an intractable mixture of decomposition products is obtained. 
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4.4. Sequential hydroformyaltion /aldol addition of enol ethers 
4.4.1. Preparation of trimethyl silyl enol ethers 
Preparation of trimethyl-[12-(2-methylprop-2-enyl)-cyclododec-1-enyloxyl]-silane 
(116) 
R 48 Amounts: 
 3.0 g    (12.7 mmol)  2-(2-methylprop-2-enyl)cyclododecanone (66) 
 2.75 g  (12.5 mmol)  TMSCl (103) 
 1.6 g   (12.5 mmol)  n-BuLi 
 2.55 g (12.15 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2 
Distillation of the resulting mixture under reduced pressure (3 x 10-2 mbar) at 120°C 
gives 3.1 g (10.0 mmol, 79 % yield), of trimethyl-12-(2-methylprop-2-enyl)-
cyclododec-1-enyloxyl]-silane (116) (C19H36OSi, 308.58 g / mol) as a colorless oil. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 
4.78 (s, 1H, CH2=C), 4.67 (s, 1H, CH2=C), 4.50 (dd, 2H, 3J = 
6.4 Hz, 3J = 1.7 Hz, CH2), 2.92-2.86 (m, 2H, CH2), 2.62 (s, 3H), 
2.16-2.02 (m, 3H, CH2), 1.91-1.79 (m, 2H, CH2), 1.51-1.10 (m, 
12H), 0.19 (s, 9H, CH3). 13C-NMR (100 MHz, CDCl3): 
δ [ppm] = 152.00 (Cq), 142.75 (CH=CH2), 111.25 (CH=CH2), 
108.64 (CH), 43.15 (CH), 41.65 (CH2), 39.39 (CH2), 36.72 
(CH2), 29.36 (CH2), 26.31 (CH2), 25.50 (CH2), 24.86 (CH2), 24.65 (CH2), 24.46 (CH2), 
24.20 (CH2), 22.01 (CH3), 0.78 (3 x CH3). 
 
 
Synthesis of ethyl 1-allyl-2-trimethylsilanoxy-cyclododec-2-ene carboxylate (117) 
R 49 Amounts:  
 8.0 g   (27.2 mmol)  ethyl 1-allyl-2-oxo-cyclododecane carboxylate  
     (74) 
 5.04 g (46.2 mmol)  TMSCl (103) 
 5.04 g (27.2 mmol)  n-BuLi 
O
Si
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  2.75 g (27.2 mmol)  diisopropylamine 
  150 ml    abs. THF 
Procedure: Analogously to R 2 
Distillation of the resulting mixture under reduced pressure (3 x 10-2 mbar) at 120°C 
gives 7.4 g (21.2 mmol, 78 % yield) ethyl 1-allyl-2-trimethylsilanoxy-cyclododec-2-ene 
carboxylate (117) (C21H38O3Si, 366.61 g / mol) as a colorless oil 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 5.60 (ddd, 1H, 3J = 17.2 
Hz, 3J = 9.97 Hz, 3J = 7.2 Hz, CH=CH2), 5.03 (d, 1H, 3J = 17.2 
Hz, CH=CHH), 5.00 (d, 1H, 3J = 10.2 Hz, CH=CHH), 4.55 (dd, 
1H, 3J = 9.47 Hz, 3J = 5.73 Hz, CH), 4.16 (q, 2H, 3J = 7.0 Hz, 
CH2CH3), 2.45 (dd, 1H, 3J = 13.46 Hz, 3J = 6.98 Hz, CH2), 2.33 
(dd, 1H, 3J = 13.46 Hz, 3J = 7.7 Hz, CH2), 2.00 (m, 2H, CH2), 
1.76 (dd, 1H, 3J = 13.96 Hz, 3J = 6.7 Hz, CH2), 1.70 (m, 1H, 
CH2), 1.51 (m, 1H, CH2), 1.30 (m, approx. 13H, CH2), 1.06 (t, 
3H, 3J = 7.0 Hz, CH2CH3), 0.15 (s, 9H, CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 
174.84 (CO), 150.59 (C=CH), 133.76 (CH=CH2), 117.76 (CH=CH2), 108.26 (C=CH), 
60.30 (CH2CH3), 56.26 (Cq), 37.18 (CH2), 29.93 (CH2), 26.73 (CH2), 26.44 (CH2), 
24.94 (CH2), 24.71 (CH2), 243.61 (CH2), 24.45 (CH2), 24.79 (CH2), 20.99 (CH2), 14.14 
(CH2CH3), 0.80 (3 x CH3). 
 
 
Synthesis of ethyl 1-(2-methylprop-2-enyl)-2-trimethylsilanoxy-cyclododec-2-ene 
carboxylate (118) 
R 50 Amounts: 
 10 g  (32.4 mmol)  ethyl 1-(2-methyl-allyl)-2-oxo-cyclododecane  
     carboxylate (75) 
 6.0 g (55 mmol)  TMSCl (103) 
 2.0 g (32 mmol)  n-BuLi 
 3.3 g (32.4 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2. 
 
O
COOEt
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Distillation of the resulting mixture under reduced pressure (3 x 10-2 mbar) at 110°C 
gives 9.2 g of ethyl 1-(2-methylprop-2-enyl)-2-trimethylsilanoxy-cyclododec-2-ene 
carboxylate (118) (24.0 mmol, 74 % yield) (C22H40O3Si, 380.63 g / mol) as a colorless 
oil. Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 4.8 (s, 1H, 
C=CHH), 4.68 (s, 1H, C=CHH), 4.57 (m, 1H, C=CH), 4.12 (q, 
2H, 3J = 7.2 Hz,, CH2CH3), 2.48 (d, 1H, 3J = 13.4 Hz, CH2), 
2.40 (d, 1H, 3J = 13.4 Hz, CH2), 2.02 (m, 2H, CH2), 1.79 (m, 
3H, CH2), 1.66 (s, 3H, CH3), 1.36 (m, 7H, CH2), 1.19 (t, 3H, 3J 
= 7.0 Hz, CH2CH3), 0.86 (m, 1H, CH2), 0.17 (s, 9H, CH3). 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 175.88 (CO), 151.12 
(C=CH), 142.42 (CH=CH2), 114.70 (CH=CH2), 108.06 
(C=CH), 60.42 (CH2CH3), 55.88 (Cq), 40.32 (CH2), 30.40 
(CH2), 21.59 (CH2), 26.56 (CH2), 25.04 (CH2), 24.82 (CH2), 24.65 (CH2), 24.43 (CH2), 
24.19 (CH2), 23.52 (CH), 21.53 (CH2), 13.95 (CH2CH3), 0.88 (3 x CH3) 
 
 
O
COOEt
Si
118
4.4.2. Hydroformylation of trimethyl silyl enol ethers 
Hydroformylation of trimethyl-[12-(2-methylprop-2-enyl)-cyclododec-1-enyloxyl]-
silane (116) 
R 51 Amounts: 
 1.0 g (3.2 mmol) trimethyl-[12-(2-methylprop-2-enyl)-cyclododec-1- 
    enyloxyl]-silane (116) 
 8.0 mg (1 mol %) [Rh(cod)Cl]2
 20 ml   abs. CH2Cl2 
Procedure: Analogously to R 21 
The crude mixture is then separated by column chromatography on alumina N (III), 
cyclohexane / MTBE (2:1). 476 mg (1.8 mmol, 56 % yield) of 3-methyl-(4-oxo-
cyclododecyl)butanal (95) (C17H30O2, 266.42 g / mol) is isolated as a colorless oil. Its 
spectroscopic characteristics are consistent with those reported in R 32. 
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Hydroformylation of ethyl 1-(2-methylprop-2-enyl)-2-trimethylsilanoxy-
cyclododec-2-ene carboxylate (118) 
R 52 Amounts: 
 1.5 g (3.65 mmol) ethyl 1-(2-methyl-2-propen)-2-trimethylsilanoxy-1- 
    cyclododecane carboxylate (118) 
 10 mg (1 mol %) [Rh(cod)Cl]2 
 20 ml   abs. CH2Cl2 
Procedure: Analogously to R 21. 
After removing of solvent, distillation of the resulting mixture under reduced pressure 
(3 x 10-2 mbar) at 125 °C gives 1.0 g (3.4 mmol, 94 % yield) of ethyl 1-(2-methyl-prop-
2-enyl)-2-oxo-cyclododecane carboxylate (75) (C19H32O3, 308.46 g / mol) as a colorless 
oil. Its spectroscopic data are consistent with those reported in R 20. 
 
 
Hydroformylation of ethyl 1-allyl-2-trimethylsilanoxy-cyclododec-2-ene 
carboxylate (117) 
R 53 Amounts: 
 4.0 g    (11.0 mmol)  ethyl 1-allyl-2-trimethylsilanoxy-cyclododec-2-ene 
     carboxylate (117) 
 15.0 mg (1 mol %)  [Rh(cod)Cl]2 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 21. 
The products are then separated by column 
chromatography on alumina N (III), cyclohexane/ 
Et2O (2:1) giving 4.0 g of ethyl 1-(4-oxo-butyl)-2-
trimethylsilanoxy-cyclododec-2-ene carboxylate 
(119) (10.2 mmol, 93 % yield) (C22H40O4Si, 396.63 g 
/ mol) as a colorless oil. Spectroscopic data: 1H-
NMR (400 MHz, CDCl3): δ  [ppm] = 9.71 (t, 1H, 3J 
= 1.2 Hz, CHO), 4.45 (dd, 1H, 3J = 9.2 Hz, 3J = 6.0 
Hz, CH), 4.12 (q, 2H, 3J = 7.0 Hz, CH2CH3), 2.38 (dd, 1H, 3J = 6.53 Hz, 3J = 1.2 Hz, 
CH2), 2.05-1.91 (m, 1H, CH2), 2.02 (m, 3H, CH2), 1.85-1.47 (m, 5H, CH2), 1.33 -1.16 
O
COOEt
O
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(m, approx. 8H, CH2), 1.19 (t, 3H, 3J = 7.0 Hz, CH2CH3), 0.86 (m, 3H, CH2), 0.14 (s, 
9H, CH3). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 202.00 (CHO), 174.89 (CO), 
150.83 (C=CH), 108.15 (C=CH), 60.46 (CH2CH3), 56.26 (Cq), 44.08 (CH2), 31.94 
(CH2), 29.72 (CH2), 26.78 (CH2), 26.43 (CH2), 24.80 (CH2), 24.56 (CH2), 24.48 (CH2), 
20.91 (CH2), 17.32 (CH2), 15.23 (CH2), 14.12 (CH2CH3), 0.83 (3 x CH3). 
 
 
Preparation of ethyl 12-hydroxy-16-oxo-bicyclo[9.4.1]hexadecan carboxylate (81) 
R 54: 4.0 g (10.0 mmol) of ethyl 1-(4-oxo-butyl)-2-trimethylsilanoxy-cyclododec-2-
ene carboxylate (119) in 30 ml of abs. CH2Cl2 is added to 1.5 ml (2.2 g, 12 mmol) of 
TiCl4 in 40 ml of CH2Cl2 at room temperature under Argon atmosphere. This mixture is 
stirred for 2 hours. After hydrolysis, the resulting organic layer is extracted with 
diethylether (3 x 30 ml) and washed with a solution of NaHCO3. The combined extracts 
are dried on MgSO4 and concentrated under vacuum. The products are separated by 
column chromatography through a pad of alumina N (III) using cyclohexane / Et2O 
(2:1) as eluent. 2.1 g (6.48 mmol, 54% yield) as a mixture of four diastereoisomers in a 
ratio of 1:2:2:1.5 of ethyl 12-hydroxy-16-oxo-bicyclo[9.4.1]hexadecan carboxylate (81) 
(C19H30O3, 324.21 g / mol) as a white solid is isolated. Its spectroscopic data are 
consistent with those reported in R 23. 
 
 
4.4.3. Preparation of TBDM-silyl enol ether 
Attempted preparation of 1-(2-methylprop-2-enyl)-2-(tert-butyl-dimethyl-
silanoxy)-cyclododec-2-ene (122) 
R 55 Amounts: 
 4.0 g   (13.6 mmol)  2-(2-methyl-1-propen)cyclododecanone (66) 
 2.52 g (23.1 mmol)  TBDMSCl (121) 
 0.74 g (13.6 mmol)   n-BuLi 
 1.37 g (13.6 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2 
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Starting material is recovered. 
 
 
Preparation of ethyl 1-allyl-2-(tert-butyl-dimethyl-silanoxy)-cyclododec-2-ene 
carboxylate (123) 
R 56 Amounts: 
 8.0 g   (27.2 mmol)  ethyl 1-allyl-2-oxo-cyclododecane carboxylate  
     (74) 
 5.04 g (46.2 mmol)  TBDMSCl (121) 
 1.74 g (27.2 mmol)  n-BuLi 
 2.74 g (27.2 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2. 
7.8 g ethyl 1-allyl-2-(tert-butyl-dimethyl-silanoxy-cyclododec-2-ene carboxylate (123) 
(21.4 mmol, 78 % yield) (C24H44O3Si, 408.69 g / mol) as a colorless oil is obtained. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 5.60 (ddd, 1H, 3J = 17.2 
Hz, 3J = 9.7 Hz, 3J = 7.23 Hz, CH=CH2), 4.85 (m, 2H, CH=CHH), 4.55 (dd, 1H, 3J = 9.7 
Hz, 3J = 4.9 Hz, CH=C), 4.02 (q, 2H, 3J = 7.2 Hz, CH2CH3), 2.45 (dd, 1H, 3J = 13.4 Hz, 
3J = 6.9 Hz, CH2), 2.40 (dd, 1H, 3J = 13.4 Hz, 3J = 7.4 Hz, CH2), 2.22 (dddd, 1H, 3J = 
10.4 Hz, 3J = 10.2 Hz, 3J = 9.72 Hz, 3J = 3.4 Hz, CH2), 
1.86-1.79 (m, 1H, CH2), 1.76-1.71 (m, 1H, CH2), 1.50 (m, 
1H, CH2), 1.35-1.19 (m, 11H, CH2), 1.21 (t, 3H, 3J = 7.2 
Hz, CH2CH3), 0.9 (m, 9H, CH3), 0.16 (s, 3H, CH3), 0.03 (s, 
3H, CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 
174.64 (CO), 149.85 (C=CH), 133.76 (CH=CH2), 117.78 
(CH=CH2), 108.81 (C=CH), 60.38 (CH2CH3), 56.20 (Cq), 
37.76 (CH2), 34.86 (Cq), 34.05 (CH2), 29.58 (CH2), 26.65 
(CH2), 26.34 (CH2), 26.20 (CH2), 25.95 (CH3), 25.27 (CH2), 24.94 (CH2), 23.69 (CH2), 
23.66 (CH2), 21.72 (CH2), 14.12 (CH2CH3), -3.34 (3 x CH3). IR (KBr/film): ν  [cm-1] = 
3467 (w), 3073 (s), 2929 (s), 2857 (s), 1736 (s), 1710 (s), 1656 (m), 1463 (m), 1256 
(m), 1200 (m), 1097 (w). 
 
O
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R 57 Amounts: 
 10 g  (32.4 mmol) ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-cyclododecane  
    carboxylate (75) 
 6.0 g (55 mmol) TBDMSCl (121) 
 2.0 g (32 mmol) n-BuLi 
 3.3 g (32.4 mmol) diisopropylamine 
 150 ml   abs. THF 
Procedure: Analogously to R 2 
9.2 g of a mixture of ethyl 1-(2-methyl-allyl)-2-trimethylsilanoxy-cyclododec-2-ene 
carboxylate (124) (34% conversion detected by 
GC-analysis) and starting material (75) is 
obtained. Spectroscopic data of the mixture of 
124 and starting material 75: 1H-NMR (500 
MHz, CDCl3) δ [ppm] = 4.8 (s, 1H, C=CHH), 
4.79 (s, 1H, C=CHH), 4.78 (s, 1H, CHH=CH), 
4.69 (s, 1H, C=CHH), 4.67 (m, 1H, C=CH), 4.14 
(q, 2H, 3J = 6.7 Hz, CH2CH3), 4.12 (m, 2H, 
CH2CH3), 2.92-2.86 (m, 2H, CH2), 2.60 (s, 2H, 
CH3), 2.48 (d, 1H, 3J = 13.4 Hz, CH2), 2.40 (m, 
1H, CH2), 2.16-2.02 (m, 3H), 2.02 (m, 3H, CH2),  
1.91-1.79 (m, 2H, CH2), 1.79 (m, 5H, CH2), 1.66 (s, 6H, CH3), 1.51-1.10 (m, 15H, 
CH2), 1.36 (m, 6H, CH2), 1.23 (t, 3H, 3J = 6.7 Hz, CH2CH3), 1.19 (t, 3H, 3J = 7.0 Hz, 
CH2CH3), 0.86 (m, 7H, CH2), 0.0 (s, 9H, CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] 
= 206.4 (CO), 175.74 (CO), 173.1 (CO), 151.38 (C=CH), 141.40 (CH=CH2), 141.4 
(CH=CH2), 114.9 (CH=CH2), 114.5 (CH=CH2), 108.31 (C=CH), 62.9 (Cq), 61.10 
(CH2CH3), 60.68 (Cq), 56.14 (CH2CH3), 55.58 (Cq), 40.58 (CH2), 38.06 (CH2), 33.79 
(CH2), 30.66 (CH2), 29.18 (CH2), 26.63 (CH2), 26.36 (2 x CH3), 26.34 (CH2), 26.82 
(CH2), 25.30 (CH2), 25.08 (CH2), 24.91 (CH2), 24.45 (CH2), 23.78 (CH3), 23.44 (CH2), 
23.21 (CH3), 22.63 (CH2), 22.14 (CH2), 21.98 (CH2), 21.79 (CH2), 21.46 (CH2), 13.87 
(CH2CH3), 13.18 (CH2CH3), -2.01 (3 x CH3) 
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4.4.4. Hydroformylation of ethyl 1-allyl-2-(tert-butyl-dimethyl-silanoxy)-
cyclododec-2-ene carboxylate  
R 58 Amounts: 
 4.0 g   (11.0 mmol)  ethyl 1-allyl-2-(tert-butyl-dimethyl-silanox)- 
     cyclododec-2-ene carboxylate (123) 
 15.0 mg (1 mol %)  [Rh(cod)Cl]2 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 21. 
The products are then separated by column 
chromatography on alumina N (III), cyclohexane/ Et2O 
(2:1) giving 4.1 g of ethyl 1-(4-oxo-butyl)-2-(tert-butyl-
dimethyl-silanoxy)-cyclododec-2-ene carboxylate (125) 
(9.5 mmol, 87 % yield) (C25H46O4Si, 438.71 g / mol) as 
a colorless oil. Spectroscopic data: 1H-NMR (500 
MHz, CDCl3): δ [ppm] = 9.70 (t, 1H, 3J = 1.50 Hz, 
CHO), 4.40 (dd, 1H, 3J = 9.7 Hz, 3J = 1.0 Hz, CH), 4.02 
(m, 2H, CH2CH3), 3.62 (dd, 1H, 3J = 6.4 Hz, 3J = 1.2 Hz, CH2), 3.59 (dd, 1H, 3J = 6.7 
Hz, 3J = 1.5 Hz, CH2), 2.42 (m, 2H,CH2), 2.20 (m, 1H, CH2), 2.01-1.45 (m, 6H CH2), 
1.40–1.27 (m, 9H, CH2), 1.21 (t, 3H, 3J = 7.2 Hz, CH2CH3), 0.9 (s, 9H, CH3), 0.0 (s, 6H, 
CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 201.58 (CO), 176.67 (CO), 149.76 
(C=CH), 108.34 (C=CH), 60.20 (CH2CH3), 55.78 (Cq), 43.76 (CH2), 43.60 (Cq), 32.14 
(CH2), 29.13 (CH2), 26.34 (CH2), 25.90 (CH3), 25.67 (CH2), 24.80 (CH2), 24.65 (CH2), 
24.49 (CH2), 23.49 (CH2), 23.35 (CH2), 21.41 (CH2), 21.20 (CH2), 16.92 (CH2), 13.76 
(CH2CH3), -3.73 (3 x CH3). 
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4.4.5. Enolboration /hydroformylation /aldol addition 
Enolboration / hydroformylation / aldol cyclization of 2-allyl-cyclododecanone (48) 
R 59: A solution of 377 mg (1.7 mmol) of 2-allyl-cyclododecanone (48), 0.2 ml (172 
mg, 1.7 mmol) of NEt3 in 25 ml of abs. CH2Cl2 is stirred for 10 min at 0°C. 4.3 mg (1 
mol %) of [Rh(acac)(CO)2] in anhydrous dichloromethane (20 ml), under Ar, 0.4 ml 
(360 mg, 1.7 mmol) of (cy-hex)2BCl are added dropwise and the mixture is placed in an 
autoclave. After flushing with argon the reactor is pressurized with 10 bar carbon 
monoxide and 10 bar hydrogen, magnetically stirred and heated to 90 °C for 24h. Then, 
the autoclave is allowed to cool to room temperature. After removing the syn gas, the 
remaining solution is filtered through alumina using MTBE as eluent. The solvent is 
removed by rotary evaporation and the residue is diluted with 15 ml of MeOH and a 
solution of NaHCO3 is added until pH=7. To the neutral solution 20 ml of H2O2 are 
added and the solution is stirred for 1h. Then, water is added and the aqueous layer is 
extracted three times with diethylether. The organic layer is back washed once with 
brine (30 ml) and dried. After removing of the solvent, the crude mixture is filtered on 
pad of alumina N (III), cyclohexane / Et2O (3:1) furnishing 86 mg (0.34 mmol, 20 % 
yield) of 12-hydroxy-bicyclo[9.4.1]hexadecan–16-one (50) as a colorless solid 
(C16H30O2, 252.21 g / mol). Its spectroscopic characteristics are consistent with those 
previously reported by C. Hollmann.  
 
 
Enolboration / hydroformylation / aldol cyclization of 2-(2-methylprop-2-
enyl)cyclododecanone (66) 
R 60 Amounts: 
 400.0 mg  (1.69 mmol) 2-(2-methylprop-2-enyl)cyclododecanone   
     (66) 
 4.3 mg     (1 mol %)  Rh(acac)(CO)2
 172 mg    (1.7 mmol)  NEt3
 360 mg    (1.7 mmol)  (cy-hex)2BCl 
 60 ml    abs. CH2Cl2 
Procedure: Analogously to R 59 
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The crude mixture is filtered through a pad of alumina N (III) using cyclohexane / Et2O 
(2:1) to furnish 0.3 g of a mixture of β-ketoester 66 and 12-hydroxy-14-methyl-16-oxo-
bicyclo[9.4.1]hexadecane (97) (C17H30O2, 266.41 g / mol) in a ratio of 1:2.48 calculated 
by 1HNMR (from CH=C/ CHOH). Spectroscopic data: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 4.78 (s, 1H, CHH=C), 4.67 (s, 1H, CHH=C), 3.45 (m, 1H, CH), 3.43 (m, 1H, 
CH), 2.72 (m, 1H, CH), 2.40 (m, 5H, CH), 
1.83 (m, 4H, CH), 1.67-1.46 (m, approx. 
16H, CH2), 1.63 (s, 3H, CH2), 1.20 (m, 
approx. 11H, CH2), 1.34 (m, approx. 12H, 
CH2), 0.86 (m, 3H, CH2). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 215.65, 214.83 
(CO), 142.92 (C=CH), 112.09 (C=CH), 
70.33 (CH), 49.91 (CH), 40.29 (CH2), 39.61 
(CH2), 38.46 (CH2), 38.05 (CH2), 37.85 
(CH2), 36.96, 36.80 (CH2), 35.24 (CH2), 
30.74 (CH2), 30.45 (CH2), 30.05 (CH2), 27.30, 27.12 (CH), 26.20 (CH2), 25.64 (CH2), 
25.32 (CH2), 24.63 (CH2), 24.48 (CH2), 24.11 (CH2), 24.04 (CH2), 23.69 (CH2), 23.41 
(CH2), 22.60 (CH2), 22.46 (CH), 22.11 (CH2), 21.79 (CH2), 20.04, 19.90 (CH). 
 
 
Enolboration / hydroformylation / aldol cyclization of ethyl 1-allyl-2-oxo-
cyclododecane carboxylate (74) 
R 61 Amounts: 
 500.0 mg   (1.7 mmol) ethyl 1-allyl-2-oxo-cyclododecane    
     carboxylate (74) 
 4.3 mg       (1 mol %)  Rh(acac)(CO)2 
 172.0 mg   (1.7 mmol)  NEt3 
 100.0 mg   (1.7 mmol) (cy-hex)2BCl 
 20.0 ml   abs. CH2Cl2 
Procedure: Analogously to R 59. 
The crude mixture is filtered through a pad of alumina N (III) using cyclohexane / Et2O 
(2:1) to furnish 480 mg of a mixture of ethyl 12-hydroxy-16-oxo-
O
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bicyclo[9.4.1]hexadecan carboxylate (81) (C19H30O3, 324.21 g / mol) (75% yield 
calculated by NMR-analysis) as a single diastereoisomers (detected by NMR-analysis) 
and ethyl 2-oxo-1-(4-oxo-butyl)-cyclododecane carboxylate (80) (C19H32O4, 324.45 g / 
mol), (25% yield calculated by NMR-analysis). Its spectroscopic data are consistent 
with those reported in R 23. 
 
 
Enolboration / hydroformylation / aldol cyclization of 1-(2-methyl-allyl)-ethyl 2-
oxo-cyclododecane carboxylate (75) 
R 62 Amounts: 
 0.5 g     (1.7 mmol)  ethyl 1-(2-methyl-prop-2-enyl)-2-oxo-  
      cyclododecane carboxylate (75) 
 4.3 mg  (1 mol %)  Rh(acac)(CO)2 
 172 mg (1.7 mmol)  NEt3 
 100 mg (1.7 mmol)  (cy-hex)2BCl 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 59. 
The crude mixture is filtered through a pad of 
alumina N (III) using cyclohexane / Et2O (2:1) 
to furnish 0.3 g of a mixture of β-ketoester 75 
and ethyl 12-hydroxy-14-methyl-16-oxo-
bicyclo[9.4.1]hexadecan carboxylate (139) 
(C20H34O4, 338.49 g / mol) in a ratio of 1: 2 
calculated by 1HNMR (from CH=C/ CHOH). 
Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 4.78 (d, 1H, CHH=C, Jgem 
= 1.5 Hz), 4.67 (s, 1H, CHH=C), 4.13 (q, 2H, 
3J = 7.2 Hz, CH2CH3), 4.09 (q, 2H, 3J = 7.2 
Hz, CH2CH3), 3.45 (m, 1H, CH), 2.92-2.86 (m, 2H, CH2), 2.60 (s, 3H, CH2), 2.06 (m, 
5H, CH2), 2.03 (m, 6H, CH2), 1.5 (s, 6H, CH2), 1.49 (m, 4H, CH2), 1.34 (m, approx. 
18H, CH2), 1.19 (t, 3H, 3J = 7.2 Hz, CH2CH3), 0.86 (m, 6H, CH2). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 206.80, 206.53 (CO), 173.18, 169.83 (CO), 141.30 (C=CH), 
O
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114.57 (C=CH), 70.19 (CH), 63.03, 62.83 (Cq), 61.17, 61.10 (CH2CH3), 57.34 (CH) 
38.24, 37.98 (CH2), 35.33, 33.72 (CH2), 29.57, 29.08 (CH2), 26.66, 26.54 (CH2), 26.26 
(CH2), 25.34, 25.31 (CH2), 24.04 (CH2), 24.35 (CH2), 23.35 (CH2), 23.14 (CH), 22.54 
(CH2), 22.13, 22.04 (CH2), 21.93, 21.82 (CH2), 21.38 (CH2), 19.06 (CH2), 13.93, 13.79 
(CH2CH3). 
 
 
Preparation of ethyl 3-allyl-2-oxo-cyclododecane carboxylate (140) 
R 63 Amounts: 
 10.0 g (67 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 5.3 g   (73.7 mmol)  3-bromo-1-butene (63) 
 8.0 g   (134 mmol)  n-BuLi 
 13.4 g (134 mmol)  diisopropylamine 
 150 ml    abs. THF 
Procedure: Analogously to R 2 
After removing of the solvent and distillation of the resulting crude mixture under 
reduced pressure (3 x 10-2 mbar) at 125 °C gives 17 g (58.3 mmol, 87 % yield) ethyl 3-
allyl-2-oxo-cyclododecane carboxylate (140) (C18H30O3, 294.43 g / mol) as a mixture of 
two diastereoisomers in a ratio of 1:1.8 calculated by 1HNMR (from CH2CH3).as 
colorless crystals. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 5.74 
(ddd, 1H, 3J = 17.2 Hz, 3J = 10.2 Hz, 3J = 6.7 Hz, CH=CH2), 4.99 (dd, 1H, 3J = 17.2 Hz, 
Jgem = 1.75 Hz, CH=CHH), 4.93 (dd, 1H, 3J = 10.2 Hz, Jgem = 
1.5 Hz, CH=CHH), 4.12 (q, 2H, 3J = 6.9 Hz, CH2CH3), 3.97 
(dd, 1H, 3J = 11.4 Hz, 3J = 3.2 Hz, CH), 3.71 (dd, 1H, 3J = 9.7 
Hz, 3J = 4.7 Hz, CH), 2.90 (m, 1H, CH), 2.28 (m, 2H, CH2), 
2.01-1.81 (m, 4H, CH2), 1.64-1.52 (m, 3H, CH2), 1.21 (t, 3H, 
3J = 6.7 Hz, CH2CH3), 1.40-1.26 (m, 9H, CH2), 1.14-0.88 (m, 
4H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 215.88, 
207.21 (CO), 169.79 (CO), 138.31, 137.73 (CH=CH2), 114.04, 114.67 (CH=CH2), 
61.25, 61.22 (CH2CH3), 60.20 (Cq), 53.91, 54.43 (CH), 50.52, 49.59 (CH), 31.35, 31.29 
(CH2), 27.85 (CH2), 27.72, 27.59 (CH2), 26.80, 26.70 (CH2), 26.22, 26.17 (CH2), 23.62 
(CH2), 23.21, 23.17 (CH2), 21.95 (CH2), 20.42 (CH2), 14.09, 14.02 (CH2CH3). IR 
O
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(KBr/film): ν   [cm-1] = 3076 (w), 2930 (s), 2865 (s), 1743 (s), 1712 (s), 1673 (m), 
1640 (m), 1469 (m), 1445 (m), 1258 (m), 1159 (m), 1029 (m), 915 (m). 
 
 
Enolboration / hydroformylation / aldol cyclization of ethyl 3-allyl-2-oxo-
cyclododecane carboxylate (140) 
R 64 Amounts: 
 0.5 g (1.7 mmol)  ethyl 3-allyl-2-oxo-cyclododecane carboxylate  
     (140) 
 4.3 mg (1 mol %)  Rh(acac)(CO)2 
 172 mg (1.7 mmol)  NEt3 
 100 mg (1.7 mmol)  (cy-hex)2BCl 
 20 ml    abs. CH2Cl2 
Procedure: Analogously to R 59. 
The crude mixture is filtered through a pad of alumina N (III) using cyclohexane / Et2O 
(2:1) to furnish mixture of ethyl 15-hydroxy-16-oxo-bicyclo[9.4.1]hexadecan 
carboxylate (142) (C19H32O4, 324.43 g / mol) (58% NMR-yield from CHa and CHb 
signals ) and ethyl 2-oxo-3-(4-oxo-butyl)-cyclododecane carboxylate (141) (C19H32O4, 
324.43 g / mol). The compound 141 is 
present as a mixture of two 
diastereoisomers in a ratio of 1:6.2 (from 
NMR analysis from CHO signals). 
Spectroscopic data of mixture of 141 (as 
a mixture of diastereoisomers) and 142: 
1H-NMR (400 MHz, CDCl3): δ ppm] = 
9.71, 9.66 (t, 1H, 3J = 1.5 Hz, CHO), 4.21 
(q, 2H, 3J = 6.9 Hz, CH2CH3), 4.10 (q, 2H, 
3J = 7.2 Hz, CH2CH3), 3.96 (dd, 2H, 3J = 
11.7 Hz, 3J = 3.2 Hz, CHa), 3.89 (d, 1H, 3J 
= 10.7 Hz, CHb), 2.90–2.86 (m, 2H, CH2), 2.81–2.75 (m, 2H, CH2), 2.41–2.24 (m, 6H), 
2.20–1.95 (m, 7H, CH2), 1.89–1.70 (m, 6H), 1.69–1.47 (m, 6H), 1.34–1.17 (m, 2H, 
CH2), 1.28 (t, 3H, 3J = 7.2 Hz, CH2CH3), 1.23 (t, 3H, 3J = 6.9 Hz, CH2CH3), 1.07-0.86 
O
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(m, 6H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 208.71, 207.00 (CO), 202.27 
(CHO), 172.49, 169.80 (CO), 79.89 (CH), 69.22 (Cq), 61.33, 61.04 (CH2CH3), 53.68, 
51.27, 44.11, 33.93 (CH), 37.29 (CH2), 27.98 (CH2), 27.93 (CH2), 27.33 (CH2), 27.27 
(CH2), 26.83 (CH2), 26.68 (CH2), 26.27 (CH2), 26.17 (CH2), 26.05 (CH2), 23.78 (CH2), 
23.49 (CH2), 23.49 (CH2), 23.43 (CH2), 23.18 (CH2), 22.39 (CH2), 22.31 (CH2), 21.90 
(CH2), 20.82 (CH2), 20.21 (CH2), 19.99 (CH2), 14.09, 14.04 (CH2CH3). IR (KBr/film), 
ν  [cm-1] = 3524 (s), 2931 (s), 2865 (s), 1736 (s), 1710 (s), 1469 (m), 1445 (s), 1246 (m), 
1226 (m), 1176 (w), 1126 (m), 1097 (m), 1073 (m), 734 (m). LR-MS (EI, 70 eV): m/z 
(%) = 324 (M+, 1.75), 306 (4.52), 278 (6.58), 254 (16.96), 209 (7.58), 109 (16.94), 95 
(33.12), 81 (40.29), 55 (100), 29 (65.77), 18 (3.35). HR-MS (EI, 70 eV): Calcd.: 
324.2301, Found: 324.2324. 
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4.5. Sequential Michael addition / aldol reaction  
4.5.1. Stepwise Michael addition / aldol reaction of cyclododecanone derivatives 
4.5.1.1. Preparation of substituted 3-(2-oxo-cyclododecyl)propanal 
Preparation of cyclododec-1-enyloxy-trimethyl-silane (165) 
R 65: To a mixture of 30.0 ml of N,N-dimethylformammide containing 25.0 ml (122 
g, 198.0 mmol) TMSCl (103), 2.3 g (99.0 mmol) of Mg-turnings, a solution of 3.0 g 
(16.5 mmol) of cyclododecanone (11) in 15 ml of DMF is added dropwise for a period 
of 1 hour. The suspension is stirred at 5-7 °C on cooling with a water bath and stirred 
over night (18 h). Then, the solvent is removed under reduced pressure and the residue 
is dissolved in pentane and filtered on a short pad of alumina N (III) using pentane as 
eluent. The organic layer is washed with 40 ml of an aqueous solution of NaHCO3 (3 x 
30 ml), dried over MgSO4. After removal of the solvent, no product is obtained and 
only starting material is recovered. 
 
 
R 66: A solution of 4.1 g (28.0 mmol) of NaI in 30.0 ml of acetontrile is slowly added 
to a mixture of 3.0 g (16.5 mmol) of cyclododecanone (11), 3.9 ml (2.8 g, 28.0 mmol) 
of NEt3 and 3.4 ml (3.05 g, 28.0 mmol) of TMSCl (103) at RT. An exothermic reaction 
occurred with concomitant formation of a white precipitate (Et3NHI), while the 
acetonitrile solution turns brownish. The stirring is maintained for a period of 12 h. 
Then, 30 ml of cold pentane and ice-water are successively added. 
After decantation, the aqueous phase is extracted with pentane and the 
organic layer is washed with ice-water (2 x 30 ml), dried over MgSO4 
and distilled under reduced pressure (3 x 10-2 mbar) at 90°C giving 1.5 
g (6.3 mmol, 38 % yield) of cyclododec-1-enyloxy-trimethyl-silane 
(165) (C15H30OSi, 254.49 g / mol) as a yellow oil. Spectroscopic data: 
1H-NMR (400 MHz, CDCl3): δ  [ppm] = 4.50 (t, 1H, 3J = 8.0 Hz, 3J = 
7.7 Hz, CH=C), 2.40 (m, 4H, CH), 2.0 (m, 2H, CH2), 1.82 (m, 3H, 
CH2), 1.61 (m, 5H, CH2), 1.21 (m, 6H, CH2), 0.10 (s, 9H, CH3). 13C-NMR (100 MHz, 
CDCl3): δ  [ppm] = 151.249 (Cq), 108.77 (CH=C), 40.21 (CH), 27.77 (CH2), 27.22 
O
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(CH2), 24.63 (CH2), 24.49 (CH2), 24.36 (CH2), 24.19 (CH2), 24.08 (CH2), 23.78 (CH2), 
22.44 (CH2), 0.29 (3 x CH3). 
 
 
R 67: A solution of 47.0 ml (7.5 g, 118 mmol) of n-butyllithium in n-hexane (2.5 M) is 
added dropwise over a period of 30 min. to a cold (-78°C) solution of 18.1 ml (13.0 g, 
118.0 mmol) of freshly distilled diisopropylamine in 25.0 ml of abs. THF. After 20 
min., a solution of 20.0 g (109.0 mmol) of cyclododecanone (11) in 50 ml of abs. THF 
is added and the mixture is stirred for 30 min. Then, 25.7 ml (22.7 g, 185.0 mmol) of 
TMSCl (103) in 30 ml of abs. THF is added dropwise. The reaction mixture is 
maintained at -78°C for 45 min. and gradually warmed to room temperature. Then, after 
6 hours, the aqueous layer is extracted (3 x 40 ml) with Et2O. The organic layer is 
washed once with brine, filtered and dried over MgSO4. The solvent is removed in 
vacuum giving a crude mixture. Distillation of the resulting mixture under reduced 
pressure (3 x 10-2 mbar) at 90°C gives 21.5 g (85 mmol, 78 % yield) of cyclododec-1-
enyloxy-trimethyl-silane (165) (C15H30OSi, 254.49 g / mol) as a colorless oil. 
Spectroscopic data are consistent with those reported in R 66. 
 
 
Preparation of 3-(2-oxo-cyclododecyl)propanal (145) 
R 68: To a solution of 5.0 g (20.0 mmol) of cyclododec-1-enyloxy-trimethyl-silane 
(165) in 40 ml of abs. CH2Cl2 at -78°C is added slowly over a period 1 hour a solution 
of 2.2 g of acrolein (166) (40 mmol) in 60.0 ml of abs. CH2Cl2, under argon. The 
resulting solution is stirred for 8 hours at -78°C, washed with a solution of NaHCO3 and 
extracted with diethylether (3 x 30 ml). The combined extracts are dried on MgSO4 and 
concentrated under vacuum. The organic layer is separated 
and washed with a solution of Na2CO3. The combined 
organic phases are dried and the crude mixture is purified 
by bulb to bulb distillation at 85°C (4 x 10-2 mbar) 
furnishing 3.7 g (15.6 mmol, 78 % yield) 3-(2-oxo-
cyclododecyl)propanal (145) (C15H26O2, 238.37 g / mol) as 
a colorless liquid. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 9.64 
O
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(t, 1H, 3 J = 1.2 Hz, CHO), 3.30 (dd, 2H, 3J = 6.7 Hz, 3J = 6.5 Hz, CH2), 2.62 (dd, 2H, 3J 
= 9.54 Hz, 3J = 3.26 Hz, CH2), 2.55 (m, 1H, CH2), 2.36–2.33 (m, 3H, CH2), 2.32-2.27 
(m, 4H, CH2), 2.25 (dd, 2H, 3J = 8.0 Hz, 3J = 3.5 Hz, CH2), 2.20 (dd, 1H, CH2), 1.90 (m, 
2H, CH2), 1.63-1.53 (m, 4H, CH2), 1.28-1.03 (m, 4H, CH2), 0.88 (m, 1H, CH2). 13C-
NMR (100 MHz, CDCl3): δ  [ppm] = 213.49 (CO), 201.52 (CO), 50.557 (CH), 41.59 
(CH2), 37.23 (CH2), 26.109 (CH2), 25.85 (CH2), 24.08 (CH2), 23.76 (CH2), 23.31 
(CH2), 22.92 (CH2), 22.369 (CH2), 21.97 (CH2), 21.71 (CH2), 21.58 (CH2). 
 
 
R 69: To a solution of 5.0 g (20.0 mmol) of 4-cyclododec-1-en-1-yl-morpholine (70) 
in 40 ml of abs. dioxane at 90°C, a solution of 21.0 g of acrolein (166) (250.0 mmol) in 
60.0 ml of abs. dioxane is added slowly over 1 hour, under argon. The resulting solution 
is stirred for 66 hours at reflux. After cooling, 10 ml of HCl (conc.) is added and stirred 
for further 6 hours. The organic layer is separated and washed with a solution of 
Na2CO3. The organic phases are dried and the crude mixture is purified by bulb to bulb 
distillation at 45°C (4 x 10-2 mbar). Cyclododecanone (11) is recovered. 
 
 
R 70 Amounts: 
 5.0 g  (20.0 mmol)  4-cyclododec-1-en-1-yl-morpholine (70) 
 21.0 g (250.0 mmol)   acrolein (166)  
 50 ml     abs. MeOH 
Procedure: Analogously to R 69, room temperature, 25 hours. 
Cyclododecanone (11) is recovered. 
 
 
R 71 Amounts: 
 5.0 g (20.0 mmol)  4-cyclododec-1-en-1-yl-morpholine (70) 
 21.0 g (250.0 mmol)  acrolein (166) 
 50.0 ml   abs. MeOH 
Procedure: Analogously to R 69, 80 °C, 25 hours. 
Cyclododecanone (11) is recovered. 
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R 72 Amounts: 
 5.0 g (20 mmol)  4-cyclododec-1-en-1-yl-morpholine (70) 
 21.0 g (250.0 mmol)  acrolein (166)  
 50 ml    abs. Et2O 
Procedure: Analogously to R 69, 0°C, 25 hours. 
The crude mixture is purified by bulb to bulb distillation at 85°C (4 x 10-2 mbar) giving 
4.6 g (19.2 mmol, 96 % yield) of 3-(2-oxo-cyclododecyl)propanal (145) (C15H26O2, 
238.37 g / mol) as a colorless liquid. Spectroscopic data are consistent with those 
reported in R 68. 
 
 
4.5.1.2. Aldol reactions of substituted 3-(2-oxo-cyclododecyl)propanal 
Preparation of bicyclo[9.3.1]pentadec-11-en-15-one (167) 
R 73 Amounts: 
 1.0 g (3.4 mmol)  3-(2-oxo-cyclododecyl)propanaldehyde (145) 
 1.6 g (10.7 mmol)  DBU 
 80.0 ml   EtOH 
Procedure: Analogously to R 39, 16 hours, room temperature. 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane / Et2O (3:1) 
as eluent. 540 mg (2.4 mmol, 72 % yield) of bicyclo[9.3.1]pentadec-11-en-15-one (167) 
(C15H24O, 220.35 g / mol) are isolated as a white solid. Spectroscopic data: 1H-NMR 
(400 MHz, CDCl3): δ [ppm] = 6.32 (d, 1H, 3J = 4.2 Hz, CH), 2.79 (dd, 1H, 3J = 13.0 
Hz, 3J = 1.5 Hz, CH), 2.39 (m, 2H, CH), 2.27 (m, 2H, CH2), 2.03 
(m, 2H, CH2), 1.82 (m, 2H, CH2), 1.64 (m, 2H, CH2), 1.55 (dd, 
1H, 3J = 13.0 Hz, 3J = 2.2 Hz, CH), 1.43-1.01 (m, 11H, CH2). 
13C-NMR (100 MHz, CDCl3): δ  [ppm] = 204.44 (CO), 142.79 
(CH), 137.20 (Cq), 47.21 (CH), 40.49 (CH2), 30.66 (CH2), 28.50 
(CH2), 27.42 (CH2), 26.20 (CH2), 26.10 (CH2), 23.42 (CH2), 
22.67 (CH2), 22.47 (CH2), 22.20 (CH2), 21.78 (CH2). LR-MS (EI, 70 eV): m/z (%) = 
220 (M+, 30.15), 153 (33.12), 136 (20.15), 105 (11.47), 81 (6.85), 67 (36.98), 55 
(18.86), 41 (28.59), 29 (17.28). HR-MS (EI, 70 eV): Calcd. 220.1827, Found: 
O
167
  166
   Experimental part 
220.1806. Elemental Analysis: Calcd. % C 81.76, % H 10.98 Found: % C 80.5 % H 
11.03. 
 
 
Preparation of 12-hydroxy-bicyclo[9.3.1]pentadecan-15-one (168) and 
bicyclo[9.3.1]pentadec-11-en-15-one (167) 
R 74 Amounts: 
 1.0 g (3.4 mmol)  3-(2-oxo-cyclododecyl)propanaldehyde (145) 
 70 ml    HCl (7N) 
 80 ml    dioxane 
Procedure: Analogously to R 37, 16 hours, room temperature. 
The crude mixture consists of compounds 12-hydroxy-bicyclo[9.3.1]pentadecan-15-one 
(168) and bicyclo[9.3.1]pentadec-11-en-15-one (167) in a ratio of 1:1 detected by 1H-
NMR (ratio calculated with respect to the Ha and Hb). The crude mixture is separated by 
column chromatography on alumina N (III), cyclohexane / Et2O (3:1) to give 430 mg 
(1.8 mmol, 53 % yield) of 168 (C15H26O2, 238.37 g / mol) as brown oil and 320 mg (1.4 
mmol, 42 % yield) of 167 (C15H24O, 220.35 g / 
mol) as a colorless oil. The compound 168 is 
present as a mixture of two diastereoisomers in a 
ratio of 1: 2.38 as detected by 1H-NMR (ratio 
calculated with respect to the CHOH). 160 mg (0.7 
mmol, 20 % yield) of minor diastereisomer is 
isolated by recrystallization from Et2O. 
Spectroscopic data of the minor diastereoisomer: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 3.91 (m, 1H, CHOH), 2.90 (dd, 1H, 3J = 5.2 Hz, 3J = 2.7 Hz, CH), 2.65 (dd, 
1H, 3J = 5.2 Hz, 3J = 3.2 Hz, CH), 1.95-1.86 (m, 5H, CH), 1.82-1.77 (m, 1H, CH2), 
1.66-1.59 (m, 1H, CH), 1.50-1.11 (m, 14H, CH), 1.08-1.01 (m, 1H, CH), 0.96-0.86 (m, 
1H, CH2). 13C-NMR (125 MHz, CDCl3): δ  [ppm] = 214.78 (CO), 72.92 (CH), 60.26 
(CH), 42.18 (CH), 30.02 (CH2), 29.13 (CH2), 26.92 (CH2), 26.14 (CH2), 25.54 (CH2), 
22.69 (CH2), 22.56 (2 x CH2), 22.24 (CH2), 22.14 (CH2), 22.04 (CH2). 
Spectroscopic data of 167 are consistent with those reported in R 73 
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4.5.2. Stepwise Michael addition / aldol addition of β-ketoester 
4.5.2.1. Michael addition  
Preparation of ethyl 2-oxo-1-(3-oxo-propyl)cyclododecane carboxylate (171) 
R 75: To a mixture of 2.0 g (7.88 mmol) of ethyl 2-oxo-cyclododecane carboxylate 
(72) and 10.0 g of Al2O3 is added 0.6 ml (0.4 g 7.88 mmol) of acrolein (166). The 
mixture is stirred for 20 hours, then, filtered through a short pad of alumina N (III). 
After removing of solvent the residue is distilled under vacuum 110°C (4 x 10–2 mbar) 
and starting material is recovered. 
 
 
R 76: To a mixture of 5.0 g (20.0 mmol) of ethyl 2-oxo-cyclododecane carboxylate 
(72) in 20ml THF 2.1 g (20.0 mmol) of Na2CO3 and a solution of 1.4 g (20 mmol) of 
acrolein (166) in 10 ml of abs. THF is added. The mixture is stirred at RT for 24 h. 
Then, the mixture is poured in water, and 30 ml of HCl are added. The organic phase is 
separated and the aqueous layer is extracted with Et2O (3 x 30 ml). The combined 
organic extracts are dried over MgSO4. After removing of the solvent the residue is 
distilled under vacuum (120°C, 1.4 10-1 mbar) and starting material is recovered. 
 
 
R 77: To a mixture of 3.0 g (12 mmol) of ethyl 2-oxo-cyclododecane carboxylate (72) 
in 20 ml THF and 3.7 g (11.81 mmol) of piperidine, a solution of 1.0 ml (0.8 g, 12 
mmol) of acrolein (166) in 10 ml of abs. THF is added. The mixture is stirred at RT for 
72 h. Then, the mixture is poured in 30 ml of water and 10 ml of HCl (conc.) are added. 
The organic phase is separated and the aqueous layer is extracted with Et2O (3 x 30 ml). 
The combined organic extracts are dried over MgSO4. After removing of the solvent the 
residue is distilled under vacuum (110°C, 1.4 10-1 mbar) and starting material is 
recovered.  
 
 
 
 
  168
   Experimental part 
R 78 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 2.0 g (11.8 mmol)   molecular sieves 
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     toluene 
Procedure: Analogously to R 75, 12 hours, refluxing toluene 
After removing of solvent the residue is distilled under vacuum 120°C (4 x 10–2 mbar), 
10 % conversion in compound 171 is detected by GC-analysis. 
 
 
R 79: To a mixture of 15.0 g (60.0 mmol) of ethyl 2-oxo-cyclododecane carboxylate 
(72) and 0.9 ml (60 mg, 6.0 mmol) of NEt3 in 60 ml DMF a solution of 8 ml (60.0 
mmol) of acrolein (166) in 20 ml of DMF is added. The mixture is stirred at RT for 20 
h. Then, the mixture is poured in 40 ml of water and 10 ml of HCl (conc.) are added. 
The organic phase is separated and the aqueous layer is 
extracted with Et2O (3 x 30 ml). The combined organic 
extracts are dried over MgSO4. After removing of solvent 
the residue is distilled under vacuum (130°C, 1.4x10-1 
mbar) giving 15.4 g (50 mmol, 83 % yield) of ethyl 2-oxo-
1-(3-oxo-propyl)cyclododecane carboxylate (171) 
(C18H30O4, 310.43 g / mol) as a colorless oil. Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm]: 9.63 (t, 1H, 3J = 1.7 Hz, CHO), 4.09 (q, 2H, 3J = 7.0 Hz, CH2CH3), 
2.80 (m, 1H, CH), 2.24 (m, 4H, CH2), 2.00 (m, 2H, CH2), 1.70 (dd, 2H, 3J = 13.5 Hz, 3J 
= 6.0 Hz, CH), 1.23 (t, 3H, 3J = 6.9 Hz, CH2CH3), 1.24-1.13 (m, approx. 13H, CH2), 
0.79 (m, 2H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 206.43 (CO), 200.92 
(CO), 172.21 (CO), 62.36 (Cq), 61.32 (CH2CH3), 38.79 (CH2), 34.12 (CH2), 29.53 
(CH2), 29.31 (CH2), 26.37 (CH2), 26.19 (CH2), 23.36 (CH2), 22.54 (CH2), 21.87 (CH2), 
21.73 (CH2), 21.39 (CH2), 18.76 (CH2), 13.86 (CH2CH3). 
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Preparation of ethyl 12-hydroxy-13-methyl-15-oxo-bicyclo[9.3.1]pentadecan 
carboxylate (175) 
R 80 Amounts: 
 2.0 g  (7.87 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 6.0 mg (0.78 mmol)  NEt3
 0.8 g  (15.74 mmol)  methacrolein (169) 
 50 ml    DMF 
Procedure: Analogously to R 79 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (3:1) as 
eluent to obtain 1.5 g (4.8 mmol, 61 % yield) of ethyl 12-hydroxy-13-methyl-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (175) (C19H32O4, 324.45 g / mol) as a mixture of 
diastereoisomers in a ratio of 1:1:1 detected by 1HNMR analysis (ratio calculated with 
respect to CH3) as colorless crystals. Spectroscopic data: 1HNMR (400 MHz, CDCl3): 
δ [ppm] = 4.10 (q, 2H, 3J = 7.0 Hz, CH2CH3), 3.6 (m, 1H, CH), 3.39 (dd, 1H, 3J = 7.0 
Hz, 3J = 3.5 Hz, CH), 2.90 (m, 1H, CH), 2.47 (m, 1H, 
CH2), 1.90 (m, 2H, CH2), 2.39 (m, 2H, CH2), 2.18-1.81 (m, 
5H, CH2), 1.64-1.33 (m, 6H, CH2), 1.34 (m, approx. 5H, 
CH2), 1.19 (t, 3H, 3J = 7.0 Hz, CH2CH3), 0.89, 087, 0.83 
(d, 9H, 3J = 3.5 Hz, CH3). 13C-NMR (100 MHz, CDCl3): 
δ [ppm] = 210.57, 210.48, 209.45 (CO), 172.64, 172.64 
(CO), 73.84, 72.38, 71.61 (CH), 66.08, 65.97, 65.65 
(CH2CH3), 60.68, 60.64, 60.55 (Cq), 49.82, 49.06, 47.57 (CH), 38.50, 38.87, 38.38 
(CH2), 37.24, 37.59 (CH), 32.97 (CH2), 26.00 (CH2), 25.96, 25.91 (CH2), 24.86, 24.79 
(CH2), 22.23, 22.16 (CH2), 22.06, 22.01 (CH2), 21.77, 21.82 (CH2), 21.36 (CH2), 19.60 
(CH2), 15.98, 16.05, 16.08 (CH3), 14.02 (CH2CH3). IR (neat): ν   [cm-1] = 3503 (s), 
2937 (s), 1739 (s), 1703 (s), 1470 (m), 1427 (s), 1250 (m), 1122 (m). 
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Preparation of ethyl 14-methyl-12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan 
carboxylate (176) 
R 81 Amounts: 
 1.5 g  (6.0 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 6.0 mg (0.6 mmol)    NEt3
 0.66 g  (12.0 mmol)   crotonic aldehyde (170) 
 50 ml     DMF 
Procedure: Analogously to R 79 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (3:1) as 
eluent to furnish 1.0 g (3.24 mmol, 54 % yield) of ethyl 14-methyl-12-hydroxy-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (176) (C19H32O4, 324.45 g/ mol) as a mixture of 
diastereoisomers in a ratio of 1 (DS1): 1.4 (DS2): 1.1 (DS3) detected by 1HNMR 
analysis (ratio calculated with respect to CH3) as a colorless crystal. A mixture of two 
diastereoisomers is isolated in a ratio of 1 (DS2) : 7 (DS3) detected by 1HNMR analysis 
(ratio calculated with respect to CH3) after recristallization from Et2O. Spectroscopic 
data of a mixture of DS2 and DS3: Spectroscopic data: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 4.08 (q, 2H, 3J = 7.2 Hz, CH2CH3), 3.7 (m, 1H, CH), 2.95 (m, 1H, CH), 2.50 
(dd, 1H, 3J = 6.9 Hz, 3J = 2.4 Hz, CH), 1.90 (m, 3H, CH2), 
1.70 (m, 1H, CH2), 1.58-1.42 (m, 6H, CH2), 1.254 (m, 
approx. 14H, CH2), 1.19 (t, 3H, 3J = 7.2 Hz, CH2CH3), 0.92, 
0.88 (d, 4H, 3J = 6.9 Hz, CH3). 13C-NMR (125 MHz, 
CDCl3): δ [ppm] = 210.29 (CO), 170.66 (CO), 72.74, 71.87 
(CH), 66.70, 66.78 (Cq), 60.42 (CH2CH3), 49.92 (CH), 38.58, 
38.67 (CH2), 37.38, 37.57 (CH), 33.46 (CH2), 26.13 (CH2), 26.08 (CH2), 25.00 (CH2), 
22.28 (CH2), 22.25 (CH2), 21.93 (CH2), 21.52 (CH2), 19.75, 19.81 (CH2), 16.10 (CH3), 
14.16 (CH2CH3). IR (neat): ν  [cm-1] = 3503 (s), 2937 (s), 1739 (s), 1703 (s), 1470 (m), 
1427 (s), 1250 (m), 1122 (m). 
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4.5.2.2. Intramolecular aldol addition of 1,4-dicarbonyl compounds 
Preparation of ethyl 12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (174) 
R 82 Amounts: 
 1.0 g (3.4 mmol) ethyl 2-oxo-1-(3-oxo-propyl)cyclododecane carboxylate  
    (171) 
 70 ml   HCl (7N) 
 80 ml    dioxane 
Procedure: Analogously to R 37, 20 hours, room temperature. 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (3:1) as 
eluent to obtain 885 mg (2.8 mmol, 82 % yield) of ethyl 12-hydroxy-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (174) (C18H30O4, 310.42 g/ mol) as a mixture of 
diastereoisomers in a ratio of 1:1.6 detected by 1HNMR analysis (ratio calculated with 
respect to CH2CH3) as a colorless crystal. Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 4.12 (q, 2H, 3J = 7.2 Hz, CH2CH3), 4.08 (q, 2H, 3J = 7.2 Hz, 
CH2CH3), 3.45 (m, 1H, CH), 3.09 (d, 1H, 3J = 4.9 Hz, CHOH), 2.75 (dd, 1H, 3J = 10.4 
Hz, 3J = 1.2 Hz, CH), 2.18 (dd, 3J = 13.4 Hz, 3J = 4.2 Hz, 1H, 
CH), 2.10 (m, 2H, CH2), 1.96 (s, 1H, OH), 1.85-1.70 (m, 6H, 
CH2), 1.32-1.03 (m, approx. 17H, CH2), 1.22 (t, 3H, 3J = 7.2 
Hz, CH2CH3), 1.20 (t, 3H, 3J = 7.2 Hz, CH2CH3), 0.86 (m, 
1H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 209.46, 
208.45 (CO), 172.67, 172.56 (CO), 75.56, 73.43 (CH), 62.36, 
61.57 (Cq), 60.70, 60.65 (CH2CH3), 53.60, 49.66 (CH), 32.46, 32.06 (CH2), 31.33, 
30.95 (CH2), 28.83 (CH2), 26.88, 26.72 (CH2), 25.81, 25.78 (CH2), 25.03 (CH2), 22.94, 
22.88 (CH2), 22.83 (CH2), 22.48, 22.37 (CH2), 21.99 (CH2), 21.06, 21.00 (CH2), 13.98, 
13.95 (CH2CH3). IR (KBr/film): ν  [cm-1] = 3503 (s), 2937 (s), 1739 (s), 1703 (s), 1470 
(m), 1427 (s), 1250 (m), 1122 (m). LR-MS (EI, 70 eV): m/z (%) = 310 (M+, 10), 292 
(43), 263 (27), 219 (35), 207 (32), 123 (58), 109 (96), 95 (98), 81 (72), 55 (45). HR-MS 
(EI, 70 eV): Calcd. 310.2144, Found 310.2140. Elemental Analysis: Calcd. % C 69.64, 
% H 9.74, Found % C 69.7, % H 9.9 
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Preparation of ethyl 15-oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (177) 
R 83 Amounts: 
 1.0 g  (3.4 mmol) ethyl 2-oxo-1-(3-oxo-propyl)cyclododecane carboxylate  
    (171) 
 0.5 mg (3.8l mmol) BF3·OEt2
 80 ml   CH2Cl2 
Procedure: Analogously to R 37, 24 hours, room temperature 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (2:1) as 
eluent to obtain 804 mg (2.7 mmol, 81 % yield) of ethyl 15-oxo-bicyclo[9.3.1]pentadec-
11-ene carboxylate (177) (C18H28O3, 292.41 g / mol). Spectroscopic data: 1H-NMR 
(400 MHz, CDCl3): δ [ppm] = 6.43 (d, 1H, 3J = 3.5 Hz, CH), 4.12 (q, 2H, 3J = 7.0 Hz, 
CH2CH3), 2.80 (m, 1H, CH), 2.61-2.33 (m, 4H, CH2), 1.95-1.65 (m, 7H, CH2), 1.58 (dd, 
3J = 13.0 Hz, 3J = 2.7 Hz, 2H, CH2), 1.19 (t, 3H, 3J = 7.0 Hz, 
CH2CH3), 1.14 (m, approx. 7H, CH2), 0.86 (m, 1H, CH2). 13C-
NMR (100 MHz, CDCl3): δ [ppm] = 197.55 (CO), 172.88 
(CO), 143.86 (Cq), 137.29 (CH), 60.53 (CH2CH3), 57.80 (Cq), 
32.28 (CH2), 30.81 (CH2), 29.12 (CH2), 26.52 (CH2), 25.98 
(CH2), 22.85 (CH2), 22.47 (CH2), 22.40 (CH2), 22.19 (CH2), 
21.80 (CH2), 19.07 (CH2), 13.98 (CH2CH3). IR (KBr/film): ν   [cm-1] = 2937 (s), 1735 
(s), 1672 (s), 1469 (m), 1432 (s), 1347 (m), 1252 (m), 1182 (m), 1097 (m), 1027 (m). 
LR-MS (EI, 70 eV): m/z (%) = 292 (M+, 2.62), 219 (100), 149 (2.34), 136 (3.44), 105 
(7.73), 81 (22.55), 67 (16.39), 55 (19.72), 41 (11.49), 29 (32.91). HR-MS (EI, 70 eV): 
Calcd. 292.2038, Found 292.2027. 
 
 
R 84 Amounts: 
 1.0 g (3.4 mmol)  ethyl 2-oxo-1-(3-oxo- propyl)cyclododecane 
     carboxylate (171) 
 590.0 mg (3.8l mmol) NaOH 
 80 ml    EtOH 
Procedure: Analogously to R 79, 24 hours, refluxing ethanol 
O
COOEt
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The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (3:1) as 
eluent to obtain 614 mg (2.1 mmol, 86 % yield) of ethyl 15-oxo-bicyclo[9.3.1]pentadec-
11-ene carboxylate (177) (C18H28O3, 292.20 g / mol). Spectroscopic data are consistent 
with those reported in R 83.  
 
 
R 85 Amounts:  
 1.0 g  (3.4 mmol)  ethyl 2-oxo-1-(3-oxo-propyl)cyclododecane  
     carboxylate (171) 
 590 mg (3.8l mmol)  NaOH 
 80 ml    EtOH 
Procedure: Analogously to R 79, 72 hours, refluxing ethanol 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (2:1) as 
eluent to furnish 725 mg (3.3 mmol, 97 % yield) of bicyclo[9.3.1]-pentadec-11-en-15-
one (167) (C15H24O, 220.35 g / mol) as a white solid. Spectroscopic data are consistent 
with those reported in R 73. 
 
 
4.5.3. One-Pot Michael addition / aldol cyclisation 
Preparation of ethyl 12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (174) 
R 86: To a mixture of 2.0 g (7.88 mmol) of ethyl 2-oxo-cyclododecane carboxylate 
(72) and 1.6 g (11.81 mmol) K2CO3 in 70 ml of EtOH, 0.6 ml 0.4 g (7.88 mmol) of 
acrolein (166) is added. The mixture is stirred at RT for 18 hours. Then, the mixture is 
filtered through a short pad of alumina. After removing of the solvent, the crude mixture 
is filtered on pad of alumina N (III) using cyclohexane / Et2O (2:1) as eluent. 1.5 g (4.8 
mmol, 61 % yield) of ethyl 12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate 
(174) (C18H30O4, 310.42 g / mol) are isolated as a colorless crystal. Spectroscopic data 
are consistent with those reported in R 82. 
 
 
 
 
  174
   Experimental part 
R 87 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.8 mol)   K2CO3 
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 72 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to obtain 1.4 g (4.5 mmol, 58 % yield) of ethyl 
12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (174) (C18H30O4, 310.42 g / 
mol) as a mixture of two diastereoisomers in a ratio of 1:1 detected by 1HNMR 
(calculated by respect to CHOH). Spectroscopic data are consistent with those reported 
in R 82. 
 
 
R 88 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 18 hours, refluxing EtOH. 
After removing of the solvent, the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent. 1.3 g (4.4 mmol, 56 % yield) of ethyl 12-
hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (174) (C18H30O4, 310.42 g / mol) 
are obtained as a mixture of two diastereoisomers in a ratio of 1:1.09 detected by 
1HNMR (calculated by respect to CHOH). Spectroscopic data are consistent with those 
reported in R 82. 
 
 
R 89 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.8 mol)   K2CO3 
 0.4 g (7.88 mmol)   acrolein (166) 
  175
   Experimental part 
 50 ml     EtOH 
Procedure: Analogously to R 86, 72 hours, refluxing EtOH. 
After removing of the solvent, the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent. 1.2 g (5.2 mmol, 67 % yield) of ethyl 15-oxo-
bicyclo[9.3.1]pentadec-11-ene carboxylate (177) (C18H28O3, 291.42 g / mol) are 
isolated. Spectroscopic data are consistent with those reported in R 83.  
 
 
R 90 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     acetone 
Procedure: Analogously to R 86, 18 hours, room temperature. 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (5:1) as 
eluent to obtain 1.9 g (6.1 mmol, 78 % yield) of ethyl 2-oxo-1-(3-oxo-
propyl)cyclododecane carboxylate (171) (C18H30O4, 310.43 g / mol) as a colorless oil. 
Spectroscopic data are consistent with those reported in R 79. 
 
 
R 91 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     acetone 
Procedure: Analogously to R 86, 72 hours, room temperature. 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (3:1) as 
eluent to give 1.6 mg (5.2 mmol, 67 % yield) of ethyl 12-hydroxy-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (174) (C18H30O4, 310.42 g / mol) are obtained. 
Spectroscopic data are consistent with those reported in R 82. 
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R 92 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 18 hours, room temperature. 
After removing of the solvent, the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent. 1.5 g (4.5 mmol, 58 % yield) of ethyl 12-
hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (175) (C19H32O4, 324.45 g / mol) 
are obtained as a colorless crystal. Spectroscopic data are consistent with those 
reported in R 80. 
 
 
R 93 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 72 hours, room temperature. 
After removing of the solvent the crude mixture contains a mixture of ethyl 12-hydroxy-
15-oxo-bicyclo[9.3.1]pentadecan carboxylate (175) (C19H32O4, 324.45 g / mol) and 
methyl 15-oxo-13-methyl-bicyclo[9.3.1]pentadec-11-ene 
carboxylate (182) (C19H30O3, 306.44 g / mol). The products are 
separated by chromatography using alumina N (III) and 
cyclohexane / Et2O (5:1) as eluent to give 0.76 g (2.3 mmol, 30 
% yield) of compound 175 as a mixture of two 
diastereoisomers in a ratio of 1:1.33 detected by 1HNMR 
analysis (calculated with respect to the CH3) and 0.86 g (2.7 
mmol, 35 % yield) of methyl 15-oxo-13-methyl-bicyclo[9.3.1]pentadec-11-ene 
carboxylate (182). 
Spectroscopic data of compound 175 are consistent with those reported in R 80.  
O
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Spectroscopic data of ethyl 13-methyl-15-oxo-bicyclo[9.3.1]pentadec-11-ene 
carboxylate (182) are assigned by the most significant signals: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 6.67 (s, 1H, CH) 13C-NMR (100 MHz, CDCl3): δ [ppm] = 201.54 
(CO), 143.01 (Cq), 137.49 (CH). 
 
 
R 94 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 18 hours, refluxing ethanol 
After removing of the solvent the residue is filtered on pad of alumina N (III) using 
cyclohexane/ Et2O (3:1) as eluent, to give 1.2 g (3.4 mmol, 43 % yield) of ethyl 12-
hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (175) (C18H31O4, 324.45 g / mol) 
as a mixture of two diastereoisomers in a ratio of 1:1.68:1.37 detected by NMR analysis 
(ratio calculated with respect to the CH3), as colorless crystal. Spectroscopic data are 
consistent with those reported in R 80 
 
 
R 95 Amounts: 
 2.0 g (7.88 mmol.)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 72 hours, refluxing ethanol 
After removing of the solvent a crude mixture of ethyl 12-hydroxy-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (175) (37.5 % 1HNMR-yield calculated with 
respect to the CH=C / CHO) (C19H32O4, 324.24 g / mol) and methyl 15-oxo-13-methyl-
bicyclo[9.3.1]pentadec-11-ene carboxylate (182) (62 % 1HNMR-yield calculated with 
respect to the CH=C / CHO) (C19H30O3, 306.42 g / mol) is obtained. Compound 175 is 
present as a mixture of two diastereoisomers in a ratio of 1:1 detected by 1HNMR 
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analysis (calculated with respect to the CH3). Spectroscopic data are consistent with 
those reported in R 93. 
 
 
R 96 Amounts: 
 2.0 g (7.88 mmol.)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)  methacrolein (169) 
 50.0 ml   acetone 
Procedure: Analogously to R 90, 18 hours, room temperature. 
After removing of the solvent the residue is filtered on pad of alumina N (III) using 
cyclohexane/ Et2O (5:1) as eluent, to give 2.1 g (6.6 mmol, 85% yield) of ethyl 1-(2-
methyl-3-oxo-propyl) 2-oxo-cyclododecane carboxylate (172) (C19H32O4, 324.45 g / 
mol) as mixture of diastereoisomers in a ratio of 1:1.6 detected 
by 1HNMR analysis (ratio calculated with respect to CHO) as a 
colorless oil. Spectroscopic data: 1H-NMR (500 MHz, 
CDCl3): δ [ppm]: 9.63 (d, 1H, 3J = 3.0 Hz, CHO), 4.09 (q, 2H, 
3J = 7.2 Hz, CH2CH3), 2.80 (m, 1H, CH), 2.24-1.90 (m, 18H, 
CH2), 1.23 (m, 2H, CH2), 1.21 (t, 3H, 3J = 7.2 Hz, CH2CH3), 
1.02, 0.99 (d, 6H, 3J = 7.0 Hz, CH3), 0.79 (m, 4H, CH2). 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 206.83, 206.55 (CO), 201.79, 201.38 (CO), 
171.31, 171.21 (CO), 61.17, 61.13 (Cq), 61.07, 61.00 (CH2CH3), 48.53 (CH2), 45.97 
(CH), 38.23 (CH2), 34.23, 35.03 (CH2), 29.52, 29.20 (CH2), 28.13 (CH), 29.92 (CH2), 
26.68, 26.60 (CH2), 26.42, 26.36 (CH2), 25.26 (CH2), 24.94 (CH2), 23.92, 23.96 (CH2), 
22.19 (CH2), 23.34, 23.38 (CH2), 22.38 (CH2), 21.89, 21.84 (CH2), 18.66, 18.24 (CH2), 
17.14 (CH3), 14.01, 13.89 (CH2CH3) 
 
 
R 97 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   methacrolein (169) 
   Experimental part 
 50 ml     acetone 
Procedure: Analogously to R 86, 72 hours, room temperature. 
After removing of the solvent a mixture of ethyl 1-(2-methyl-3-oxo-propyl) 2-oxo-
cyclododecane carboxylate (172) (C19H32O4, 324.45 g / mol) and ethyl 12-hydroxy-15-
oxo-bicyclo[9.3.1]pentadecan carboxylate (175) (C19H32O4, 324.45 g / mol) is obtained 
The products are then separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1) to give 1.5 g (4.8 mmol, 61 % yield) of 175 as a mixture of 
diastereoisomers in a ratio of 1:2:1 detected by 1HNMR (ratio calculated with respect to 
the CH3) as colorless crystal and 0.8 g (2.6 mmol, 33 % yield) of 172 are isolated. 
Spectroscopic data of compound 172 are consistent with those reported in R 96. 
Spectroscopic data of compound 175 are consistent with those reported in R 80.  
 
 
R 98 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.8 mol)   K2CO3 
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     EtOH 
Procedure: Analogously to R 86, 18 hours, room temperature.  
After removing of the solvent, the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent. 1.3 g (4. 1 mmol, 53 % yield) of ethyl 12-
hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (176) (C19H32O4, 324.245 g / 
mol) as a mixture of two diastereoisomers in a ratio of 1:1.15 detected by 1HNMR (ratio 
calculated with respect to the CH3) as a colorless crystal. Spectroscopic data are 
consistent with those reported in R 81. 
 
 
R 99 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.8 mol)   K2CO3 
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     EtOH 
  180
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Procedure: Analogously to R 86, 72 hours, refluxing EtOH.  
After removing of the solvent the product  is isolated by column chromatography on 
alumina N (III), cyclohexane/ Et2O (2:1) furnishing 1.9 g (6.0 mmol, 76 % yield) of 
ethyl 14-methyl-15-oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (183) (C19H30O3, 
306.42 g / mol). Spectroscopic data 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 6.43 (d, 1H, 3J = 4.0 Hz, CH), 4.14 (q, 
2H, 3J = 7.0 Hz, CH2CH3), 2.86 (m, 1H, CH2), 2.60 (m, 1H, 
CH2), 2.40 (m, 1H, CH2), 2.34 (m, 1H, CH2), 2.20 (m, 1H, 
CH2), 1.98 (m, 1H, CH2), 1.65 (m, 2H, CH2), 1.23 (m, 7H, 
CH2), 1.19 (t, 3H, 3J = 7.0 Hz, CH2CH3), 0.95 (d, 3H, 3J = 7.0 
Hz, CH3), 0.86 (m, 3H, CH2). 13C-NMR (100 MHz, CDCl3): 
δ [ppm] = 196.39 (CO), 171.33 (CO), 142.07 (CH), 137.96 (Cq), 61.32 (Cq), 60.47 
(CH2CH3), 35.47 (CH), 31.59 (CH2), 30.72 (CH2), 30.39 (CH), 27.84 (CH2), 26.39 
(CH2), 24.14 (CH2), 23.72 (CH2), 23.40 (CH2), 22.75 (CH2), 21.17 (CH2), 17.12 (CH3), 
14.19 (CH2CH3). IR (KBr/film): ν [cm-1] = 2937 (s), 1735 (s), 1672 (s), 1469 (m), 
1432 (s), 1347 (m), 1252 (m), 1182 (m), 1097 (m), 1027 (m). 
 
 
R 100 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     acetone 
Procedure: Analogously to R 86, 18 h, room temperature. 
After removing of the solvent the product is isolated by column chromatography on 
alumina N (III), cyclohexane/ Et2O (2:1) furnishing, 2.1 mg (6.6 mmol, 84 % yield) of 
1-(1-methyl-3-oxo-propyl)-ethyl 2-oxo-cyclododecane 
carboxylate (173) (C19H32O4, 324.45 g / mol) as mixture of 
diastereoisomers in a ratio of 1:2.8 detected by 1HNMR 
analysis (ratio calculated with respect to CHO) as a colorless 
oil. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): 
δ [ppm]: 9.69 (t, 1H, 3J = 1.5 Hz, CHO), 4.19 (q, 2H, 3J = 
O
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7.2 Hz, CH2CH3), 3.69 (m, 1H, CH), 2.77-2.61 (m, 2H, CH2), 2.56-2.40 (m, 3H, CH2), 
2.07-1.80 (m, 4H, CH2), 1.27-1.20 (m, approx. 13H, CH2),1.16 (t, 3H, 3J = 7.2 Hz, 
CH2CH3), 0.91, 0.88 (d, 3H, 3J = 6.9 Hz, CH3), 0.86 (m, 3H, CH2). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 206.96, 206.79 (CO), 201.99, 201.58 (CO), 169.81, 169.50 
(CO), 65.83, 66.25 (Cq), 61.11, 61.16 (CH2CH3), 48.68 (CH2), 46.03 (CH), 40.25 (CH2), 
29.26, 29.24 (CH2), 28.24 (CH), 26.41, 26.47 (CH2), 25.32 (CH2), 24.99 (CH2), 24.00, 
23.65 (CH2), 23.38, 23.21 (CH2), 21.89, 21.79 (CH2), 18.70, 18.28 (CH2), 17.21 (CH3), 
14.02, 13.97 (CH2CH3). 
 
 
R 101 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   K2CO3 
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     acetone 
Procedure: Analogously to R 86, 72 hours, room temperature. 
After removing of the solvent the residue is filtered on pad of alumina N (III) using 
cyclohexane/ Et2O (2:1) as eluent to give 1.4 g (4.5 mmol, 57 % yield) of ethyl 12-
hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (176) (C19H32O4, 324.24 g / mol) 
as a colorless crystal. Spectroscopic data are consistent with those reported in R 81. 
 
 
R 102 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 18 hours, room temperature 
The product is isolated by column chromatography on alumina N (III), cyclohexane/ 
Et2O (2:1) giving 1.4 g (4.9 mmol, 63 % yield) of ethyl 15-oxo-bicyclo[9.3.1]pentadec-
11-ene carboxylate (177) (C18H28O3, 291.42 g / mol). Spectroscopic data are consistent 
with those reported in R 83.  
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R 103 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     MeOH 
Procedure: Analogously to R 77, 72 hours, room temperature. 
The crude mixture is filtered on pad of alumina N (III) using cyclohexane/ Et2O (2:1) as 
eluent furnishing 1.5 g (5.6 mmol, 72 %) of methyl 15-oxo-bicyclo[9.3.1]pentadec-11-
ene carboxylate (184) (C17H26O3, 278.38 g / mol). 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 
6.43 (d, 1H, 3J = 3.7 Hz, CH), 3.6 (s, 3H, CH3), 2.85 (m, 1H, 
CH2) 2.60-2.57 (m, 4H, CH2), 1.95-1.92 (m, 1H, CH2), 1.82-
1.69 (m, 5H, CH2), 1.58 (dd, 2H, 3J = 12.5 Hz, 3J = 3.5 Hz, 
CH2), 1.14 (m, approx. 8H, CH2), 0.86 (m, 1H, CH2). 13C-
NMR (125 MHz, CDCl3): δ [ppm] = 197.66 (CO), 172.52 (CO), 143.97 (Cq), 137.43 
(CH=C), 58.10 (Cq), 51.89 (CH3), 32.40 (CH2), 30.87 (CH2), 29.292 (CH2), 26.62 
(CH2), 26.10 (CH2), 23.00 (CH2), 22.60 (CH2), 22.51 (CH2), 22.31 (CH2), 21.96 (CH2), 
20.01 (CH2). IR (KBr/film): ν   [cm-1] = 2937 (s), 1735 (s), 1672 (s), 1469 (m), 1432 
(s), 1347 (m), 1252 (m), 1182 (m), 1097 (m), 1027 (m). 
 
 
R 104 Amounts: 
 2.0 g (7.88mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 18 hours, refluxing ethanol 
The crude mixture is separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1) giving 414 mg (1.4 mmol, 18 %) of ethyl 15-oxo-
bicyclo[9.3.1]pentadec-11-ene carboxylate (177) (C18H28O3, 292.20 g / mol). 1.0 g (4.9 
mmol, 63 % yield) of bicyclo[9.3.1]pentadec-11-en-15-one (167) (C15H24O, 220.35 g / 
O
COOMe
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mol) as a white solid. Spectroscopic data of 177 are consistent with those in R 83. 
Spectroscopic data of 167 are consistent with those reported in R 73. 
 
 
R 105 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   acrolein (166) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 72 hours, refluxing ethanol. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent, to give 121 mg (0.55 mmol, 7 % yield) of 
bicyclo[9.3.1]pentadec-11-en-15-one (167) (C15H24O, 220.35 g / mol) as a white solid. 
Spectroscopic data are consistent with those reported in R 73. 
 
 
R 106 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)    NaOH
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 18 hours, room temperature 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to furnish 550 mg (1.9 mmol, 23 % yield ) of 
ethyl 14-methyl-15-oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (183) (C19H30O3, 
306.42 g / mol). Spectroscopic data are consistent with those reported in R 99. 
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R 107 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 72 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent, to obtain 1.7 g (5.6 mmol, 71 % yield ) of ethyl 
14-methyl-15-oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (183) (C19H30O3, 306.42 
g / mol). Spectroscopic data are consistent with those reported in R 99. 
 
 
R 108 Amounts: 
 2.0 g (7.88 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)  NaOH
 0.4 g (7.88 mmol)  crotonic aldehyde (170) 
 50ml    EtOH 
Procedure: Analogously to R 77, 18 hours, refluxing ethanol. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to give 940 mg (4.0 mmol, 51 % yield) of 14-
methyl-bicyclo[9.3.1]pentadecan-11-en-15-one (185) (C16H26O, 234.20 g / mol). 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 6.25 (m, 1H, CH), 2.85-
2.80 (m, 1H, CH2), 2.75-2.67 (m, 1H, CH2), 2.45-2.42 (m, 2H, CH2), 
2.13-2.09 (m, 2H, CH2), 2.03-1.97 (m, 1H, CH2), 1.72-1.66 (m, 2H, 
CH2), 1.70-1.67 (m, 1H, CH2), 1.65 (dd, 3H, 3J = 12.8 Hz, 3J = 2.5 Hz, 
CH2), 1.38-1.08 (m, approx. 7H, CH2), 0.98 (m, 3H, 3J = 7.2 Hz, 
CH3), 0.81 (m, 3H, CH2). 13C-NMR (100 MHz, CDCl3): δ   [ppm] = 
204.38 (CO), 142.40 (CH), 136.83 (Cq), 54.97 (CH), 40.34 (CH), 
34.67 (CH), 29.91 (CH2), 26.34 (CH2), 24.70 (CH2), 24.18 (CH2), 22.84 (CH2), 22.82 
(CH2), 22.42 (CH2), 22.28 (CH2), 21.94 (CH2), 19.97 (CH3). Elemental Analysis: 
Calcd. % C 81.99, % H 11.18, Found % C 81.8, % H 11.4. 
 
O
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R 109 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.6 g (11.81 mmol)   NaOH
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     EtOH 
Procedure: Analogously to R 77, 72 hours, refluxing ethanol. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to give 0.3 g (1.6 mmol, 21 % yield) of 14-
methyl-bicyclo[9.3.1]-pentadecan-11-en-15-one (185) (C16H26O, 234.20 g / mol) are 
isolated. Spectroscopic data are consistent with those reported in R 108.  
 
 
Preparation of ethyl 2-oxo-cyclotridecane carboxylate (186) 
R 110: 4.11 ml (4.61 g, 40.5 mmol)of boron trifluorid etherate is added to a solution of 
5.0 g (27.0 mmol) of cyclododecanone (11) in dry 40 ml of diethylether at 0°C. A 
solution of 5.25 ml (5.75 g, 40.5 mmol) ethyl diazoacetate (187) (40.5 mmol) in 20 ml 
of dry diethylether is then added over a period of 15 min, and the resulting solution is 
stirred at room temperature under an argon atmosphere. When the reaction is completed, 
it is cooled to 0°C and neutralized with 40 ml of saturated aqueous sodium bicarbonate 
solution. The resulting mixture is extracted with chloroform (3 x 
30 ml). The combined extracts are washed with saturated 
aqueous sodium chloride solution, dried, and concentrated. After 
removing of solvent the residue is distilled under vacuum 120°C, 
1.4x10-1 mbar. 6.5 g (24.3 mmol, 90 % yield) of ethyl 2-oxo-
cyclotridecane carboxylate (186) (C16H30O3, 267.34 g / mol) are 
isolated. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 4.11 (q, 2H, 3J = 6.9 Hz, CH2CH3), 3.50 (dd, 2H, 3J = 3.7 Hz, 3J = 2.4 Hz, 
CH), 2.65 (m, 3H, CH2), 2.57 (m, 2H, CH2), 1.90 (m, 2H, CH2), 1.80 (m, 5H, CH2), 
1.60 (m, 2H, CH2), 1.25 (m, approx. 9H, CH2), 1.19 (t, 3H, 3J = 6.9 Hz, CH2CH3). 13C-
NMR (100 MHz, CDCl3): δ  [ppm] = 206.81 (CO), 169.82 (CO), 61.13 (CH2CH3), 
58.15 (CH), 41.16 (CH2), 27.62 (CH2), 26.27 (CH2), 25.96 (CH2), 25.37 (CH2), 25.15 
(CH2), 24.83 (CH2), 24.27 (CH2), 24.16 (CH2), 23.04 (CH2), 22.63 (CH2), 13.99 
O
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(CH2CH3). IR (KBr/film): ν  [cm-1] = 2999 (s), 2992 (s), 2937 (s), 2928 (s), 1741 (s), 
1705 (s), 1471 (m), 1427 (s), 1250 (m), 1128 (m). 
 
 
R 111 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.2 g (7.88 mmol)   DBU 
 0.4 g (7.88 mmol)   acrolein (166) 
 50ml     EtOH 
Procedure: Analogously to R 77, 18 h, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (3:1) as eluent to give 1.7 g (5.6 mmol, 72 % yield) of ethyl 
12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (174) (C18H30O4, 310.42 g / 
mol) as a brown oil as a mixture of two diastereoisomers in a ratio of 1:1.8 (detected by 
NMR). 0.7 g (2.5 mmol, 32 % yield) of compound 174 as a colorless crystal is obtained 
as a single diastereoisomer, by recrystallization from Et2O. Spectroscopic data are 
consistent with those reported in R 82. 
 
 
R 112 Amounts: 
 2.0 g (7.88 mmol)  ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.2 g (7.88 mmol)  DBU 
 0.4 g (7.88 mmol)  acrolein (166) 
 50.0 ml   EtOH 
Procedure: Analogously to R 77, 18 hours, refluxing ethanol. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent, to give 940 mg (3.2 mmol, 41 %) of ethyl 15-
oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (177) (C18H28O3, 291.42 g / mol). 
Spectroscopic data are consistent with those in R 83. 
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R 113 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.2 g (7.88 mmol)   DBU 
 0.4 g (7.88 mmol)   acrolein (166) 
 50.0 ml    EtOH 
Procedure: Analogously to R 77, 72 hours, refluxing ethanol. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent to give 1.6 g (5.7 mmol, 73 %) of ethyl 15-
oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (177) (C18H28O3, 291.42 g / mol). 
Spectroscopic data are consistent with those in R 83. 
 
 
Preparation of methyl 12-hydroxy-13-methyl-15-oxo-bicyclo[9.3.1]pentadecan 
carboxylate (188) 
R 114 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.2 g (7.88 mmol)   DBU 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     MeOH 
Procedure: Analogously to R 77, 18 h, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to give 255 mg (0.78 mmol, 10 % yield) of 12-
hydroxy-13-methyl-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (175) (C19H32O4, 
324.45 g / mol) and 1.7 g (5.6 mmol, 71 % yield) of methyl 13-methyl-12-hydroxy-15-
oxo-bicyclo[9.3.1]pentadecan carboxylate (188) (C18H30O4, 310.42 g / mol). Compound 
188 is obtained as a mixture of diastereoisomer in a ratio of 1:1.5 detected by 1HNMR 
analysis (ratio calculated with respect to CH3). 0.9 g (2.9 mmol, 37 % yield) of 188 are 
isolated as a single diastereoisomer by recrystallization from Et2O. Spectroscopic data: 
1H-NMR (500 MHz, CDCl3): δ [ppm] = 3.76 (m, 1H, 3J = 5.7 Hz, CH), 3.71 (s, 3H, 
CH3), 3.11 (dd, 2H, 3J = 5.9 Hz, 3J = 2.4 Hz, CH), 2.15-1.86 (m, 8H, CH2), 1.74-1.65 
(m, 2H, CH2), 1.59-1.52 (m, 1H, CH2), 1.36-1.03 (m approx. 12H, CH2), 1.16, 1.10 (d, 
3H, 3J = 6.7 Hz, CH3). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 210.16 (CO), 171.082 
  188
   Experimental part 
(CO), 80.47 (CH), 61.34 (Cq), 51.97 (CH), 46.84 (CH3 / CH), 41.18 (CH2), 36.90 (CH / 
CH3), 35.15 (CH2), 26.17 (CH2), 26.070 (CH2), 22.92 
(CH2), 22.625 (CH2), 22.36 (CH2), 21.96 (CH2), 21.81 
(CH), 20.40 (CH2), 20.04 (CH3). IR (neat): ν  [cm-1] = 
3514 (s), 2942 (s), 2915 (s), 2864 (s), 1739 (s), 1703 (s), 
1470 (m), 1433 (m), 1310 (m), 1298 (m), 1073 (m), 1063 
(m), 969 (m), 878 (m), 819 (m), 784 (m). LR-MS (EI, 70 
eV): m/z (%) = 310 (M+, 2.78), 292 (43), 205 (7.20), 123 
(4.34), 109 (8.40), 95 (13.15), 81 (26.06), 67 (28.43), 55 (44.81), 41 (61.57), 28 (38.47), 
18 (100). HR-MS (EI, 70 eV): Calcd 310.2144, Found 310.2140. Elemental Analysis: 
Calcd. % C 69.64, % H 9.74, Found % C 69.7, % H 9.8%. 
 
 
Preparation of methyl 12-hydroxy-14-methyl-15-oxo-bicyclo[9.3.1]pentadecan-1-
carboxyl (189) 
R 115 Amounts: 
 2.0 g (7.88mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 1.2 g (7.88 mmol)   DBU 
 0.4 g (7.88 mmol)   crotonic aldehyde (170) 
 50 ml     MeOH 
Procedure: Analogously to R 77, 18 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent to give 1.8 g (5.7 mmol, 73 % yield) of methyl 
12-hydroxy-14-methyl-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (189) (C18H30O4, 
310.42 g / mol) as a mixture of diastereoisomer in a ratio of  1:1.33 detected by 1HNMR 
analysis (ratio calculated with respect to CH3). 1.3 g (4.4 mmol, 62 % yield) of 189 are 
isolated as a single diastereoisomer by recrystallization from Et2O. Spectroscopic data: 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 3.74 (m, 1H, CHOH), 3.66 (s, 3H, CH3), 2.95 
(m, 2H, CH2/CH), 2.50 (m, 3H, CH2), 2.30 (d, 2H, 3J = 3.4 Hz, CH2), 2.12 (m, 4H, 
CH2), 1.90 (m, 1H, CH2), 1.70–1.42 (m, 2H, CH2), 1.29-1.14 (m, approx. 9H, CH2), 
1.16, 1.12 (d, 3H, 3J = 6.9 Hz, CH3). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 211.91 
(CO), 172.72 (CO), 74.16 (CH), 67.85 (Cq), 51.42 (CH), 52.87 (CH), 40.01 (CH2), 
O
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38.89 (CH), 34.62 (CH2), 27.57 (CH2), 26.44 (CH2), 23.88 (CH2), 23.77 (CH2), 23.70 
(CH2), 22.99 (CH2), 21.20 (CH2), 20.04 (CH2), 17.66 (CH). IR (neat): ν  [cm-1] = 3514 
(s), 2942 (s), 2915 (s), 2864 (s), 1739 (s), 1703 (s), 1470 
(m), 1433 (m), 1310 (m), 1298 (m), 1073 (m), 1063 (m), 
969 (m), 878 (m), 819 (m), 784 (m). LR-MS (EI, 70 eV): 
m/z (%) = 310 (M+, 2.78), 251 (9.6), 236 (19.03), 222 
(2.21), 208 (4.04), 180 (1.59), 166 (1.58), 152 (3.61), 124 
(7.51), 110 (9.85), 96 (19.25), 82 (36.71), 68 (22.16), 55 
(44.81), 41 (61.57), 29 (27.42), 18 (100). HR-MS (EI, 70 eV): Calcd. 310.2144, Found 
310.2140. Elemental Analysis: Calcd. % C 69.64, % H 9.74, Found % C 69.7, % H 
9.9. 
 
 
Preparation of ethyl 12-hydroxy-15-oxo-bicyclo[9.3.1]hexadecan carboxylate (190) 
R 116 Amounts: 
 2.0 g (7.88 mmol)  ethyl 2-oxo-cyclotridecane carboxylate   
     (186) 
 1.2 g (7.88 mmol)  DBU 
 0.4 g (7.88 mmol)  acrolein (166) 
 50 ml    EtOH 
Procedure: Analogously to R 77, 18 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane / Et2O (2:1) as eluent giving 1.9 g (6.1 mmol, 78 % yield) of ethyl 
12-hydroxy-15-oxo-bicyclo[9.3.1]hexadecan carboxylate 
(190) (C19H32O4, 324.45 g/ mol) as a mixture of two 
diastereoisomers in a ratio of 1:1 (detected by NMR analysis 
with respect to the CH2CH3). 0.6 g (1.8 mmol, 23 % yield) of 
compound 190 is isolated as a single diastereoisomer by 
recrystallization from Et2O. Spectroscopic data: 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 4.17, 4.12 (q, 2H, 3J = 7.2 
Hz, CH2CH3), 3.50 (m, 1H, CH), 2.61 (m, 1H, CH2), 2.14 (m, 3H, CH), 1.84 (m, 6H, 
CH2), 1.56-1.34 (m, approx. 11H, CH2), 1.24, 1.22 (t, 3H, 3J = 7.2 Hz, CH2CH3), 1.07 
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(m, 5H, CH2). 13C-NMR (125 MHz, CDCl3): δ [ppm] = 208.02 (CO), 172.65 (CO), 
73.70 (CH), 60.96 (CH2CH3), 60.84 (Cq), 55.25 (CH), 33.90 (CH2), 30.70 (CH2), 30.13 
(CH2), 29.95 (CH2), 27.14 (CH2), 26.88 (CH2), 26.33 (CH2), 25.77 (CH2), 25.26 (CH2), 
24.85 (CH2), 23.11 (CH2), 22.99 (CH2), 14.07 (CH2CH3). IR (neat): ν  [cm-1] = 3435 
(s), 2975 (s), 2930 (s), 2861 (s), 1734 (s), 1711 (s), 1446 (m), 1380 (s), 1250 (m), 1184 
(s), 1119 (m). LR-MS (EI, 70 eV): m/z (%) = 324 (M+, 9.65), 196 (7.41), 98 (9.16), 84 
(45.07), 81 (30.48), 56 (50.70), 42 (20.39), 29 (84.32), 18 (43.99), 15 (6.650). HR-MS 
(EI, 70 eV): Calcd. 324.2301, Found 324.5303. 
 
 
Preparation of methyl 13-methyl-12-hydroxy-15-oxo-bicyclo[9.3.1]hexadecan 
carboxylate (191) 
R 117 Amounts: 
 2.0 g (7.88 mmol)   ethyl 2-oxo-cyclotridecane carboxylate  
      (186) 
 1.2 g (7.88 mmol)   DBU 
 0.4 g (7.88 mmol)   methacrolein (169) 
 50 ml     MeOH 
Procedure: Analogously to R 77, 18 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent giving 1.7 g (5.3 mmol, 68 % yield) of a 
mixture of diastereoisomers in a ratio of 1:3:8:2 detected by 1HNMR analysis (ratio 
calculated with respect to CH3) of methyl 12-hydroxy-13-
methyl-15-oxo-bicyclo[9.3.1]hexadecan carboxylate (191) 
(C19H32O4, 324.45 g / mol) as colorless crystal. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 3.66, 3.64 (s, 3H, CH3), 3.55 (m, 1H, CH), 2.95 
(m, 2H, CH), 2.88, 2.85 (d, 1H, 3J = 5.4 Hz, CH), 2.60 (m, 
5H, CH2), 2.11-1.01 (m, approx. 18H, CH2), 1.06, 0.95 (d, 
3H, 3J = 6.9 Hz, CH3), 1.02 (m, 5H, CH2). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 210.51, 208.07 (CO), 173.23, 173.14 (CO), 78.50, 76.45 
(CH), 61.31, 60.87 (Cq), 54.06, 53.25, 51.92 (CH3 / CH), 39.15, 38.38 (CH2), 35.96 
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(CH2), 34.40 (CH2), 35.18, 33.00 (CH), 30.08 (CH2), 27.07 (CH2), 26.75, 26.68 (CH2), 
26.39 (CH2), 25.18 (CH2), 25.67 (CH2), 25.18 (CH2), 23.12 (CH2), 23.03 (CH2), 17.81, 
15.21 (CH3).  IR (neat), ν [cm-1] = 3512 (s), 2928 (s), 2857 (s), 1739 (s), 1711 (s), 1459 
(m), 1369 (w), 1247 (m), 1121 (s), 1055 (m). LR-MS (EI, 70 eV): m/z (%) = 324 (M+, 
20.32), 306 (13.21), 82 (11.52), 68 (14.77), 54 (12.12), 41 (100), 29 (37.17), 18 (69). 
HR-MS (EI, 70 eV): Calcd. 324.2301, Found 310.2140. 
 
 
Preparation of methyl 14-methyl-12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan 
carboxylate (192) 
R 118 Amounts: 
 2.0 g (7.88 mmol)  ethyl 2-oxo-cyclotridecane carboxylate (186) 
 1.2 g (7.88 mmol)  DBU 
 0.4 g (7.88 mmol)  crotonic aldehyde (170) 
 50 ml    MeOH 
Procedure: Analogously to R 77, 18 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent giving 1.5 g (4.8 mmol, 62 % yield) of methyl 
14-methyl-12-hydroxy-15-oxo-bicyclo[9.3.1]hexadecan carboxylate (192) (C19H32O4, 
324.45 g / mol) as a mixture of two diastereoisomers in a of ratio of 1:1.37 detected by 
1HNMR analysis (ratio calculated with respect to CH3). Spectroscopic data: 1H-NMR 
(500 MHz, CDCl3): δ [ppm] = 3.73, 3.66 (s, 3H, CH3), 
3.69 (m, 1H, CH), 2.78 (m, 2H, CH), 2.58 (m, 3H, CH2), 
2.23 (m, 2H, CH2), 2.62 – 2.36 (m, 4H, CH2), 2.04-1.57 
(m, 4H, CH2), 1.45 (m, 2H, CH2), 0.87 (d, 3H, 3J = 1.9 
Hz, CH3), 0.80 (d, 3H, 3J = 2.7 Hz, CH3). 13C-NMR (125 
MHz, CDCl3): δ [ppm] = 209.27, 208.05 (CO), 171.08 
(CO), 72.22, 71.34 (CH), 65.81, 65.46 (Cq), 54.56, 
53.56(CH3 / CH), 52.03, 51.56 (CH / CH3), 38.83 (CH2), 38.22 (CH2), 33.99 (CH2), 
33.09 (CH2), 33.82, 30.84 (CH), 28.36 (CH2), 27.11 (CH2), 26.84 (CH2), 26.77, 26.66 
(CH2), 26.57 (CH2), 26.33 (CH2), 25.79, 25.65 (CH2), 25.04 (CH2), 24.91 (CH2), 23.06 
(CH2), 22.79 (CH2), 16.10, 15.99 (CH3). IR (neat): ν   [cm-1] = 3512 (s), 2928 (s), 2857 
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(s), 1739 (s), 1711 (s), 1459 (m), 1369 (w), 1247 (m), 1121 (s), 1055 (m). LR-MS (EI, 
70 eV): m/z (%) = 324 (M+, 3.68), 98 (9.36), 84 (61.45), 70 (5.78), 59 (18.32), 31 
(100), 29 (74), 18 (22.69), 15 (7.77). HR-MS (EI, 70 eV): Calcd. 324.2301, Found 
324.2283. 
 
 
R 119: To a 50 ml of dry EtOH, 360 mg (16.0 mmol) of Na is added slowly under 
stirred at 0°C. The suspension is stirred until Na is completely dissolved. Then, 
carefully a solution of 4.0 g (15 mmol) of ethyl 2-oxo-cyclododecane carboxylate (72) 
is added, the solution is stirred for 1 h and, finally, a solution of 2.0 ml (0.8 g 15 mmol) 
of acrolein (166) is added. The whole solution is, then, stirred at RT for 18 h. A solution 
of 40 ml of acetic acid is added until Na is completely reacted and the excess of acetic 
acid is removed with a solution of 50 ml of sodium carbonate. The organic layer is 
separated and the aqueous phase is extracted with diethylether (3 x 30 ml). The 
combined organic layers are dried over anhydrous MgSO4 and the solvent is removed in 
vacuum. A mixture of ethyl 12-hydroxy-15-oxo-bicyclo[9.3.1]pentadecan carboxylate 
(174) (C19H32O4, 324.24 g / mol) and ethyl 15-oxo-bicyclo[9.3.1]pentadec-11-ene 
carboxylate (177) (C18H28O3, 292.20 g / mol) is obtained in a ratio of 1.6:1 detected by 
NMR. The products are separated by column chromatography on alumina N (III), 
cyclohexane / Et2O (2:1) giving 2.7 g (8.4 mmol, 56 % yield) of compound 174 and 1.3 
g (4.5 mmol, 30 % yield) of  compound 177. 
Spectroscopic data of ethyl 15-oxo-bicyclo[9.3.1]pentadec-11-ene carboxylate (174) 
are consistent with those reported in R 82. Spectroscopic data of ethyl 15-oxo-
bicyclo[9.3.1]pentadec-11-ene carboxylate (177) are consistent with those reported in R 
83.  
 
 
R 120 Amounts: 
 4.0 g (15.0 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 360 mg (15.0 mmol)   Na
 0.8 g (15.0 mmol)   methacrolein (169) 
 50 ml     abs. MeOH  
  193
   Experimental part 
Procedure: Analogously to R 119, 18 hours, room temperature. 
After removing of the solvent the crude mixture is consistent of methyl 12-hydroxy-15-
oxo-bicyclo[9.3.1]pentadecan carboxylate (188) (C19H32O4, 310.45 g / mol) and methyl 
15-oxo-13-methyl-bicyclo[9.3.1]pentadec-11-ene carboxylate 
(193) (C18H28O3, 292.20 g / mol) in 54 and 46% yield, 
respectively (NMR-calculated with respect to the CH3). 
Spectroscopic data of methyl 13-methyl-15-oxo-
bicyclo[9.3.1]pentadec-11-ene carboxylate (193) are assigned 
by the most significant signals: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 6.63 (s, 1H, CH) 13C-NMR (100 MHz, CDCl3): 
δ [ppm] = 201.54 (CO), 143.01 (Cq), 137.49 (CH). 
Spectroscopic data of compound 188 are consistent with those reported in R 114 
 
 
R 121 Amounts: 
 4.0 g (15.0 mmol)   ethyl 2-oxo-cyclododecane carboxylate (72) 
 360 mg (15.0 mmol)   Na 
 0.8 g (15.0 mmol)   crotonic aldehyde (170) 
 50 ml     abs. EtOH 
Procedure: Analogously to R 119, 18 hours, room temperature. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (2:1) as eluent giving 2.9 g (10.2 mmol, 68 % yield) of ethyl 
15-oxo-13-methyl-bicyclo[9.3.1]pentadec-11-ene carboxylate (183) (C18H28O3, 292.20 
g / mol). Spectroscopic data are consistent with those reported in R 99. 
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4.6. Preparation of tricyclic compounds starting from bicyclic 
compounds 
4.6.1. Preparation of starting material 
Preparation of methyl 12-allyl-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (197) 
R 122: To a solution of 1.6 g (6.55 mmol) of methyl 15-oxo-bicyclo[9.3.1]pentadec-11-
ene carboxylate (184) in 30 ml of dry dichloromethane under argon is added a solution 
of 0.7 ml TiCl4 (101) (1.2 g, 6.55 mmol) in 20 ml of abs dichloromethane dropwise with 
a syringe. After additional stirring for 30 min., 1.23 ml of allyltrimethylsilane (62) (0.8 
g, 7.8 mmol) in 15 ml of abs. dichloromethane is added from a dropping funnel at –
78°C and the mixture is stirred for 16 hours. 50 ml of water and, under stirring, 
carefully, a solution of sodiumhydrogenocarbonate is added to the mixture which is 
subsequently extracted with diethylether (3 x 30 ml). The organic layer is washed with 
water, dried over MgSO4 and concentrated at reduced 
pressure. The residue is subjected to silica gel column 
chromatography using as eluent a solution of 
cyclohexane - diethylether (10:1) yielding 2.0 g (6.2 
mmol, 96 % yield) of methyl 12-allyl-15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (197) 
(C20H32O3, 320.49 g / mol). Spectroscopic data: 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 5.74 (ddd, 1H, 3J = 16.3 Hz, 3J = 10.2 Hz, 3J = 
7.2 Hz, CH=CH2), 4.99 (m, 2H, CH=CH2), 3.67 (m, 1H, CH), 3.71 (s, 3H, CH3), 2.30 
(m, 2H, CH2), 2.15 (m, 4H, CH2), 1.96 (m, 6H, CH2), 1.60 (m, 5H, CH2), 1.36-1.26 (m, 
approx. 3H, CH2), 0.80 (m, 5H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 211.38 
(CO), 174.22 (CO), 135.96 (CH=CH2), 116.70 (CH=CH2), 61.18 (Cq), 55.11 (CH3 / 
CH), 52.03 (CH3 / CH), 41.43 (CH3 / CH), 38.10 (CH2), 36.40 (CH2), 31.79 (CH2), 
30.12 (CH2), 26.36 (CH2), 25.73 (CH2), 24.18 (CH2), 23.05 (CH2), 21.91 (CH2), 21.49 
(CH), 20.48 (CH2), 20.19 (CH2). IR (KBr): ν  [cm-1] = 3034 (w), 2942 (s), 2915 (s), 
2864 (s), 1739 (s), 1703 (s), 1470 (m), 1433 (m), 1310 (m), 1298 (m), 1073 (m), 1063 
(m), 969 (m), 878 (m), 819 (m), 784 (m). 
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Conversion of methyl 12-enyl-15-oxo-bicyclo[9.3.1]pentadecan carboxylate (200). 
R 123: 14.7 ml of vinyl bromide (198) (0.8g, 11.7 mmol) in 30 ml THF are stirred at –
10°C under Argon. 0.8 g of CuI (11.7 mmol) is added to the slurry in one portion. After 
30 min. at –10°C, the mixture is cooled at –78°C. 4 g (11.7 mmol) of methyl 12-enyl-
15-oxo-bicyclo[9.3.1]pentadecan carboxylate (184) in 30 ml of dry THF are added 
dropwise over 30 min. to the reaction mixture. The cooling bath is removed and the 
mixture reaction is warmed to the room temperature. The reaction mixture is added to 
100 ml of a mixture of saturated ammonium chloride:ammonium hydroxide (9:1) and 
200 ml of cyclohexane. The aqueous layer is separated and extracted with cyclohexane 
(3 x 30 ml). The organic layer are individually washed with 9:1 mixture of saturated 
ammonium chloride:ammonium hydroxide until the aqueous phase is no longer blue. 
The organic layers are then washed with 40 ml of water and 30 ml of brine, combined 
and dried over MgSO4. The residue is purified by silica gel chromatography using as a 
solvent a mixture of cyclohexane-diethylether (10:1). Products derived from 
decomposition are recovered. 
 
 
R 124 Amounts: 
 1.0 g (4.5 mmol)  bicyclo[9.3.1]pentadec-11-en-15-one (167) 
 0.8 g (9.13 mmol)  vinylmagnesiumchloride (198)
 0.8 g (4.50 mmol)  CuI 
 50 ml    abs. THF 
Procedure: Analogously to R 123 
After removing of the solvent, 8% conversion of compound 167 is detected by GC-
analysis. 
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4.6.2. Tandem hydroformylation / aldol addition. 
Preparation of methyl 18-hydroxy-19-oxo-tricyclo[9.7.1.01.14]nonadecan-11-
carboxylate (201). 
R 125 Amounts: 
 2.0 g (6.25 mmol)  methyl 12-allyl-15-oxo-bicyclo[9.3.1]pentadecan 
     carboxylate (197) 
 20.1 mg (1 mmol %)  Rh(acac)(CO)2 
 16.3 mg (4 mmol %)  BIPHEPHOS (16) 
 24.7 mg (5 mmol %)  p-TsOH 
 50 ml    abs. CH2Cl2
Procedure: Analogously to R 18. 
After removing of the solvent the crude mixture is filtered on pad of alumina N (III) 
using cyclohexane/ Et2O (10:1) as eluent giving 946 mg (2.6 mmol, 43 % yield) of 
methyl 18-hxdroxy-19-oxo-tricyclo[9.7.1.01.14]nonadecan-11-carboxylate (201) 
(C21H34O4, 350.491 g / mol). Spectroscopic data: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 4.1 (s, 1H, OH), 3.71 (s, 3H, CH3), 2.4 (m, 3H, CH), 2.15 (m, 8H, CH2), 2.10 
(d, 2H, 3J = 4.2 Hz, CH2), 1.96-1.36 (m, approx. 9H, 
CH2), 1.26-1.15 (m, approx. 8H, CH2). 13C-NMR (100 
MHz, CDCl3): δ [ppm] = 210.16 (CO), 174.61 (CO), 
67.52 (CH), 61.08 (Cq), 60.82 (Cq), 52.81 (CH), 38.31 
(CH), 32.73 (CH2), 30.07 (CH2), 28.45 (CH2), 27.51 
(CH2), 27.48 (CH2), 26.78 (CH2), 26.78 (CH2), 23.74 
(CH2), 23.66 (CH2), 23.60 (CH2), 23.46 (CH2), 23.22 
(CH2), 23.14 (CH2), 19.77 (CH2). IR (neat): ν [cm-1] = 3514 (s), 2942 (s), 2915 (s), 
2864 (s), 1739 (s), 1703 (s), 1470 (m), 1433 (m), 1310 (m), 1298 (m), 1073 (m), 1063 
(m), 969 (m), 878 (m), 819 (m), 784 (m). Elemental analysis: Calcd. % C 71.96, % H 
9.78, Found % C 72.0, % H 10.3. 
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4.7. Fragmentation reaction and rings expansion methods 
4.7.1. Baeyer-Villiger oxidation 
Oxidation of 12-hydroxy-bicyclo[9.4.1]pentadecan-16-one (50) 
R 126:  A solution of 1.0 g (3.96 mmol) of 12-hydroxy-
bicyclo[9.4.1]pentadecan-16-one (50) in abs. chloroform is added to a solution of 0.84 g 
(7.56 mmol) of m-chloroperbenzoic acid (212) in 30 ml of abs. CHCl3. The reaction 
mixture is heated at 0°C for 16 hours. Then, the mixture is cooled in ice-water; the 
solvent is removed under vacuum on a rotary evaporator. The residue is taken up in 50 
ml of Et2O, washed three times with 20 ml of aqueous K2CO3 and once with brine 
solution. After drying and removing of the solvent, the white crystalline starting 
material is recovered.  
 
 
R 127 Amounts 
 1.0 g (3.96 mmol)  12-hydroxy-bicyclo[9.41]hexadecane-16-one (50) 
 0.84 g (7.56 mmol)  m-CPBA (212) 
 3.0 g (29.0 mmol)  NaHCO3
 30 ml    abs. CHCl3
Procedure: Analogously to R 126, 20°C, 18h. 
Starting material is recovered. 
 
 
Preparation of bicyclo[9.4.1]hexadec-12-en-16-one (96) 
R 128:  1.0 g (3.96 mmol) of 12-hydroxybicyclo[9.4.1]hexadecan-16-one (50) is 
dissolved in 40 ml of toluene and 20 ml of H2SO4 (98%) are added dropwise at a 
moderate rate with mechanical stirred. The mixture is stirred at room temperature for 20 
hours. The brown resulting suspension is poured onto cracked ice and the mixture is 
treated with a solution of Na2CO3. The organic extracted with diethylether are dried 
over MgSO4 and the solvent is removed under reduced pressure. Filtration on alumina 
N (III), cyclohexane / Et2O (5:1) purifies the crude product. 140 mg (0.6 mmol, 15 % 
yield) of bicyclo[9.4.1]hexadec-12-en-16-one (96) (C16H26O, 234.38 g / mol) as a white 
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solid compound are obtained. Its spectroscopic characteristics are consistent with those 
reported in R 39. 
 
 
R 129:  1.2 g (4.7 mmol) of 12-hydroxy bicyclo[9.4.1]hexadecan-16-one (50) is 
dissolved in 40 ml of toluene and 6.5 g (32.9 mmol) of p-TsOH are added. The mixture 
is stirred at room temperature for 20 hours. The reaction mixture is treated with 30 ml of 
a solution of Na2CO3. The organic extracted with diethylether are dried over MgSO4 
and the solvent is removed under reduced pressure. Filtration on alumina N (III), 
cyclohexane / Et2O (5:1) purifies the crude mixture. 384 mg (1.6 mmol, 35 % yield) of 
bicyclo[9.4.1]hexadec-12-en-16-one (96) (C16H26O, 234.42 g / mol) as a white solid 
compound are obtained. Its spectroscopic characteristics are consistent with those 
reported in R 39. 
 
 
R 130:  1.0 g (3.96 mmol) of 12-hydroxy bicyclo[9.4.1]hexadecan-16-one (50) is 
dissolved in 50 ml of pyridine. The solution is cooled in an ice bath and stirred 
magnetically while 3.3 ml (5.3 g, 44 mmol) of thionyl chloride is added dropwise at a 
slow rate. The mixture is stirred for 12 hours as it warmed to ambient temperature. The 
brown resulting suspension is poured onto ice-water and the mixture is acidified with 20 
ml of cold mixture of HCl (20 %). The organic extracted are dried over MgSO4 and the 
solvent is removed under reduced pressure. By GC analysis only 25 % conversion in 
bicyclo[9.4.1]hexadec-12-en-16-one (96) (C16H26O, 234.42 g / mol) is observed. Its 
spectroscopic characteristics are consistent with those reported in R 39. 
 
 
R 131:  0.5 g (1.93 mmol) of 12-hydroxybicyclo[9.4.1]hexadecan-16-one (50) is 
dissolved in 80 ml of toluene and 1.82 g (1.93 mmol) CuSO4 / silica  (the catalyst is 
prepared from a mixture of one part of copper (II) sulfate pentahydrate and three parts 
of silica gel (by being dried at 240°C for 1 hour gel) is added. The mixture is heated at 
reflux with stirring for 20 hours. After cooling, the catalyst is removed by filtration. The 
solvent is removed under reduced pressure and starting material is recovered. 
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R 132:  0.54 g (3.8 mmol) of P2O5 is placed in a flask containing 30 ml of abs. 
toluene under Argon. 0.5 g (1.93 mmol) of 12-hydroxy bicyclo[9.4.1]hexadecan-16-one 
(50) is dissolved in 80 ml of toluene and the solution is added dropwise at a moderate 
rate with mechanical stirred. The mixture is heated at reflux for 18 hours. The P2O5 
formed a dark, viscous deposit on the walls of the flask. The mixture is cooled to room 
temperature and filtered through alumina N (III). After removing of the solvent on the 
rotary evaporator, a mixture of the two isomers are, then, purified by column 
chromatography on alumina N (III), cyclohexane / Et2O (5:1) 649 mg (2.7 mmol, 73 % 
yield) of bicyclo[9.4.1]hexadec-12-en-16-one (96) (C16H26O, 234.42 g / mol) is 
observed. Its spectroscopic characteristics are consistent with those reported in R 39. 
 
 
R 133: Amounts 
 0.5 g (1.93 mmol)  12-hydroxybicyclo[9.4.1]hexadecan-16-one (50) 
 0.54 g (3.8 mmol)  DBU 
 50 ml    EtOH 
Procedure: Analogously to R27, 16 hours, refluxing EtOH. 
After removing of the solvent by rotary evaporator, the crude mixture of the two 
isomers are then purified by column chromatography on alumina N (III), cyclohexane/ 
Et2O (5:1). 383 mg (1.6 mmol, 85 %) of bicyclo[9.4.1]hexadec-12-en-16-one (96) 
(C16H26O, 234.42 g / mol) is observed. Its spectroscopic characteristics are consistent 
with those reported in R 39. 
 
 
Preparation of bicyclo[9.4.1]hexadecan-16-one (215) 
R 134:  A solution of 1.2 g (8.5 mmol) of bicyclo[9.4.1]hexadecan-12-ene-16-
one (96) in ethylacetate is hydrogenated over 300 mg Pd - C (10 % mmol) at room 
temperature and atmospheric pressure. The uptake of hydrogen ceased after 18 hours. 
The mixture is filtered from catalyst. Evaporation of the solvent furnish 1.3 g (5.4 
mmol, 64 % yield) of bicyclo[9.4.1]hexadecan-16-one (215) (C16H28O, 236.40 g / mol) 
as a white solid. Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ  [ppm] = 2.93-
2.86 (dd, 2H, 3J = 11.80 Hz, 3J = 2.76 Hz, CH), 2.24 (m, 3H, CH2), 1.90 (m, 4H, CH2), 
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1.70 (m, 4H, CH2), 1.60-1.51 (m, 4H, CH2), 1.25 (m, 8H, CH2), 
0.8 (m, 3H, CH2). 13C-NMR (100 MHz, CDCl3): δ  [ppm] = 
218.70 (CO), 55.58 (CH), 44.57 (CH), 35.90 (CH2), 32.12 (CH2), 
31.64 (CH2), 31.60 (CH2), 30.58 (CH2), 27.27 (CH2), 26.86 
(CH2), 26.10 (CH2), 24.24 (CH2), 23.70 (CH2), 23.05 (CH2), 
21.73 (CH2), 21.63 (CH2). IR (neat): ν   [cm-1] = 2927 (s), 2858 
(s), 1708 (s), 1632 (w), 1604 (w), 1138 (w), 729 (m). LR-MS 
(EI, 70 eV): m/z (%) = 236 (M+, 18), 207 (100), 191 (17), 179 (15), 147 (25), 119 (18), 
98 (40), 73 (58), 67 (25), 55 (38). 
 
 
Attempted oxidation of bicyclo[9.4.1]hexadecan-16-one (215) 
R 135: 1.0 ml (1.1 g, 15.0 mmol) of peracetic acid (217) is added to a cooled solution of 
1.0 g (4.6 mmol) of bicyclo[9.4.1]hexadecan-16-one (215) in dichloromethane 
containing 0.6 g of NaHCO3. The resulting mixture is stirred at 0°C for 10 hours, 
washed with 30 ml of a solution of saturated aqueous NaHSO3, The organic extracted 
with diethylether are dried over MgSO4. After removing of the solvent, starting material 
is recovered. 
 
 
R 136 Amounts: 
 0.8 g (3.38 mmol)  bicyclo[9.4.1]hexadecan-16-one (215) 
 0.77 g (4.56 mmol)  m-CPBA (212) 
 43 mg (0.4 mmol)  NaHCO3 
 30 ml    abs. CHCl3
Procedure: Analogously to R 126, 20 hours, room temperature. 
After removing of the solvent, starting material is recovered. 
 
 
R 137 Amounts: 
 0.8 g (3.38 mmol)  bicyclo[9.4.1]hexadecan-16-one (215) 
 0.77 g (4.56 mmol)  m-CPBA (212) 
O
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 43 mg (0.4 mmol)  NaHCO3 
 30 ml    abs. CHCl3
Procedure: Analogously to R 126, 48 hours, refluxing. 
After removing of the solvent, starting material is recovered. 
 
 
R 138 Amounts: 
 1.0 g (4.6 mmol)  bicyclo[9.4.1]hexadecan-16-one (215) 
 2.0 g (27.4 mmol)  peracetic acid (217) 
 0.4 g (3.0 mmol)  BF3·OEt2
 30 ml    abs. CH3CCl3
Procedure: Analogously to R 126, 5 days, 50°C. 
After removing of the solvent, starting material is recovered. 
 
 
Baeyer Villiger of bicyclo[9.3.1]pentadecane derivatives 
Preparation of ethyl 15-oxo-bicyclo[9.3.1]pentadecan carboxylate (219) 
R 139 Amounts: 
 1.0 g (4.27 mmol)  ethyl bicyclo[9.3.1]pentadecan-11-ene-15-one- 
     carboxylate (177) 
 300 mg   Pd / C
 50 ml    EtOAc 
Procedure: Analogously to R 134 
Evaporation of solvent furnish 0.9 g (3.1 mmol, 74 % yield) ethyl 15-oxo-
bicyclo[9.3.1]pentadecan carboxylate (219) (C18H28O3, 
294.42 g / mol) in a ratio of 1:1 detected 1HNMR (ratio 
calculated with respect to CH2CH3) as a white solid 
compound. Spectroscopic data: 1H-NMR (400 MHz, 
CDCl3): δ [ppm] = 4.11, 4.09 (q, 2H, 3J = 7.0 Hz, 
CH2CH3), 2.80 (dd, 1H, 3J = 12.0 Hz, 3J = 3.51 Hz, CH), 
2.43-2.40 (m, 1H, CH2), 2.38-2.34 (dd, 1H, 3J = 11.5 Hz, 3J 
= 3.5 Hz, CHH), 2.36-2.34 (dd, 1H, 3J = 9.0 Hz, 3J = 2.5 Hz, CHH), 1.97 (ddd, 4H, 3J = 
COOEt
O
219
  202
   Experimental part 
12.5 Hz, 3J = 5.7 Hz, 3J = 5.0 Hz, CH), 1.80 (m, 3H, CH), 2.03-1.91 (m, 3H, CH2), 1.88-
1.58 (m, 4H, CH2), 1.45-1.05 (m, 4H, CH2), 1.20, 1.19 (t, 3H, 3J = 7.0 Hz, CH2CH3), 
0.86 (m, 3H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 211.10 (CO), 173.64 
(CO), 61.72 (Cq), 60.71 (CH2CH3), 52.15, 49.88 (CH), 40.27, 39.64 (CH2), 36.09 (CH2), 
35.68 (CH2), 32.30 (CH2), 30.64 (CH2), 28.27 (CH2), 26.34, 26.36, (CH2), 26.91, 25.78 
(CH2), 24.32 (CH2), 23.12 (CH2), 21.39 (CH2), 20.26, 20.24 (CH2), 17.33 (CH2), 14.12 
(CH2CH3). IR (neat): ν  [cm-1] = 2929 (s), 2865 (s), 1735 (s), 1697 (s), 1469 (m), 1445 
(s), 1240 (m), 1178 (m), 1152 (w), 1121 (w). LR-MS (EI, 70 eV): m/z (%) = 294 (M+, 
92.32), 220 (33.85), 170 (100), 122 (11.77), 95 (23.34), 81 (30.72), 55 (81.02), 41 
(90.91), 29 (31.91). HR-MS (EI, 70eV): Calcd. 294.2195, Found 294.2169. 
 
 
R 140 Amounts: 
 1.0 g (1.26 mmol)  ethyl 15-oxo-bicyclo[9.3.1]pentadecan carboxylate 
     (219) 
 0.9 g (9.2 mmol)  NaHCO3 
 300 mg   m-CPBA (212) 
 20 ml    abs. CHCl3
Procedure: Analogously to R 127. 
Starting material is recovered. 
 
 
Preparation of bicyclo[9.3.1]pentadecan-16-one (218) 
R 141 Amounts: 
 2.2 g (10.0 mmol)  bicyclo[9.3.1]pentadec-1-(14)-en-15-one (167)  
 300.0 mg   Pd / C
 50 ml    EtOAc 
Procedure: Analogously to R 134 
Evaporation of the solvent furnished 2.1 g (9.6 mmol, 96 % yield) of 
bicyclo[9.3.1]pentadecan-15-one (218) (C15H26O, 222.36 g / mol) as a white solid. 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ   [ppm] = 2.80 (dd, 1H, 3J = 11.8 
Hz, 3J = 3.5 Hz, CH), 1.97 (m, 4H, CH), 1.98-1.94 (m, 1H, CH), 1.90-1.82 (m, 2H, 
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CH2), 1.77-1.64 (m, 3H, CH2), 1.38-1.31 (m, 4H, CH2), 1.45-1.05 (m, 3H, CH2), 1.28-
1.06 (m, 8H, CH2). 13C-NMR (100 MHz, CDCl3): δ [ppm] = 
216.12 (CO), 52.22, 50.88 (CH), 39.69 (2 x CH2), 33.23 (CH2), 
32.58 (CH2), 28.32 (2 x CH2), 26.87, 26.42 (CH2), 25.97, 25.84 
(CH2), 24.75, 24.49 (CH2), 22.69, 22.44 (CH2), 21.21 (2 x CH2), 
16.84 (CH2). LR-MS (EI, 70 eV): m/z (%) = 222 (M+, 16.71), 96 
(6.21), 81 (15.95), 67 (29.79), 55 (62.14), 41 (100), 29 (33.06). 
HR-MS (EI, 70 eV): Calcd. 222.1984, Found 222.1987. Elemental analysis: Calcd. % 
C 81.02, % H 11.79, Found % C 81.0, % H 11.9. 
 
 
R 142 Amounts: 
 1.0 g  (4.54 mmol)  bicyclo[9.3.1]pentadecan-16-one (218) 
 1.5 g  (9.0 mmol)  m-CPBA (212) 
 70.0 mg (0.4 mmol)  Na2CO3
Procedure: Analogously to R 127 
Starting material is recovered. 
 
 
4.7.2. Fragmentation reaction under acetalization conditions 
Attempted conversion of 3-(2-oxo-cyclododecyl)propanal (145) 
R 143 Amounts  
 1.0 g (3.8 mmol)  3-(2-oxocyclododecyl)propanal (145) 
 1 ml (26 mmol)  BF3·OEt2
 3.27ml (19 mmol)  Ethylene glicol 
 80 ml    EtOH 
Procedure: Analogously to R 138, 16 hours, room temperature. 
Column chromatography on alumina N (III), cyclohexane / Et2O (3:1) purify the 
product 168 giving 636 mg (2.4 mmol, 63 % yield) of 12-
hydroxybicyclo[9.3.1]pentadecan-16-one (168) (C15H26O2, 238.37 g / mol) as a white 
solid. Spectroscopic data are consistent with R 74 
   Experimental part 
4.7.3. Grob fragmentation 
Preparation of 16-oxo-bicyclo[9.4.1]hexadec-2-yl-4-methylbenzenesulfonate (238) 
R 144: A solution of 3.0 g (11.6 mmol) of 12-hydroxy-bicyclo[9.4.1]hexadecan-16-one 
(50) in 30 ml dry of dichlomethane is added to 3.0 ml (2.1 g, 21.0 mmol) of 
triethylamine in 20 ml of dichloromethane at 0°C. The mixture is treated with a solution 
of 2.0 g (10.2 mmol) of tosylchloride (237) over a period of 20 min. The solution is 
stirred for 72 h at room temperature, then diluted with CH2Cl2, washed with cold water, 
10 ml of a solution of HCl (10 %), saturated with a solution of Na2CO3, and brine. The 
organic layer is separated, the aqueous phase is extracted with Et2O (3 x 30 ml), dried 
over MgSO4 and the solvent is removed under reduced pressure. Recrystallisation from 
cyclohexane gives 4.1 g (10.1 mmol, 87 % yield) of 16-oxo-bicyclo[9.4.1]hexadec-2-yl-
4-methylbenzenesulfonate (238) as a white solid (C23H34O4S, 406.58 g / mol). 
 Spectroscopic data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 7.93 (d, 1H, 3J = 8.5 
Hz, CH), 7.83 (d, 1H, 3J = 8.2 Hz, CH), 7.42 (d, 1H, 3J = 8.2 Hz, CH), 7.39 (d, 1H, 3J = 
8.2 Hz, CH), 4.64 (d, 1H, 3J = 9.2 Hz, CH), 2.79 (dd, 1H, 3J = 11.8 
Hz, 3J = 2.52 Hz, CH), 2.51 (s, 3H, CH3), 1.98 (m, 1H, CH2), 1.78-
1.71 (m, 2H, CH2), 1.62-1.48 (m, 4H, CH2), 1.41-1.10 (m, approx. 
11H, CH2) 1.08-0.95 (m, 6H, CH2). 13C-NMR (125 MHz, CDCl3): 
δ [ppm] = 214.31 (CO), 144.96 (CH), 146.78 (CH), 130.20 (CH), 
129.84 (CH), 127.75 (CH), 127.02 (CH), 85.37 (CH), 61.33 (CH), 
46.17 (CH), 36.48 (CH2), 34.30 (CH2), 31.66 (CH2), 27.70 (CH), 27.26 (CH2), 26.63 
(CH2), 26.42 (CH2), 23.90 (CH2), 23.53 (CH2), 22.35 (CH2), 21.80 (CH3), 21.63 (CH2), 
21.43 (CH2). IR (neat): ν [cm-1] = 3047 (w), 2928 (s), 2898 (s), 2862 (s), 2846 (s), 
2364 (w), 1930 (w), 1702 (s), 1595 (m), 1469 (m), 1369 (s), 1191 (s), 1174 (s), 1093 
(m), 964 (m), 814 (s), 668 (s), 553 (s). LR-MS (EI, 70 eV): m/z (%) = 190 (M-189), 91 
(100), 63 (8.84), 39 (9.50), 27 (2.01). 
 
 
 
 
 
O
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Preparation of 1-cyclopentadec-5-enyl-methanol (239) 
R 145:  A solution of 2.0 g (6.0 mmol) of toluene-4-sulfonic acid-16-oxo-
bicyclo[9.4.1]hexadec-12-yl-ester (238) in 25 ml of THF is treated with 0.8 g (21 
mmol) of LiAlH4. The resulting suspension is heated at reflux for 16 hours, and then 
cooled. 100 ml of water (carefully) is added, and then HCl (conc.) is added until a clear 
solution is obtained. The solution is extracted with Et2O (3 x 30 ml). The combined 
ether layers are dried over MgSO4, the solvent removed to leave a crude product. 
Recrystallization from cyclohexane yielded 1.2 g (5.2 mmol, 88 % yield) 
cyclopentadec-5-en-1-ylmethanol (239) (C16H30O, 238.41 g / mol). 
Spectroscopic data: 1H-NMR (400 MHz, CDCl3): δ [ppm] = 5.32 (ddd, 2H, 3J = 5.2 
Hz, 3J = 2.7 Hz, 3J = 2.5 Hz, CH), 3.51 (dd, 1H, 3J = 10.5 Hz , 3J = 4.7 Hz, CHH), 3.43 
(dd, 1H, 3J = 10.5 Hz , 3J = 6.2 Hz, CHH), 2.10-2.00 (m, 4H, 
CH2), 1.95-1.880 (m, 4H, CH2), 1.51-1.11 (m, approx. 18H, CH2). 
13C-NMR (100 MHz, CDCl3): δ  [ppm] = 131.31 (CH), 130.85 
(CH), 66.00 (CH2), 39.46 (CH), 31.66 (CH2), 31.56 (CH2), 29.86 
(CH2), 28.09 (CH2), 27.89 (CH2), 27.07 (CH2), 26.90 (CH2), 26.90 
(3 x CH2), 26.15 (CH2), 25.37 (CH2). IR (neat): ν [cm-1] = 3338 
(bs), 2928, (s), 2861 (s), 1468 (s), 1443 (s), 1260 (s), 1021 (s), 799 (s). LR-MS (EI, 70 
eV): m/z (%) = 238 (M+, 29.96), 220 (52.66), 136 (26.13), 122 (11.94), 108 (17.81), 94 
(46.65), 80 (97.29), 66 (7.70), 55 (100). HR-MS (EI, 70 eV): Calcd. 238.2297, Found: 
239.4309. 
 
 
Preparation of 12-iodo-14-methylbicyclo[9.4.1]hexadecan-16-one (241) 
R 146:  To 50 ml of dry dichloromethane are added in order: 2.0 g (11.2 mmol) 
of triphenylphosphine, 0.7 g (11.2 mmol) of imidazole and 2.8 g (11.2 mmol) of iodine 
(240). A solution of 2.0 g (7.51 mmol) of 12-hydroxy-14-methyl-
bicyclo[9.4.1]hexadecan-16-one (97) in dry dichloromethane is added and the mixture is 
stirred at room temperature under for 18 hours. When the reaction is completed, most of 
the solvent is removed under vacuum and the product is purified by passing it through a 
column silica gel with pentane as solvent and combining the fractions containing the 
product. After removing of solvent 2.4 g (6.3 mmol, 85 % yield) of 12-iodo-14-
OH
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methylbicyclo[9.4.1]hexadecan-16-one (C17H29IO, 376.31 g / mol) (241). The 
crystalline product is obtained without further purification. Spectroscopic data: 1H-
NMR (400 MHz, CDCl3): δ [ppm] = 4.47 (m, 1H, CH2), 2.50 (m, 1H, CH), 3.15-2.80 
(m, 2H, CH), 2.74-2.640 (m, 1H, CH), 2.46-2.34 (m, 2H, CH), 
2.30 (m, 1H, CH2), 2.29-1.01 (m, approx. 20H, CH2), 0.97 (d, 
3H, 3J = 6.7 Hz, CH3). 13C-NMR (100 MHz, CDCl3): δ [ppm] 
= 211.08 (CO), 53.85 (CH), 51.46 (CH2), 48.18 (CH), 40.55 
(CH2), 40.47 (CH), 32.91 (CH2), 31.98 (CH2), 30.075 (CH), 
27.44 (CH2), 26.631 (CH2), 24.33 (CH3), 24.220 (CH2), 23.28 
(CH2), 22.28 (CH2), 21.70 (CH2), 21.57 (CH2) IR (neat): ν  
[cm-1] = 2940 (s), 2924 (s), 2904 (s), 2862 (s), 1697 (s), 1468 (m), 1255 (m). LR-MS 
(EI, 70 eV): m/z (%) = 249 (M+-I, 100), 231 (3.65), 175 (1.20), 149 (3.73), 135 (6.23), 
109 (10.7), 95 (16.50), 83 (19.84), 69 (21.80), 55 (25.93), 41 (14.57), 29 (2.82). 
Elemental analysis for C17H30OI: Calcd. % C: 54.26, % H: 7.77, Found: % C: 54.7, % 
H: 7.9. 
 
 
Preparation of (3-methylcyclopentadec-5-en-1-yl)methanol (242) 
R 147 Amounts: 
 1.0 g (2.3 mmol)  12-iodo-14-methyl-bicyclo[9.4.1]hexadecan-16- 
     one (241). 
 0.8 g (21.0 mmol)  LiAlH4
 30.0 ml   abs. THF  
Procedure: Analogously to R 145 
After removing of the solvent the crude mixture is consistent of 12-
iodo-14-methylbicyclo[9.4.1]hexadecan-16-one (C17H29IO, 376.31 
g / mol) (241) and (3-methylcyclopentadec-5-en-1-yl)methanol 
(242) (C17H32O, 252.43 g / mol) in a ratio of 2: 1 (NMR-calculated 
with respect to the CH=CH / CH-I). Spectroscopic data of (3-
Methylcyclopentadec-5-en-1-yl)methanol (242) (C17H32O, 252.43 g 
/ mol) are assigned by the most significant signals: 1H-NMR (400 MHz, CDCl3): 
δ [ppm] = 6.32 (m, 2H, CH=CH).13C-NMR (100 MHz, CDCl3): δ [ppm] = 131.73 
O
I
241
OH
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(CH=CH), 128.88 (CH=CH), 66.13 (CH2), 37.93, (CH), IR (neat): ν   [cm-1] = 3440 
(s), 2929 (s), 2857 (s), 1047 (m), 967 (m).  
 
 
Preparation of ethyl 15-oxo-12-iodo-bicyclo[9.3.1]pentadecan carboxylate (243) 
R 148 Amounts: 
 4.0 g (13.0 mmol)  ethyl 15-oxo-bicyclo[9.3.1]pentadecan  
     carboxylate (174) 
 5.4 g (20.0 mmol)  PPh3
 1.3 g (2.0 mmol)  Imidazole 
 5.0 g (11.2 mmol)  I2 (240) 
 30.0 ml   abs. CH2Cl2
Procedure: Analogously to R 146 
After completion of the reaction most of the solvent ie removed under vacuum and the 
product is isolated by passing it through a column of silica gel with pentane as eluent, 
followed by three washings. Combining the fractions and 
evaporation of the solvent gave, without further purification, 
4.8 g (11.6 mmol, 85 % yield) of ethyl 15-oxo-12-iodo-
bicyclo[9.3.1]pentadecan carboxylate (243) (C18H29IO3, 
420.12 g / mol) as a colorless crystal. 
Spectroscopic data: 1H-NMR (500 MHz, CDCl3): 
δ [ppm] = 4.62 (m, 1H, CH), 4.20 (q, 2H, 3J = 6.4 Hz, 
CH2CH3), 2.90 (dd, 2H, 3J = 12.9 Hz, 3J = 4.4 Hz, CH2), 2.70 (m, 2H, CH2), 2.36 (m, 
4H, CH2), 2.16 (m, 1H, CH2), 1.40 (m, 1H, CH2), 1.25 (m, approx. 10 H, CH2), 1.23 (t, 
3H, 3J = 6.4 Hz, CH2CH3), 0.98 (m, 3H, CH2). 13C-NMR (125 MHz, CDCl3): δ [ppm] 
= 205.87 (CO), 171.98 (CO), 61.69 (Cq), 60.43 (CH2CH3), 49.51 (CH), 39.62 (CH), 
34.58 (CH), 32.87 (CH2), 31.97 (CH2), 30.31 (CH2), 26.89 (CH2), 25.82 (CH2), 23.27 
(CH2), 22.69 (CH2), 22.53 (CH2), 21.40 (CH2), 20.62 (CH2), 14.07 (CH2CH3). IR 
(neat): ν  [cm-1] = 2927 (s), 2867 (s), 1745 (s), 1711 (s), 1468 (m), 1437 (m), 1366 (m), 
1279 (m), 1208 (m). HR-MS (FAB): m/z (%) = 421.23 [M+H]+. LR-MS (EI, 70 eV): 
m/z (%): 293 (100), 247 (50.39), 219 (45.70), 109 (23.36), 95 (44.94), 81 (37.65), 67 
(47.10), 55 (42.79), 41 (55.97), 29 (45.11). HR-MS (EI 70 eV): Calcd. 420.1161, 
243
O
I
COOEtH
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   Experimental part 
Found 421.1270. Elemental analysis: Calcd. % C 51.43, % H 6.95, Found % C 51.5, % 
H 6.9. 
 
 
Preparation of 1-hydroxymethyl-bicyclo[9.3.1]pentadecane-15-ol (244) 
R 149 Amounts: 
 1.6 g (3.8 mmol)  ethyl 15-oxo-12-iodo-bicyclo[9.3.1]pentadecan  
     carboxylate (243) 
 2.8 g (7.62 mmol)  LiAlH4
 30 ml    abs. THF 
Procedure: Analogously to R 147 
After removing of the solvent 564 mg (2.22 mmol, 75 % yield) of 1-
(hydroxymethyl)bicyclo[9.3.1]pentadecan-15-ol (244) are obtained without further 
purification (C16H30O2, 254.22 g / mol). Spectroscopic 
data: 1H-NMR (500 MHz, CDCl3): δ [ppm] = 3.75 (d, 
1H, 3J = 10.7 Hz ), 3.48  (t, 2H, 3J = 11.2 Hz, CH2), 2.72 (s, 
OH), 2.25 (m, 3H, CH2), 2.00–1.88 (m, 8H, CH2), 1.78–
1.54 (m, 4H, CH2), 1.51–1.37 (m, 4H, CH2), 1.26–1.09 (m, 
2H, CH2), 0.98-0.88 (m, 4H, CH2). 13C-NMR (125 MHz, 
CDCl3): δ  [ppm] = 82.72 (CHOH), 72.13 (CH2OH), 43.10 
(CH2), 34.87 (CH2), 34.32 (CH), 33.18 (CH2), 29.97 (CH2), 29.85 (CH2), 27.41 (CH2), 
25.79 (CH2), 24.20 (CH2), 23.56 (CH2), 22.66 (CH2), 22.05 (CH2), 21.09 (CH2), 19.84 
(CH2). IR (neat): ν  [cm-1] = 3265 (s), 2927 (s), 2917 (s), 2852 (s), 1473 (m), 1463 (m), 
1086 (m), 1050 (m), 1019 (m). LR-MS (EI, 70 eV): m/z (%) = 236 (M-H2O, 100), 218 
(8.38), 205 (24.48), 109 (13.68), 95 (22.97), 81 (23.83), 67 (20.27), 55 (28.25), 41 
(33.05), 29 (8.08). 
 
244
HO
CH2OHH
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